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The use of nanoparticles (NPs) to enhance the efficacy of different radiotherapy techniques
is investigated by means of Monte Carlo simulation in this PhD project. The dose enhance-
ment of radiation therapy in order to increase the ratio of tumour cell killing to normal
tissue damage is an area of much interest in the medical physics research community. With
increasing spatial and energy modulation of radiotherapy beams, the dose to tumour tissue
can be intensified whilst sparing neighbouring healthy tissue. The advancement in capabil-
ities of beam modulation does however have limitations and this is why methods of dose
escalation preferential to cancerous tumour cells are an interesting area of current research.
Nanoparticle dose enhancement shows great potential for the optimisation of radiation
therapy modalities which is demonstrated in simulations and by experimental evidence. In
order for NP dose enhancement to be applied in a clinical radiotherapy setting, a thorough
fundamental study of the mechanism of dose enhancement is required. The mechanism of
physical dose enhancement of radiation therapy modalities, including conventional X-ray
and proton therapy, is studied by means of Geant4 Monte Carlo simulations presented in
this thesis.
This PhD thesis presents simulation studies on both micro- and nano-scales calculat-
ing dose enhancement from novel ceramic oxide NPs, compared to widely studied, dose
enhancing gold NPs. Customised Geant4 simulations have been developed in this project
to model dose enhancement in water volumes in proximity to various NPs, approximating
the conditions of radiation dose enhancement in cells or tissue. The effect of size, shape,
concentration and distribution of the NPs within a cell volume is investigated by means of
Geant4 simulations.
A Geant4 Monte Carlo simulation has been developed to model the dose distribution and
secondary electron production enhancement in a cell population due to ceramic oxide NPs.
The effect of various NP and simulation parameters including NP type, size, distribution
and photon field energy have been investigated and are presented in this thesis. Results have
shown potential dose enhancement from ceramic oxide NPs and also support and explain
the experimental results obtained by collaborating biological researchers.
The track structure simulation approach is used to calculate radial dose distributions
around various NPs in proton therapy. This is an topic of recent interest to research, poten-
tially combining the dosimetric benefits of proton therapy with the dose enhancing and ra-
diation sensitizing capabilities of high-Z nanoparticles, including ceramic oxide NPs which
are the focus of this PhD project. The dose enhancement effect with respect to proton energy,
NP material, geometry and other simulation factors are presented as well as the simulation
of the secondary electron yield from a C60 NP, compared to the analytical calculation of low
energy electron emission from decay of collective plasmon excitation. The influence and
effect of fundamental physics parameters on simulation results is presented including the
effect of atomic deexcitation and improved interaction cross-sections lowering the energy
range of simulations with more up to date Geant4 versions.
KEYWORDS: External Beam Radiation Therapy, Proton Therapy, Nanoparticles, Monte
Carlo Simulation, Geant4, Dose Enhancement
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Cancer is one of the leading causes of death in the world today [2]. As stated by the World
Health Organisation, in 2012 there were 14 million new cancer cases, and 8 million deaths
related to cancer [2]. This is an issue globally both socially and economically, with cancer
being a leading cause of death across all continents. Cancer occurs when there is uncon-
trolled proliferation of cells within the body.
Approximately 50% of cancer patients are prescribed radiation therapy (also called radio-
therapy) as part of their treatment [3]. Radiotherapy aims to irreparably damage the tumour
cells including cellular DNA or other cell structures [4] which results in cell death (by sev-
eral possible mechanisms) and prevention of cell proliferation by inhibiting the ability of
cells to replicate [4]. The continuous refinement of radiotherapy techniques is an important
area of research in order to increase the survival of patients and at the same time to lower
the chance of negative side effects from radiotherapy treatment. A major issue for consid-
eration in the development of radiation therapy treatments is, therefore, the minimisation
of unwanted damaging radiation dose delivered to normal, healthy tissue in the process of
1
1.1. Introduction 2
delivering a dose sufficient to achieve the goal of tumour control. Damage to normal tissue
can result in collateral effects such as early side-effects which give patients a reduced quality
of life, as well as an increased risk of secondary cancer induction some time after treatment.
The application of nanoparticles (NPs) within a target tumour is a novel proposed method
to enhance the clinical outcomes of radiation therapy by increasing the effectiveness of dose
delivered to the tumour and reducing the probability of normal tissue complications. High
atomic number (high-Z) NPs are currently investigated as possible solutions to improve
the clinical outcome of radiotherapy whilst at the same time reducing the negative side
effects of radiation damage to healthy tissue. This technology consists of embedding NPs
in the tumour, often by means of chemical agents, followed by irradiation. Because of their
high atomic number, the presence of NPs increases the dose delivered to target tumours,
with the possibility of optimising the treatment delivery, eventually reducing the collateral
effects. Therefore, NP enhanced radiation therapy is a current and promising area of research
targeting the improvement of cancer treatment.
This research project is dedicated to the investigation of the dose enhancement produced by
novel ceramic oxides in conventional X-ray radiotherapy and proton therapy. This project
was conducted in collaboration with the University of Wollongong’s Institute for Super-
conducting and Electronic Materials (ISEM) and the Illawarra Health and Medical Re-
search Institute (IHMRI) to evaluate novel ceramic materials developed at ISEM for radio-
enhancement. Novel ceramic oxide nanomaterials have different characteristics from the
widely studied gold NPs, both in terms of their chemical and biological behaviour in cells
and the physical interaction of radiation with them. It is therefore important to carefully
study such proposed ceramic NPs ceramic oxide nanoparticles to understand the basis of
their dose enhancement of radiation therapy.
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This project investigates the role of Ta2O5, Bi2O3 and CeO2 NPs to enhance the effectiveness
of kV and MV photon, and proton radiation therapy. This study has been performed by
means of Monte Carlo simulations.
1.1.1 Radiobiology of Cancer Therapy
The aim of radiotherapy is to cause damage to tumour cells, including cellular DNA, so
that the tumour cells die and do not divide and spread. The mechanism causing tumour cell
death in radiation therapy is a combination of physical, chemical, and biological processes
including direct ionization and energy deposition (direct damage), increased water radiolysis
and free radical actions (indirect damage). Direct damage occurs when either primary or
secondary radiation directly breaks the DNA double helix structure whereas indirect damage
occurs when reactive oxygen species (ROS) are created in the vicinity of cell nucleus, and
cause damage to the DNA structure by physical-chemical and chemical reactions [7]. ROS
are species of reactive oxygen with a free electron in the outer electron shell which allows
the molecule, or radical, to readily react with other molecules [6].
DNA damage can occur by several mechanisms, including single strand breaks (SSB) and
double strand breaks (DSB). SSBs result when damage occurs to a single strand of the
DNA double helix. Likewise, DSBs result when both strands of the DNA double helix
structure are damaged within a few base pairs of each break [8]. Figure 1.1 shows the
difference between a SSB and a DSB. Two SSBs can be considered a DSB when located
within less than 10 base pairs, as determined by the ability of these to be detected as DSBs
by electrophoresis [9].
SSBs are simple to repair but DSBs are much more complicated and are more likely to result
in biological effects such as cell death or mutation. Correct repair of DSB is important in
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Figure 1.1: Graphical representation of a single-strand break of a DNA double helix (left)
compared to a double-strand break (right). Figure reproduced from Baskar et al. (2012).
order to avoid mutation in the DNA which may lead to carcinogenesis [10]. There are
multiple pathways to the repair of DSBs including homologous recombination and DNA
end-joining [10]. If DSBs are repaired by homologous repair, there is a possibility of errors
in the DNA being introduced.
Reactive species are found in elevated levels in cancer tissue, which contributes to enhanced,
out of control cell proliferation typically seen in tumour growth. A major part of the effec-
tiveness of radiotherapy is thought to be due to the action of free radical species above
normal elevated levels in cancer cells [5], resulting in indirect damage to cells and DNA.
There remains a balance in cancer cells between ROS and antioxidant actions which can be
exploited in order to promote cell killing of cancerous cells.
The increased action of free radicals in tumours as a consequence of therapeutic irradiation,
results in the increased killing of the tumour cells. This is why the action of free radicals is
an important factor when studying the enhancement mechanisms applicable in radiotherapy.
If the production of free radicals can be enhanced within a tumour during radiation therapy
treatment, it is possible that this will result in an improved outcome for cancer patients.
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The resistance of some cancer cells, for example glioblastoma cells, to the damage of ion-
izing radiation (radioresistance) poses problems for the treatment of these types of tumours
with radiotherapy [11]. Glioblastoma is a highly radioresistant form of cancer in the brain
[12]. Treatment of glioblastoma with chemotherapy is challenging due to the difficulty of
delivering the drugs to the tumour across the blood-brain barrier. When the effectiveness of
radiotherapy is reduced, and surgery is limited by the location of a tumour (for example in
sensitive areas of the brain) it would be desirable to increase the sensitivity of tumour cells
to radiation. Nanoparticles have been shown to have the potential to achieve this goal [11].
1.1.2 Radiation Therapy Techniques
This project investigates the effect of NPs in conventional (low and high energy X-ray) ra-
diotherapy and proton therapy. X-ray and electron radiotherapy are the only EBRT modal-
ities available clinically at this time in Australia, while proton and heavy-ion therapy are
envisioned for the future. In the next few years proton therapy will become available at the
Royal Adelaide Hospital in South Australia [13, 14].
EBRT is most commonly delivered by a high-energy photon beam from a megavoltage linear
accelerator (linac) but may also be delivered by kilovoltage X-ray sources for the treatment
of more superficial lesions. Linear accelerator technology has developed since the middle
of the 20th century to achieve the current technology used in cancer therapy today. A mega-
voltage photon beam is produced by an electron beam originating from an electron gun,
accelerated along a waveguide and then directed by bending magnets to hit a target, pro-
ducing X-rays by bremsstrahlung interactions [15, ch. 1]. The photon beam is then shaped
and modulated depending on the treatment requirements and prescription, as well as the
machine’s capabilities and limitations.
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EBRT commonly consists of fractionated (multiple treatments delivered over several days
or weeks) delivery of therapeutic doses of radiation. Fractionation allows a higher total
dose to be delivered to tumour tissue while normal tissue is better able to recover from
collateral damage. The fractionation and dose prescription are tumour-site dependent as well
as depending on the treatment intent (i.e. palliative or curative intent). The conformation of
treatment beams to target shape is achieved in modern radiotherapy centres by a technology
known as Intensity-Modulated Radiotherapy (IMRT). IMRT allows the shape of the incident
beam to be modulated during treatment by means of a multi-leaf collimator (MLC). The
MLC allows for dose to be delivered with a greater conformity to tumour volume, while
sparing nearby sensitive organs.
X-ray and γ-ray radiotherapy are characterised by high entrance dose and also significant
exit dose. Proton therapy, in contrast to X-ray or γ-ray radiotherapy, uses a beam of heavy
charged particles to deliver therapeutic dose to tumour tissue [16]. The main advantages of
proton therapy over photon radiotherapy modalities is the ability to get strong conformity of
dose deposition to the target tumour volume to enable better sparing of healthy tissue and the
elimination of exit dose to patients’ normal tissue. Proton therapy is suited to radioresistant,
deep-seated tumours, and tumours located in close proximity to sensitive organs or tissue.
The range of monoenergetic protons is well-defined as the depth dose distribution exhibits
the characteristic Bragg peak shown in Figure 1.2. In order to deliver dose to a volume
greater than the narrow part of tumour tissue at the end of the Bragg peak, several proton
beams of different energies are combined so that the Bragg peak is able to be essentially
"spread out" over the tumour volume - in a Spread-Out Bragg Peak (SOBP).
Studies have been performed to assess the efficacy of proton therapy for the treatment of
tumours at various sites in the body, with mixed results. A review of the advantages of
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Figure 1.2: Simulated depth dose curve showing the Bragg Peak from 280 MeV proton
beam incident on water phantom.
proton therapy for the treatment of tumours of the central nervous system (CNS) is presented
by Gridley et al. (2010). These researchers reviewed data from proton therapy studies,
including comparisons with photon radiotherapy techniques, and found that in the case of
tumours of the CNS proton therapy has the potential to treat the tumour volume with lower
toxicity to normal tissue and greater clinical outcomes.
The advantages of proton therapy over conventional therapy also include increased relative
biological effectiveness (RBE) in the Bragg peak, or SOBP region. Nikjoo et al. (1999)
showed computationally the factors which contribute to the biological effectiveness of elec-
trons, protons and alpha particles. This study shows that for a 4 MeV proton beam 61% of
DSBs are caused by direct damage while 39% are due to indirect damage deriving from free
radicals.
Protons can interact by means of electronic or nuclear interactions [18]. A nuclear interac-
tion may occur when a heavy charged particle of sufficient energy impacts the nucleus of
a target atom [19, p. 164]. This type of interaction has a low probability in the therapeu-
tic proton energy range, however is still significant as it will result in secondary neutrons
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which can deposit dose outside the target volume [18]. Paganetti (2002) showed through
Monte Carlo simulation that in a representative clinical proton therapy beam (160 MeV pri-
mary protons) about 20% of primary protons underwent nuclear interactions in the water
medium. Secondary neutrons were then able to react and produced secondary protons, re-
sulting in a dose distribution beyond the Bragg peak, and outside the target tumour volume.
Paganetti (2002) reported that the contribution of neutron dose at a point 2 cm distal and
lateral to the target volume was less than 0.02% of the SOBP dose with 160 MeV primary
protons. Figure 1.3 reproduces the depth-dose profiles due to primary or secondary particles
from Paganetti (2002). The biological effect of this dose, in terms of secondary cancer risk,
is negligible [18].
Figure 1.3: The upper figure shows the total dose and the dose due to primary and secondary
protons. The lower figure compares, on a logarithmic scale, the doses due to different types
of particles (solid lines: primary protons (p), secondary α and deuterons (d); dashed lines:
secondary p, 3He, tritons (t)). A vertical line indicates the position of the maximum of the
Bragg peak. Figure reproduced from Paganetti (2002).
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1.1.3 Nanoparticle Dose Enhancement of Radiation Therapy
1.1.3.1 X-ray Radiotherapy
The concept behind NP radio-enhancement utilizes the ability of high-Z materials, such
as increasing the number of photoelectric interactions, to produce a higher number of low
energy electrons resulting in an enhanced dose at the interface between the NP and the
surrounding tumour. The increased electron density and photon attenuation coefficients with
increasing Z, in the case of kilovoltage photons, explains the fundamental mechanism or the
origin of radio-enhancement, however in the megavoltage photon range, energy absorption
is much lower.
Terminology and calculated or measured factors used to describe radiation dose enhance-
ment (radio-enhancement) caused by NPs varies between authors and research groups. Some
terms commonly used to measure radio-enhancement are dose enhancement ratio (DER),
sensitiser or sensitisation enhancement ratio (SER), radiosensitization enhancement factor
(REF) and dose enhancement factor (DEF) or enhancement factor (EF). Alternatively, radio-
protective NP behaviour may be described using a factor such as a protection enhancement
ratio (PER) [20]. PERSF=10% is defined in Briggs et al. (2013) as the ratio of doses in the
presence of NP to the control, at 10% cell survival. SER is defined by Jain et al. (2011) as
the ratio of areas under the surviving fraction curves of untreated cells compared to cells
treated with a nanoparticle-sensitiser. Brown et al. (2013) describe a sensitisation enhance-
ment ratio (SER) calculated as the ratio of doses required with and without NP giving 10%
surviving fraction on a cell survival curve. DEF is defined by Alqathami et al. (2013) in their
paper on a 3D radiochromic dosimeter as the ratio between the slopes of dose vs. change in
optical density plots of a dosimeter doped with NPs and of a control. DER is frequently used
in Monte Carlo studies and is generalised as the ratio of dose deposited with nanoparticle
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material to that without NP material [24, 25]. As the most widely accepted term for descrip-
tion of Monte Carlo simulation study, DER will be used in the majority of the discussion in
this thesis.
The dose enhancement in kilovoltage or megavoltage irradiation is the result of different
physical effects, due to the difference in absorption of photons between these energies. In the
case of gold, at photon energies below around 500 keV, the photoelectric effect cross-section
dominates the total attenuation cross-section, while at higher energies Compton scattering
becomes more significant as well as pair production above the 1.022 MeV threshold, as
shown in Figure 1.4a. The photoelectric mass attenuation coefficient at low energy is related
to the photon energy and material atomic number (Z), as shown in Equation 1.1 obtained








where n = 3-4
(1.1)
Pair production occurs above the threshold of 1.022 MeV and results in the absorption of the
incident photon with energy transferred to an electron-positron pair. The mass attenuation
coefficient of pair production is directly proportional to the atomic number of the medium,
as shown in Equation 1.2 obtained from Attix [2004, p. 150].
µpairproduction
ρ
∝ Z (cm2/g) (1.2)
The mass attenuation coefficient associated with Compton scattering is not dependent on the




















































































































































Figure 1.4: Mass attenuation coefficients in Au, Ta2O5, Bi2O3, and CeO2. Total mass attenu-
ation coefficient (solid black line) comprises photoelectric absorption (dashed line), Comp-
ton scattering (grey line), coherent (Rayleigh) scattering (dotted line) and pair production
(dot and dash line) [26].
















Figure 1.4 shows the total mass attenuation coefficients and the contribution from each type
of photon interaction in gold (Au), Ta2O5, CeO2 and Bi2O3 with data obtained from Berger
et al. (2010).
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Table 1.1: Atomic number, K-, L-, an M-edge energy of the high-Z atoms in the NPs under
study [26, 27].
Au Bi Ta Ce
Atomic number (Z) 79 83 73 58
K-edge (keV) 80.7 90.5 67.4 40.4
L-series
LI-edge (keV) 14.3 16.4 11.7 6.5
LII-edge (keV) 13.7 15.7 11.1 6.1
LIII-edge (keV) 11.9 13.4 9.9 5.7
M-series
MI-edge (keV) 3.4 4.0 2.7 1.4
MII-edge (keV) 3.1 3.7 2.5 1.3
MIII-edge (keV) 2.7 3.2 2.2 1.2
MIV-edge (keV) 2.3 2.7 1.8 0.9
MV-edge (keV) 2.2 2.6 1.7 0.8
The atomic number, and K-, L- and M-edges for each high-Z element studied in this PhD
project are shown in Table 1.1. The K-edge of the mass attenuation coefficient of a medium,
with respect to photon energy, occurs at the binding energy of the K-shell electrons in the
atom. The L- and M-edges each correspond to binding energy of electrons from these shells
respectively. There is a peak observed and then a sharp drop-off at this K-edge and at the
lower energy L- and M- series of binding energies. This is important in high-Z NP dose
enhancement as it is desirable for the interaction probability to be highest, and so it can be
important to select incident photon energies with respect to targeting the K-edge of the NP
material, in order to maximise the dose enhancement with respect to water.
Figure 1.5 shows the ratio (converted to percentage difference) of total mass absorption co-
efficients in gold to water, for photons with energy from 1 keV to 100 MeV [26]. Figure
1.5a shows the comparison between elemental gold and water. Figure 1.5b shows the ratio
in the case of a 1% solution of gold in water, calculated by scaling the total mass absorption
coefficients for water and gold combined in such a solution. A concentration of this mag-
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nitude is a reasonable example case, according to the literature [21]. The contrast of these
two figures shows that the effect of gold NPs in terms of dose enhancement is more complex
than an exclusively macroscopic dose enhancement effect, which can only account for a
small increase in photon absorption. This is why investigations on the micro- and nanoscale



















































































(b) 1% Au / H2O
Figure 1.5: Departure of the ratio of mass absorption coefficient in gold to water from unity
(given as a percentage) [26]. Pure gold (a) and a 1% solution of gold in water (b) are shown
in each panel respectively.
1.1.3.2 Proton therapy
The interaction of charged particles with matter consists of Coulombic interaction resulting
in ionised or excited atoms, or nuclear interaction [19, ch. 8]. These interactions result in
a continuous slowing down of a particle travelling though matter which results in the sharp
drop-off in the depth-dose profile, know as the Bragg peak. The cross-section of production
of secondary electrons is dependent on the density of the medium, and inversely dependent
on the square of the velocity of the incident particle [28].
The Bethe-Bloch stopping power equation describing the energy loss of charged particles in
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a medium is shown in Equation 1.4 [29, p. 252].
































v velocity of the incident particle
c speed of light
me electron mass at rest
e charge of the electron
NA Avogadro constant
z atomic number of the incident particle
Z atomic number of the medium
A atomic mass number of the medium





For low kinetic energies the stopping power curve increases to a peak in the case of incident
protons [29]. In the kinetic energy range relevant to proton therapy the stopping power
increases then decreases with increasing kinetic energy. Lower energy primary particles
produce a higher number of δ-electrons. As there is only a small variation in the Z/A term of
the equation between most elements this term causes the stopping power to vary only slightly
between materials. Therefore the energy loss of a particular particle through equivalent
thickness (g/cm2) absorber will be approximately the same for materials of different atomic
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number [29].
The dose enhancement in proton therapy by means of NPs is a relatively new area of re-
search [30, 31]. The nature of proton energy deposition in dense tracks of ionised secondary
electrons means the dose enhancement mechanism and outcomes differ from NP enhanced
X-ray radiotherapy. An increase in low energy electron production is unlikely to be the re-
sult of physical proton interaction with a high-Z NP, but rather the interaction of secondary
electrons in the NP and these electrons will induce further direct and indirect damage to
cells. Dose enhancement of already high-LET incident particles in the SOBP region should
improve the tumour control outcomes in proton therapy.
1.2 Motivation
1.2.1 Proposed Ceramic Nanoparticles
At the ISEM novel NP materials are synthesised, developed and studied. The Targeted
Nano-Therapies (TNT) Group at the University of Wollongong studies the possible applica-
tion of such novel compounds to enhance radiotherapy [107, 108]. Novel materials studied
in this PhD project include tantalum pentoxide (Ta2O5), bismuth oxide (Bi2O3), and cerium
oxide (CeO2). Ta2O5 and Bi2O3 are studied by the TNT Group as radio-enhancers, while
CeO2 as a radio-protector [20, 22, 32–35].
Tantalum pentoxide (Ta2O5) is a ceramic compound which, when engineered as a nanos-
tructured particle, has been shown to be an effective radiosensitizer for radiation resistant
rat brain 9L cancer cells exposed to 10 MV photon irradiation [22]. The high-Z of tanta-
lum (ZTa = 73) causes Ta2O5 to behave as a high-Z NP whilst it is also biocompatible [32].
Figure 1.6 shows a transmission electron microscopy image of nanoscale Ta2O5 NPs.
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Figure 1.6: High-resolution transmission electron microscopy image of Ta2O5 NPs. Figure
reproduced from Brown et al. (2013).
The sensitising effect on 9L rat brain gliosarcoma (brain tumour) cells of Ta2O5 NPs com-
bined with 10 MV photon irradiation has been demonstrated [22, 32]. Brown et al. (2013)
found an SER of 1.33 with 50 - 70 nm diameter Ta2O5 NPs. The researchers exposed the tu-
mour cells to NPs of increasing concentration from 50 to 500 µg/mL and showed enhanced
radiosensitivity of the cells with increasing concentration of NP.
Brown et al. (2017) have since reported the effect on these radioresistant 9L tumour cell
killing of Ta2O5 NP preparation technique and X-ray beam energy [32]. The paper presents
results of Ta2O5 NPs in concentrations of 50 and 500 µg/mL combined with 150 kVp or
10 MV photon irradiation showing most dose enhancement under 10 MV irradiation with
Ta2O5 NPs fabricated using a precipitation technique. The increased radio-enhancement
at the higher photon beam energy can be explained by the tendency of these types of NPs
to collect in aggregates of several hundred microns diameter. This aggregation limits the
effectiveness of the lower energy dose enhancement due to self-absorption within the NP
material.
Bismuth oxide (Bi2O3) nanomaterials have been shown to enhance the effects of kilovolt-
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age radiotherapy irradiation of a 3D radiochromic dosimeter [23]. The high-Z of bismuth
(ZBi = 83), higher even than gold, contributes to Bi2O3 being an effective radio-enhancer.
Alqathami et al. (2013) examined the dose distribution enhancement with the application of
50 mM of 50 nm Bi2O3 NPs in a multi-compartment 3D radiochromic dosimeter and pre-
sented dose enhancement factors (DEF), defined as the ratio of the response of the dosimeter
with NP and without NP doping. The study found DEF of 1.90 with Bi2O3 NP doping of
the dosimeter irradiated to 10 Gy under a 100 kV X-ray beam. Although this study does not
take into account biological or chemical effects which may occur in cells, it does demon-
strate physical dose enhancement in the presence of Bi2O3 NPs.
Bi2O3 NPs have been fabricated and optimised at the ISEM with the final goal of applying
them as a radio-enhancer in radiotherapy [33]. Bi2O3 NPs are under study for their potential
combination with drug coatings in order to develop a theranostic system [35].
Figure 1.7 shows the platelet morphology of Bi2O3 NPs fabricated at the ISEM [34]. This
study examined the effect of a Bi2O3 NP in a concentration of 50 µg/mL on 9L gliosarcoma
cell line under 125 kVp and 10 MV photon irradiation. The influence of the shape of the
nanoceramic materials produced at the ISEM is addressed in the paper by means of Monte
Carlo simulation study developed during this PhD project. Comparison of various material
geometries in terms of dose distribution enhancement will be described in this thesis and
was motivated by the observed morphology of these Bi2O3 NPs.
The application of NPs in radiotherapy as a radio-protector reducing normal tissue damage
in proximity to tumour target tissue is another area of research interest [36–38]. Cerium
oxide (CeO2) NPs have been investigated for use as a radio-protector in cells under X-ray or
gamma irradiation [36, 37]. This material has the property of free-radical scavenging which
provides protection against damage of this mechanism from radiation. The application of
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Figure 1.7: Transmission electron microscopy (TEM) image of Bi2O3 nanoceramic
platelets. Figure reproduced from article - Stewart et al. (2016).
a radio-protector allows for sufficient damage to tumour cells to be achieved while normal
cells are less susceptible to the damage due to protective NPs working to the advantage
of normal cells. At the same time CeO2 NPs are effectively high-Z NPs (ZCe = 58) and
therefore will enhance secondary electron production in proportion to increasing Z [20].
The protective nature of these particles is deduced from their applicability as antioxidants,
which outweighs the negative effect of increased production of secondary electrons due to
their high Z [20].
Figure 1.8 shows cell survival curves comparing the survival of radioresistant 9L gliosar-
comas under megavoltage or kilovoltage photon irradiation with the application of CeO2
NPs. This figure demonstrates the difference in response with the application of 50 µg/mL
concentration of CeO2 NPs on cells to 10 MV and 150 kVp X-ray beams. The protective
properties of CeO2 NPs are shown to be more effective under the megavoltage irradiation
and this is due to the lower proportion of photoelectric interactions expected to occur un-
der 10 MV photon irradiation (where Compton scattering is dominant), compared to in the
150 kVp field (where the photoelectric effect is dominant). This means that the enhance-
ment of the production photoelectrons and subsequent dose deposition is balance by the free
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Figure 1.8: Cell survival curves after irradiation with 10 MV (A) or 150 kVp (B) X-ray
beams in the presence (triangle) and absence (square) of 50 µg/mL of CeO2 NPs. Figure
reproduced from Briggs et al. (2013).
radical scavenging properties and this balance is closer to equality in the kilovoltage case
and the protective properties are dominant in the megavoltage.
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1.3 Literature Review
1.3.1 Nanoparticle Dose Enhancement of Radiotherapy
Jain et al. (2011) and Chithrani et al. (2010) have shown dose enhancement in megavoltage
photon radiotherapy treatment by gold NPs. Jain et al. (2011) demonstrated radiosensitiza-
tion of MDA-MB-231 breast cancer cells by gold nanoparticles in megavoltage radiotherapy.
The authors used a gold nanoparticle concentration of 12 µM. The study reported sensitizer
enhancement ratios (SERs) of 1.41, 1.29 and 1.16 for breast cancer cells under 160 kVp,
6 MV and 15 MV photon irradiation respectively. The authors suggest a possible biologi-
cal mechanism of radio-enhancement, for example causing increased ROS production and
hypoxia, could account for the radio-enhancement reported in the MV field. Chithrani et al.
(2010) used a much lower gold nanoparticle concentration of 1 × 10−3% in their studies of
dose enhancement by nanoparticles.
McMahon et al. (2011) showed, by means of Monte Carlo simulation, that the mechanism of
dose enhancement in kilovoltage radiotherapy by gold NPs must take into account nanoscale
effects. The enhancement of the dose within a few hundred nanometres of the NP surface
is primarily due to Auger electrons generated after 40 keV photon interaction in the NP
depositing energy in the surrounding water. The dose enhancement was shown in this study
to fall off rapidly beyond the range of the low energy, Auger electrons [40].
McMahon et al. (2011b) reported Monte Carlo simulation results of dose enhancement by
gold NPs irradiated in megavoltage photon fields. The authors modelled the effect of the
dose enhancement due to a 0.05% by mass concentration of NPs on MDA-MB-231 cells
and compared the results to previously published clonogenic survival results [21]. These
researchers were able to demonstrate dose enhancement in the MV photon field, at a depth
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of 5 cm in water. Although Compton scattering dominates at higher photon energies, inter-
actions in the NP at the depth of interest are dominated by electron impact and photoelectric
interactions due to scattered photons and secondary electron in the water phantom [41].
The change in the dose enhancement effect of high-Z NPs with respect to x-ray beam spectra
is an important aspect of NP dose enhancement study. Studies have demonstrated dose
enhancement in both kilovoltage and megavoltage radiotherapy beams [22, 32, 39, 41].
In the case of a kilovoltage beam it is possible theoretically to select beam energy in order
to optimise dose enhancement depending on NP material to select the optimum energy for
photoelectric interactions [42]. This is because enhancement of tumour cell killing with the
application of nanoparticles is thought to be due in part to an increase in the production of
secondary electrons local to the NP. This also results in an increase in low energy Auger
electron production and cascades which can be connected to complex damage to DNA if the
source is close to the nucleus in the cell target. For example, gold is expected to be most
effective for kV beams with mean beam energy of around 100 keV, or just above the K-edge
of gold. This optimisation could potentially be adopted in microbeam radiation therapy as
well [42].
Experimental results have shown radio-enhancement from NPs in both kilovoltage and
megavoltage photon radiation therapy. Chithrani et al. (2010) compared dose enhancement
due to 50 nm gold NPs (with a concentration of 1 × 10−3%) in cells irradiated by photon
beams from 105 kVp up to 6 MV. This study found (at a level of 10% on the cell survival
curve) a maximum radiosensitization enhancement factor (REF) of (1.66 ± 0.05) for the
105 kVp photon irradiation (compared to 220 kVp and 6 MV photon irradiations). The
REF was calculated as the ratio of dose required with and without the application of NPs
to achieve 10% survival in HeLa cells. The study reported a REF of (1.17 ± 0.02) for the
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6 MV irradiation.
McMahon et al. (2011b) showed by a Monte Carlo simulation study a potential reason for
dose enhancement in MV photon field is due to the presence of lower energy photons at
depth in a phantom due to scattering of the primary photons. They also showed the effect of
secondary electron ionisations within a NP is important in MV photon fields [41].
1.3.2 Nanoparticles for Radio-enhancement
Nanoparticles are usually less than 100 nm in size and are fabricated with desirable prop-
erties such as bio-compatibility, preferential uptake by cells, targeting to tumour cells, as
contrast in imaging, and as drug carriers [43].
Hainfeld et al. (2004) showed for the first time in vivo evidence in mice with subcutaneous
mammary carcinomas of the dose enhancement in radiotherapy by means of NPs. This
study reported an increase in the one-year survival from 20% to 86% in mice receiving
intravenous injection of 1.9 nm gold NPs combined with 250 kVp X-ray therapy, compared
to mice receiving the radiotherapy alone [44]. The NP concentrations delivered were 1.35
and 2.70 g Au/kg in 0.01 ml per g mouse weight. Zheng and Sanche (2009) showed the
enhancement of damage to DNA irradiated with 60 keV electrons with the application of
fabricated (5 ± 2) nm diameter gold NPs with a concentration of (0.5 ± 0.2) µM.
Since then, gold NPs have been shown to enhance the effects of ionising radiation by many
studies on cell and animal models and also by simulation studies. Gold is relatively inert
and biocompatible material which are desirable characteristics for dose enhancement in a
biological setting. Several studies have investigated the dose enhancement from 1.9 nm
gold NPs fabricated by Nanoprobes, Inc. (Yaphank, New York) [44, 46, 47]. Larger gold
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Figure 1.9: Electron micrographs from a patient with inoperable ductal carcinoma of the
breast. Magnification is 20,000 X, and the line at the bottom is 0.4 µm. Black dots in the
tumour micrograph are gold NPs. Figure reproduced from Libutti et al. (2010).
NPs have also been fabricated and studied for their effectiveness as dose enhancers, based
on a fabrication method developed by Turkevich et al. (1951) [49].
Libutti et al. (2010) have since reported results of a phase I dose escalation trial testing the
toxicity in humans of a nanomedicine, CYT-6091, consisting of recombinant human tumour
necrosis factor alpha (rhTNF) and thiolyated polyethylene glycol bonded to 27 nm gold NPs.
The study showed that a higher dose of the rhTNF was able to be delivered when bound to
PEGylated gold NPs than in previous studies of the drug alone as well as preferential uptake
by tumour tissue, compared to healthy tissue (shown in Figure 1.9). Although this trial was
aimed to study the dose and targeted delivery of the rhTNF, it shows in vivo evidence of the
application of gold NPs in a human trial.
Iron oxide and platinum materials are under investigation as potential radio-enhancers [51,
52]. Novel NP materials under study also include ceramic oxides. These compounds have
high-Z properties and are also developed to be relatively biocompatible, possibly due to the
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oxide bonding [32].
Theranostic systems are designed to combine diagnostic and therapeutic capabilities of NPs.
Gadolinium-based nanomaterials have been investigated because of their dual functionality,
acting as a radiation enhancer of traditional X-ray or γ-ray radiotherapy, heavy-ion or proton
therapy as well as acting as an MRI contrast agent (theranostics) [53–56]. By combining
chemotherapeutic or tumour-targeting drugs with CT or MRI contrast-enhancing nanoma-
terials, it is suggested that an advantageous combination of effects can be achieved [35].
Carbon nanomaterials have been studied to investigate how to improve the outcome of pa-
tients undergoing breast cancer surgery as well as improving radiotherapy outcomes [57,
58]. Monte Carlo simulation has also shown the advantage of increased concentration of
carbon in cells to enhance particle therapy due to the stopping power advantage of carbon
[59]. This is an area of ongoing development and research interest.
1.3.2.1 Effect of NP Size
Gold NPs of varying sizes have been used in previous studies of dose enhancement in X-
ray irradiation of DNA, cells and in animal studies. Gold NPs with a diameter of 1.9 nm
have been widely studied [44, 47] and also larger diameters, up to 92 nm [49]. The change
in effectiveness with increasing NP diameter is due to a combination of effects including
toxicity, uptake by cells or tumour vasculature and physical interaction with treatment beam.
Experiments using plasmid-DNA to measure dose enhancement in kilovoltage (10 keV -
80 keV) photon irradiation from gold NPs have examined the effect of NP concentration,
and NP size on the increase of damage to DNA [49]. Brun et al. (2009) found the greatest
dose enhancement at high NP concentration, relative to the concentration of DNA. The NP
concentration was kept constant (5 nM) in order to compare the dose enhancement factor
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with respect to NP diameter. The researchers showed an increased dose enhancement factor
for larger diameter NP (up to 92 nm diameter) with 49 keV effective X-rays on plasmid
DNA.
Jiang et al. (2008) investigated the size-dependence of cell uptake of gold NPs with surfaces
modified with Herceptin molecules. The dependence of NP uptake by human breast cancer
SK-BR-3 cells of gold NPs with Herceptin surface coating on the NP diameter (2-100 nm)
was reported in this study. The researchers found that the gold NPs with diameter of 40-
50 nm was optimal for Herceptin binding and subsequent cellular uptake.
Chithrani et al. (2010) compared cellular uptake of three NP sizes (14, 50 and 74 nm) and
found the 50 nm particles exhibited the highest level of cellular uptake in a HeLa cell culture.
A 1 nM concentration of gold nanoparticle solution was used. This concurs with the previous
result of Jiang et al. (2008) who found optimum uptake by NPs in the 40-50 nm diameter
range on a breast cancer cell line.
The cellular uptake of NPs by cells depends on several processes, including the size of pores
in tumour vasculature, and interactions of NP and any surface modification with cellular
membranes, influencing mechanisms of internalisation.
1.3.3 Dose Enhancement of Proton Therapy
Studies have shown the potential dose enhancement in proton and heavy-ion therapy by
high-Z NPs by in vitro [30, 31] and in vivo experiments [61].
Proton therapy has been shown to have increased killing capabilities of malignant cell lines
with the application of pegylated gold NPs. Pegylated NPs have their surface modified with
polyethylene glycol (PEG) which leads to an increased uptake and concentration of NPs
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within a tumour and reduced concentration in healthy tissue [30]. The PEG coating also
works to counteract the immune response which, in the absence of surface modification,
leads to the excretion of a large proportion of intravenously injected Au NPs [30]. Liu et al.
(2010) studied the nanoparticle-induced dose enhancement of the irradiation of two cancer
cell lines. The study used mouse breast cancer cells and colorectal adenocarcinoma cells
treated with pegylated gold NPs in concentrations of 400, 500 or 1000 µM. An enhancement
in cell killing of 2 - 11.9% under 3 MeV proton irradiation is reported in this study [30].
Gold NPs have been shown to enhance the radiobiological efficiency of proton therapy
killing prostate cancer cells [31]. Polf et al. (2011) reported an increased RBE of approxi-
mately 15 - 20% in the effectiveness of proton radiation therapy killing prostate tumour cells.
They applied gold NPs with diameter = (44 ± 8) nm to DU145 human prostate carcinoma
cells under three experimental conditions. The first was cell treated with an internalising
bacteriophage ("phage") combined with gold NPs [62], described as Au-treated cells. The
researchers compared the cells’ response with two control situations - the first with the in-
ternalising phage only (to examine any sensitising effect of this component) and the second
with neither phage nor gold NPs. After application of the NP material and incubation, the
researchers found NP uptake of approximately 1 ng/cell. Treatment with a clinical 60Co
photon source was used as a comparison for the purpose of calculating the RBE. Two differ-
ent measures of RBE were used - 10% cell survival fraction and 50% survival, or RBE10 and
RBE50 respectively. The study reported a 20% increase in RBE10, from 1.6 to 1.9 when cells
were treated with the gold NP and a 15% increase in RBE50 from 1.3 to 1.5. The survival
curves are shown in Figure 1.10.
Nanoparticle enhanced proton therapy has been shown to be effective compared to non-
enhanced proton therapy in an in vivo animal study [63]. Kim et al. (2010) showed an
increase effectiveness using in vivo mouse models and in vitro CT26 tumours studies with
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Figure 1.10: Cell survival as a function of dose for untreated cells irradiated with 60Co (red
circles) and proton (black squares) beams, as well as for phage-only (green diamonds) and
Au-treated (blue triangles) cells irradiated with protons. Figure reproduced from Polf et al.
(2011).
45 MeV proton irradiation. Gold or iron NPs with concentrations of 0.1 - 2 mg/ml were in-
troduced to the cells before irradiation. The cell study showed increased dose enhancement
in proton therapy with increasing gold and iron NP concentration. They attributed this result
to particle induce X-ray emission (PIXE) from the NPs. They found that with injection of
NP in concentration 300 mg/kg body weight there was increased tumour regression of 33 -
65% compared to 25% on the control.
In a comment on this research Dollinger (2011) pointed out that the statistical proportions
of energy being transferred to a NP from incident protons is extremely low and any resultant
energy deposition from PIXE, or other energy transfer modes such as increased electron
emission, will be statistically insignificant in the overall scenario. In a subsequent comment
on this research Le Sech et al. (2012) agreed with Dollinger’s critic of the work and pre-
sented an alternative interpretation of the results, suggesting that the increase in tumour cell
death should be attributed to increased free radical activity, namely water radiolysis, rather
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than PIXE as described by Kim et al. (2010).
Kim et al. (2012) have since published further research into proton therapy enhanced with
NPs. This paper again showed the dose enhancement in proton therapy with 100 - 300 mg/kg
body weight with increasing radiation dose to tumour in mice.
The effect of free radical production enhancement has been further examined in the context
of high-Z NP enhanced, high-LET radiation [66]. Porcel et al. (2012) compared the damage
to DNA induced by different LET incident radiation in the presence of molecular platinum
(Pt) or Pt NPs (ZPt = 78). The researchers compared gamma rays, fast helium particles and
fast carbon ions. A particularly interesting finding of the study was that the 90% of the
increased DNA damage induced by the presence of Pt could be attributed to the activity
of free radicals, in particular water radicals. The researchers state that the effect of the
presence of the NPs is to create an initial increase in secondary electrons which then induce
the production of free radicals which have the most impact on DNA damage.
These studies show that radio-enhancement by NPs in proton therapy is a complex system
involving direct and indirect effects, the complete mechanisms of which we are yet to fully
understand.
1.4 Methods
1.4.1 Study of Nanoparticle Dose Enhancement
Monte Carlo simulations are a useful tool to investigate the physics foundation of the mech-
anism of dose enhancement produced by NPs in radiation therapy and to characterise im-
portant associated physics quantities such as the energy deposition and the energy spectra
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of the electrons emitted by the NP, to provide an insight into both the direct and indirect
damage of radiation.
Geant4 [67–69] and other Monte Carlo simulation codes model particle interactions either
in event-by-event tracking or condensed history approximations [70]. A condensed history
approximation [71] of particle interaction can be implemented, where appropriate, in order
to minimise execution time requirement of simulations. In large geometries particle interac-
tions are modelled with enough accuracy by approximating many interactions in a particle
track as a single “condensed” step undertaken by the particle. This approach is valid when
tracking particle interactions where energy loss is greater than about 1 keV, determined by
the binding energy of electrons in the medium, [72, 73] however, for lower energy (shorter
range) particle interactions, more accurate models are required. To model particle tracks
below this general limit of 1 keV (or in some cases 100 - 250 eV), at small particle ranges of
micro- and nanometres, event-by-event transport codes allowing modelling of energy loss
down to very low energies become necessary [73].
1.4.2 Track structure Monte Carlo codes
When investigating dose enhancement due to NPs it is advantageous to use techniques that
model dose deposition on the nanoscale in order to accurately assess damage to DNA. Pho-
ton dose deposition can be approximated as a uniform dose spread, on the scale of the cellu-
lar environment. The dose response of tissue (represented by survival curves) can therefore
be related to absolute absorbed dose in the tissue.
In the case of traditional radiation therapy this macroscopic approach is sufficient to predict
the biological response of tissue to photon radiation dose however with the recent develop-
ment of proton and heavy-ion therapy this way of understanding cell response to damage
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is insufficient. Ions deposit dose in non-uniform, dense ionisation tracks and so the dose
distribution is not uniform across a small volume such as the cell. This means that the to-
tal absorbed dose is not necessarily the best quantity to relate to biological effect in this
case. A more complex understanding of the track-structure is important to be able to predict
dose-response curves [74, 75].
Radial dose distribution around ion tracks are used to assess the dose-response in tissue
of proton or heavy-ion irradiation [76]. Cucinotta et al. (1999) describe methods to model
biological damage from radiation by modelling radial dose or ionisation distributions, and
ionisation clustering.
Micro- and nano- scale simulations of event-by-event track structure of secondary electron
tracks becomes a useful tool when assessing the local clustering of ionisations within a cell.
This allows the known photon dose and corresponding cell response to be related to radial
dose quantities in ion beam radiation therapy.
Previous studies have investigated secondary electron yield and dose enhancement in the
presence of different NPs [24, 25, 40, 77–85]. Gold NPs have been studied extensively due
to their wide use in early biological studies of dose enhancement [77, 80, 83]. Other NP
materials studied include a variety of metallic NPs [82].
Earlier simulation studies of dose enhancement from nanoparticles model a uniform dis-
tribution of calculated concentration of NP within a tumour volume irradiated by various
photon sources [77]. Jones et al. (2010) used the Monte Carlo code EGSnrc to simulate the
secondary electron spectra within a tumour with an approximated concentration of embed-
ded gold NPs under 125I, 103Pd, 169Yb, 192Ir, 50 kVp and 6 MV X-ray irradiation. This study
showed an increased number of secondary electrons in the tumour when NPs are placed
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in tumour loaded with an equivalent to 7 mg Au/g of tumour. The microscopic dose dis-
tribution around a gold NP was subsequently simulated using another code, NOREC [86].
NOREC is a Monte Carlo code applicable to tracking electrons down to low energy in liquid
water, tracking secondary electron down to 7.4 eV in water. This study is limited in that it
does not take into account the NP geometry or nano- or microscale effects on DNA dam-
age but only takes into account the difference of the electron yield within the tumour with
and without the gold NPs. The microscopic distribution of NPs within cells is an important
factor when considering the magnitude of dose enhancement, as will be investigated in this
PhD thesis.
Nanoparticles have been shown in previous simulation studies to be dose enhancing in
brachytherapy, kilovoltage, and megavoltage radiation fields [78]. Lechtman et al. (2011)
investigated, by means of a combination of the Monte Carlo codes, MCNP-5 and PENE-
LOPE 2008.1, the enhancement of photoelectric interactions within gold NPs and dose
enhancement surrounding gold NPs with respect to NP diameter and photon energy. En-
hancement was calculated in terms of the increase in photoelectric absorption cross-section
in a 1 mm thick region, the spectra from which was used as a primary source for a subse-
quent nanoscale simulation. The study reported increased dose enhancement efficiency in
terms of gold NP mass concentration for smaller diameter NPs, in lower energy fields. This
is due to the increased likelihood of low energy Auger electrons escaping smaller NPs.
With the advancement of the available physics models, subsequent research has modelled
NPs dose enhancement in photon fields on the nanoscale [40]. McMahon et al. (2011)
used Geant4 to model secondary electron production from and dose enhancement around a
single gold NP with an incident photon beam. This study then used the local effect model
(LEM) [87] to compare simulation results to cell survival data [40]. The basic premise of
the LEM as described in Scholz and Elsässer (2007) is “...that the local biological effect,
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i.e. the biological damage in a small subvolume of the cell nucleus is solely determined
by the expectation value of the energy deposition in that subvolume and is independent of
the particular radiation type leading to that energy deposition”. This model examines the
track structure of energy deposition on a nanoscale and relates this to photon dose response,
depending on cell or tissue type.
The effect of the incident photon energy has been studied by means of nanoscale Monte
Carlo simulation [80]. Chow et al. (2012) used Geant4 to simulate the secondary electron
spectra from a 100 nm diameter gold NP irradiated by kilovoltage photon beams. The dose
distribution around the NP was simulated with the Monte Carlo code, NOREC. Geant4
with Penelope models was used to create electrons down to 250 eV. The study did not
find a significant difference between the low energy part of the secondary electron spectra
from the three photon beams studied - 35, 73.3 and 660 keV. The higher energy photons
showed wider spread of energy deposition [80]. This occurs because of the different photon
interaction processes which become more dominant at higher photon energies, resulting in a
more divergent beam, and higher energy secondaries which will travel further in a medium,
depositing energy at a greater distance from their origin.
Clinically realistic phantom configurations have been developed in Geant4 and the dose
enhancement effect of gold NPs calculated in this context [24]. Douglass et al. (2013) re-
ported a Monte Carlo study of the dose enhancement effect of gold NPs in a randomised cell
model, irradiated by kilovoltage and megavoltage photon fields. The researchers reported
dose enhancement ratios (DERs) in a model of cells (with randomised diameter between 9
and 15 µm) due to 80 kVp and 6 MV photon fields. They showed greater dose enhancement
in the kilovoltage field, and a dose enhancement dependent on the geometrical configura-
tion of the gold NP, either in a 400 nm diameter aggregate, cluster, or in a 300 nm layer
around the nucleus. On the scale of the cell these simulations revealed Auger electrons had
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an insignificant effect on dose enhancement [24].
The importance of the selection of the geometry of a Monte Carlo simulation has be re-
ported only recently [85]. Zygmanski et al. (2013) examined the effect of simulation geom-
etry when assessing the dose enhancement properties in the case of gold NPs. This study
reports the effect on DER of small generated source sizes and with reducing source to NP
distance. Zygmanski et al. (2013) also showed by means of their Monte Carlo simulations
that increasing gold NP clustering in X-ray radiotherapy translates to a nonlinear dose en-
hancement. The work presented in this thesis differentiates from ref [85] in the type of
nanoparticle aggregate considered and in the shape of the aggregate, dictated by our exper-
imental observations described in Chapter 3. Results in Chapter 3 show a saturation effect
with increasing ceramic NP concentration in a cell population which is in agreement with
a similar trend described in ref [85], although this is for the case of clustered gold NPs in
solution.
The simulation study presented in this thesis (Chapter 3) further examines and compares the
effect of a completely homogeneous distribution of NP materials as well as the magnitude of
the effect of atomic de-excitation on the DER. The simulation study reported in ref [85] was
performed in two stages utilising a phase space file technique for storing results of the first
stage to then use as input to a more refined second stage. The effect of the secondary source
size and distance to target is examined by Zygmanski et al. (2013). These considerations
are not directly applicable in the case of simulations presented in this thesis as the present
work was performed as a single simulation step, including realistic depth in phantom to
correspond to experimental measurements.
Zygmanski et al. (2013) presented a method to relate simulated dose enhancement in the
form of a calculated DER to biological quantities such as RBE and linear quadratic model
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parameters, α and β by utilising a local effect model framework [87].
Wälzlein et al. (2014) used the Monte Carlo code TRAX (developed at GSI, Darmstadt, Ger-
many) to model secondary electron production from five types of metallic NPs (Fe, Ag, Gd,
Pt and Au). They investigated the electron production and subsequent dose enhancement
by these NPs with 2 and 22 nm radius with directly incident 2, 80 or 300 MeV monoener-
getic protons. Their study modelled ionisation, excitation and elastic scattering interactions
in each NP material and water as well as production of Auger electrons and plasmon ex-
citation in the NPs. This study reported dose enhancement of up to a factor of 2. The
researchers showed that Auger electrons are produced with low energy and contribute to
dose enhancement close to the NP surface.
Lin et al. (2014) compared the dose enhancement from monoenergetic protons, a clinical
proton spectrum, monoenergetic kilovoltage photon sources and a clinical 150 kVp and a
6 MV photon spectra. Lin et al. used the Monte Carlo package, TOPAS, which is a user-
interface of Geant4 (based on program version 9.6p02, in this case) to model 50 nm diameter
gold NPs. The researchers used Penelope physics models in the gold NP with a cut-off of
250 eV. The dose enhancement factor (DEF) was defined in this study as the ratio of dose in
water with a GNP to a sphere of water up to 10 µm distant from the GNP surface. This study
reported a DEF in the proton beam of a factor up to 14 (independent of proton energy). The
dose enhancement reported in the photon fields varied with photon energy and had a much
larger effect at a larger distance from the NP compared to proton dose enhancement. This
study was not able to track secondary Auger electrons below 250 eV which would have an
effect on the dose enhancement in the nanometre region close to the NP surface.
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1.4.3 Geant4
Geant4 is a simulation toolkit for the simulation of the production and transport of radiation
in matter [67–69]. Geant4 is maintained by an international collaboration who continue to
develop the code to improve the accuracy of the physics models and expand the functionality
of the software. Geant4 is based on Object-Oriented technology and is written in the C++
programming language. Geant4 can be used for nano- and micro-dosimetric applications as
it is possible to model the transport of particles from within nanoscale objects, such as the
DNA-helix, up to human phantoms and detectors [88, 89]. Physics models in Geant4 cover
interactions from very low energy (tracking down to nanoscale range), up to high energy
physics.
Particle transport in Geant4 is limited by range cuts or energy thresholds. Range cuts are
converted to material-specific energy thresholds at the point of initialisation. By the imple-
mentation of production cuts, particles with a range lower than a set threshold will not be
created in the simulation. Particles that are produced above this threshold are then tracked
to zero range, unless special user defined cuts are invoked for a particular volume.
In most experimental situations relevant to medical physics, accuracy to a micron-scale is
sufficient for good agreement with verified experimental results. However, in the field of
nanomedicine, the tracking of particles on the nanoscale (down to the eV level) becomes
increasingly important.
Currently, low energy models in most solid state materials in Geant4 are limited to produc-
tion and transport of secondary electrons above a 100 eV threshold cut when using Pene-
lope models [90]. Penelope models are inherited from the PENELOPE (PENetration an
Energy LOss of Positrons and Electrons) code which simulates the transport of electrons
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and positrons in a medium by combined simulation technique of event-by-event and mul-
tiple scattering calculations [90, 91]. Geant4-DNA allows for transportation of electrons
event-by-event down to 0 eV.
Geant4-DNA is an extension to Geant4 which allows the event-by-event tracking of parti-
cles in liquid water down to the nanometre scale [92, 93]. At present, cross-sections are
only implemented in Geant4-DNA for liquid water. However, development of a wider range
of models is ongoing within the Geant4-DNA project [94]. Models in Geant4-DNA allow
the event-by-event tracking of a variety of particles including electrons, protons, hydrogen
atoms, helium ions and an increasing number of heavy-ions. The particle interactions and
relevant models implemented in Geant4-DNA are shown in Table 1.2. Gamma photon in-
teractions are modelled using Geant4 Livermore cross-sections by default.
Table 1.2: Physical interactions modelled with Geant4-DNA (table adapted from geant4-dna.org [94]). Models applied in Geant4
v.10











elastic scattering G4DNAElastic G4DNAChampionElasticModel 0 eV 1 MeV 7.4 eV
electronic excitation G4DNAExcitation G4DNABornExcitationModel 9 eV 1 MeV -
ionisation G4DNAIonisation G4DNABornIonisationModel 11 eV 1 MeV -
vibrational excitation G4DNAVibExcitation G4DNASancheExcitationModel 2 eV 100 eV -





G4DNAMillerGreenExcitationModel 10 eV 500 keV -
G4DNABornExcitationModel 500 keV 100 MeV -
ionisation G4DNAIonisation
G4DNARuddIonisationModel 0 eV 500 keV 100 eV
G4DNABornIonisationModel 500 keV 100 MeV -
electron capture G4DNAChargeDecrease G4DNADingfelderChargeDecreaseModel 100 eV 100 MeV -
H
electronic excitation G4DNAExcitation G4DNAMillerGreenExcitationModel 10 eV 500 keV -
ionisation G4DNAIonisation G4DNARuddIonisationModel 0 keV 100 MeV 100 eV




















The Physics Reference Manual [70] also describes how Geant4 handles atomic relaxation
including fluorescence, Auger electron production and Particle Induced X-ray Emission
(PIXE). These processes describe X-rays and electrons emitted as an atom relaxes back
to neutrality after some process causing atomic excitation. The Auger process is important
in the simulation of NP induced dose enhancement of radiation therapy and is implemented
in Geant4 for 5 < Z < 100 elements. Geant4 generates two random shell numbers - the first
for selecting the electron that will fill the vacancy from the previous interaction, and the
second to determine from which shell the Auger electron is emitted.
Recent advances included in the evolving physics models of Geant4 allow for the simulation
of complete Auger cascades in version 10.2Beta, on top of the Auger electron emissions in-
cluded in the Geant4 version used for the simulations presented in this thesis [95]. Incerti
et al. (2016) shows emission from nano-sized Au volumes of Auger electron cascades. Fig-
ure 1.11 shows the way in which Auger electron emission is modelled in Geant4 up to ver-
sion 10.1 and visually shows the part of the process omitted before the more recent Geant4
release.
Figure 1.11 represents a Auger electron emission after an electron is ejected after ionisation
induced by an incident particle (blue sphere). The figure represents a KL3M1 Auger tran-
sition. The vacancy (“V1”) left by the electron (green sphere) filling the vacancy (“V0”)
on the K-shell after ionization of an electron (red sphere) is taken into account by Geant4.
However, the “V2” vacancy left by the emitted Auger electron (purple sphere) is neglected
in Geant4 version 10.1 and earlier releases.
Examples of use of Geant4 and Geant4-DNA very low energy extension in nanodosimetry
include studies of the interaction of particles with DNA dinucleosome previously described
[88], as well as the study of the track structure in water of proton or electron tracks [96–101].
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Figure 1.11: Illustration of the limitation of Geant4 for the tracking of Auger
electron vacancies up to Geant4 release 10.1 (December 2014) (adapted from
https://www.ikp.unikoeln.de/research/pixe/). Figure reproduced from Incerti et al. (2016)
[95]. Further described in text.
The application of Geant4-DNA for nanodosimetric modelling of radial dependence of en-
ergy deposition has been studied in the case of liquid water [96]. Incerti et al. (2014) stud-
ied with Geant4-DNA the radial energy deposition from ion tracks in liquid water on a
nanoscale, important for the calculation of radiobiological quantities. The researchers re-
ported a comparison of Geant4-DNA calculated radial energy deposition with reference data
and found good agreement.
The dose in microscopic volumes has also be calculated with Geant4-DNA models [97].
Byrne et al. (2013) examined the dose due to low energy electrons and photons on a micro-
scopic cell. The number of ionisations and energy deposited in a modelled cell cytoplasm
and nucleus was calculated for the photon and electron energies studied, relevant to out-of-
field radiation in photon radiotherapy. The cell model consisted of a 5 µm radius spherical
cell containing a 2 µm radius spherical nucleus with the approximated chemical composition
of each. Geometry of this scale allowed for the application of low energy physics models,
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rather than event-by-event tracking such as Geant-DNA (which is only applicable in liquid
water at present). The study showed there are proportionally more ionisations occurring in
the cytoplasm, compared to the cell nucleus and that the composition and size of cellular
structures is important when considering out of field dose in photon radiotherapy.
Nanoscale Geant4-DNA simulations calculate the dose effects as well as ionisation clus-
tering from particle tracks [99, 100]. Lazarakis et al. (2012) examined the nanoscale dose
effects and track structure due to particle interactions in nanosized volumes [99, 100]. This
research used Geant4-DNA to calculate the effect of magnetic field on the track structure of
protons, electrons and alpha particles [99]. The Geant4-DNA code was compared with the
PTB MC track structure code PTra, finding most difference in the simulation of electrons
below 300 eV [100].
Lazarakis et al. (2018) recently investigated the energy deposition by electrons in liquid
water with various physics models and parameters selected in Geant4. Liquid water spheres
of increasing diameter (from 1 nm to 1 m) were modelled with electron beams of energies
from 50 eV to 10 keV. This study reported the agreement between condensed history and
track structure models available in Geant4. The best agreement between the condensed
history and Geant4-DNA models was reported to be for Livermore with a low (10 eV) cut,
compared to Penelope and higher production cuts.
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1.5 Summary
Nanoparticles show a great potential for enhancement of radiation therapy including photon
radiotherapy and proton therapy. The enhancement of the dose delivery to a tumour volume
may allow for the reduction in the overall dose delivered to normal tissue, reducing the
likelihood of adverse effects to the patient such as secondary cancer induction. Studies in the
field of NP dose enhancement of radiation therapy have demonstrated the dose enhancement
in simulation, cell, and small animal studies, as described in the literature review.
The body of research in this field aims to ultimately incorporate NP-induced enhancement
into radiation therapy treatments in order to improve outcomes for patients. Preliminary
clinical trial studies of the safety of nanoparticles for use in humans have shown promising
results as to their safety for use in a clinical setting [50]. The effect on cells and tissues of
NP combined with radiation is a combination of biological, chemical and physical interac-
tions. For the ultimate goal of clinical implementation of NP enhanced radiation therapy
to be realised, a detailed understanding of the physical mechanism of dose enhancement is
required. The further elaboration of the fundamental physical interactions within a NP and
in surrounding medium is an important area of study in this field.
The fundamental cause of potential physical dose enhancement in different radiation ther-
apy modalities including conventional megavoltage and kilovoltage X-ray as well as proton
therapy is an important aspect to study as different effects will come into play for varying
photon energy, and particle types. Monte Carlo simulations provide a useful tool to inves-
tigate NP induced dose enhancement in radiation therapy. The effect of the size, shape,
concentration and distribution of NPs within a cell volume is important when studying the
dose enhancement deriving from NPs in radiotherapy.
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This thesis will describe several Geant4 Monte Carlo simulations designed to investigate
multiple aspects of NP-induced enhancement of radiation dose in clinical radiation therapy
fields. Enhancement of dose in cells due to novel ceramic oxide NPs as well as the nanoscale
dose distribution around a single nanosphere of variable material are investigated by means
of customised Monte Carlo simulations. The limitations of the Monte Carlo models used are
investigated and discussed in the context of nanoscale simulations. Ultimately, this thesis
aims to present various techniques used and results of studies of several factors influencing
the enhancement of radiation dose due to NPs.
Chapter 2 describes the results of the Monte Carlo simulation study of dose enhancement
from novel ceramic oxide NPs irradiated with realistic kilovoltage and megavoltage pho-
ton radiotherapy treatment beams. Chapter 3 describes the extension of the application
described in Chapter 2 to the investigation of dose enhancement in realistic cell geometry,
examining the effect of NP aggregation and morphology.
Chapter 4 examines the nanoscale radial dose distribution around high-Z NPs in proton ther-
apy. A customised Geant4 Monte Carlo code has been developed to allow the modelling of
proton interactions in a nano-sized volume of ceramic oxide material and to track secondary
particles to the level of the DNA, in water. A study was performed to evaluate the effect of
plasmon excitations on the secondary electron yield originating from a carbon NP, due to an
incident proton beam typical of the Bragg peak position in proton therapy. This work was
performed in collaboration the MBN Research Center in Frankfurt, Germany and the Monte
Carlo simulation aspect of this study was developed as part of this PhD project. Results of
this study have been published in Verkhovtsev et al. (2015b) and are included in Chapter 4.
This work is an important contribution to the body of research into NP enhanced radiation
therapy as the fundamental physical dose enhancement must be understood in combination
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with biological and experimental results. Chapter 5 summarises the outcomes of this project
and outlines directions for the future development of this work.
Chapter 2
Dose Enhancement by Nanoparticles in
Conventional X-Ray Radiotherapy
The enhancement of photon radiotherapy by gold and ceramic oxide NPs has been demon-
strated in experimental studies described in Chapter 1. This chapter now presents the first
Monte Carlo simulation study of the dose enhancement in conventional X-ray radiotherapy
by novel ceramic oxide NPs. This is the first study aimed to calculate and quantify the
dose enhancement, secondary electron spectrum and LET of secondary electrons produced
within novel ceramic oxide NPs with respect to gold NPs in kilovoltage or megavoltage pho-
ton fields. Of the ceramic oxide NP materials studied Ta2O5 and Bi2O3 are investigated as
potential radio-enhancers whilst CeO2 is known as a radio-protector (see Chapter 1). Gold
was selected for comparison as it is a well known and widely studied radio-enhancer (see
Chapter 1).
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2.1 Methods: the Geant4 simulation application
Monte Carlo simulations were performed using Geant4 version 9.6 patch 2 and version
10.1 to verify the consistency of the results between the two versions of the Geant4 toolkit
[67, 68]. The simulation set-up consisted of an array of spherical water volumes with 10 µm
diameter, modelling cells. The array of cells is shown in Figure 2.1 placed in a water phan-
tom at a depth of 6 mm or 25 mm corresponding approximately to the depth of maximum
energy deposition in the case of a kilovoltage and megavoltage beam, respectively. The lo-
cation of the cells is also dictated by the necessary experimental conditions, as described in
refs [22, 32].
A 10 µm diameter spherical NP is located in the centre of the cell array, as shown in Figure
2.1b, modelling an aggregate of NPs. The material of this NP aggregate sphere is defined
as Au, CeO2, Ta2O5, Bi2O3, or water in the case of no NP. Modelling of cells and the NP
aggregate as simple spherical volumes is an approximation which does not take into account
the real morphology of NP aggregate or cells however this approach is adequate to compare
the different NPs in terms of energy deposition and secondary electron spectra.
The Low Energy Electromagnetic Physics package [103] with Penelope physics models was
selected to describe particle interactions. This choice was dictated by the capability of the
Penelope model to track secondary electrons down to 100 eV (limit recommended in ref
[91]), coupled with shorter simulation execution times compared to Geant4-DNA very low
energy extensions. Although event-by-event Monte Carlo codes are the state of the art to
study the effect of radiation at cellular and subcellular level, Stewart et al. (2002) showed that
Penelope physics models can be used to estimate physical quantities of interest at cellular
level with an agreement between 1% and 25% with event-by-event Monte Carlo codes when
calculating the mean specific energy. Lazarakis et al. (2018) reported the difference between
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(a) Y-Z plane (b) X-Y plane
Figure 2.1: Geometry of cell array with solid NP sphere.
types of physics models in Geant4 and showed that for a target diameter applicable in this
project (10 µm) results from condensed history models correlate well with track structure
models such as Geant4-DNA. Atomic deexcitation, including Auger electron emission and
fluorescence, were modelled in the simulation.
A 100 µm × 100 µm square photon source was incident normally on the edge of the phan-
tom. Figure 2.2 shows the incident photon spectra. The kilovoltage photon source spec-
tra used were provided by Prince of Wales Hospital, Randwick and were modelled using
the SpekCalc software [105]. The 150 kVp spectrum (Figure 2.2b) was simulated using
SpekCalc v1.1 and corresponds to the beam generated by a Nucletron Oldelft Therapax
DXT 300 Series 3 Orthovoltage unit (Nucletron B.V., Veenendaal, The Netherlands) peak
accelerating potential of 150 kV, Tungsten anode, inherent filtration of 3 mm Beryllium, ad-
ditional filtration of 1.5 mm Aluminium and 0.35 mm Copper; first half value layer (HVL) of
0.67 mm Cu [105]. The 125 kVp spectrum was also obtained using the SpekCalc software
and corresponds to the beam generated with peak voltage of 125 kV, Tungsten anode, in-
herent filtration of 3 mm Beryllium, additional filtration of 2.5 mm Aluminium and 0.1 mm
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Copper; first HVL of 0.285 mm Cu. The 10 MV spectrum was obtained from ARPANSA
[104].
The dose enhancement from each NP material in the kV and MV photon radiation fields
compared to dose in the water phantom, without NPs, are studied. The total dose delivered
to each of the cells was calculated as well as the secondary electron spectrum and the re-
sulting LET of electrons entering cells. The spectrum of the secondary electrons originating
from each type of photon interaction modelled (photoelectric, Compton scattering, pair pro-
duction) was examined for each NP material. The proportion of these secondary electrons
escaping each NP volume was also scored. The resulting LET of secondary electrons was
determined using the secondary electrons’ kinetic energy, and electron stopping power data
from ref [106].
The dose enhancement due to the presence of a high-Z NP sphere was calculated as a ratio
of the dose in the presence of the NP sphere to the dose with water in the NP sphere and























































Figure 2.2: Incident photon energy spectra modelled in the simulation study, in terms of
frequency per primary photon [104, 105]
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where DNP = dose in the cells with a NP sphere, and
D∗C = dose in the cells with a water sphere
The secondary electrons produced within the NP material, and entering cells in the array
were also analysed in terms of kinetic energy and LET. A comparison of electrons entering
cells in close proximity to the NP aggregate and cells further away allows an understand-
ing of the range of the physical dose enhancement effect. The mean energy of secondary
electrons emitted from the NP is compared to that of electrons from a water sphere and the
range of the secondary electrons is analysed.
2.2 Results
2.2.1 Dose enhancement produced by different NP types
The DER calculated (using Equation 2.1) for each NP material under study was mapped onto
2D maps. Dose enhancement maps are represented with square bins, although it should be
noted that in the simulation set-up the dose was in reality calculated in spherical volumes
of 10 µm diameter. The DER is determined by increased production of secondary electrons,
however, with higher density and Z, such electrons also tend to be absorbed more easily by
the NP itself.
Figure 2.3 shows the DER 2D maps obtained in the case of each photon spectrum under
study incident on a Au NP. The DER is maximum in the cell downstream of the high-Z
sphere and is also high in the cells adjacent to the sphere. It is important to note than the
scale on the 2D DER maps from the megavoltage incident beam simulation is five times
smaller than the scale applied to the kilovoltage due to the much lower DERs observed in
















































































































































































































































































































































































































































































































































































































































































Figure 2.3: DER distribution due to Au NP in a 10 MV (top row), 150 kVp (middle row),
and 125 kVp (bottom row) photon radiation field. Layers 1-3 are defined in Figure 2.1a.
in the cell immediately downstream of the high-Z gold sphere with a 125 kVp incident
photon radiation field. This compared to a maximum DER in the same cells of (7.07 ±
0.17) in the 150 kVp and (1.13 ± 0.04) in the 10 MV photon radiation fields. The dose
enhancement observed in the 10 MV photon radiation field is more subtle than the lower
energy photon fields. The dose enhancement in the kilovoltage photon radiation field is due
primarily to an increase in photoelectric interactions, however in the 10 MV photon field
Compton scattering is the more dominant process (see Figure 1.4a) and the enhancement of
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photoelectric interactions is lower.
Figure 2.4 shows the DER maps due to a 10 µm sphere of Bi2O3 in the cell array with each
of the three photon radiation fields under study. A maximum DER of (7.20 ± 0.16) was
found for the case of the Bi2O3 NP with a 125 kVp incident photon radiation field. This is
a significant enhancement in the cell immediately behind the NP sphere, compared to that
seen in the presence of the Au NP sphere of (7.50 ± 0.15). Similar to the Au NP case, the
DERs due to the Bi2O3NP in the 10 MV photon radiation field are much less significant than
those calculated in the kV photon fields.
Figures 2.5 and 2.6 show the DER maps due to Ta2O5 and CeO2 NPs, respectively for
each incident photon radiation field. A maximum DER of (5.80 ± 0.08) is observed in the
cell immediately downstream of the high-Z Ta2O5 sphere with a 125 kVp incident photon
radiation field. This compared to a maximum DER of (5.29 ± 0.12) in the 150 kVp photon
beam and (1.03 ± 0.03), or a negligibly small enhancement, in the 10 MV case. A maximum
DER of (5.38 ± 0.11) is observed in the cell immediately downstream of the CeO2 sphere
with a 125 kVp incident beam. This compared to a maximum DER of (5.27 ± 0.11) in the
150 kVp beam and (1.05 ± 0.02) in the 10 MV case.
The DER calculated for the cell immediately behind each NP type and energy studied is
shown in Table 2.1. This is also the maximum DER of all cells (DERmax) in all NP cases
and occurs due to forward ejected electrons being in close proximity to this cell. The mean
total DER over all the cells and the DER with depth of slice, or layer (shown in Figure 2.1a)
were calculated in order to analyse the difference in enhancement depending on location of
the NP sphere with respect to the cells. The total DER calculated across the array and for
















































































































































































































































































































































































































































































































































































































































































Figure 2.4: DER distribution due to Bi2O3 NP in a 10 MV (top row), 150 kVp (middle row),
and 125 kVp (bottom row) photon radiation field. Layers 1-3 are defined in Figure 2.1a.
It is observed that Au is the most enhancing NP material across the photon energies studied,
followed by Bi2O3. The radiosensitising Ta2O5 shows significant enhancement while the
radio-protector CeO2 shows the lowest radiation enhancement capability.
The 125 kVp spectrum simulations show more dose enhancement compared to the higher
energy, 150 kVp incident photons. This is due to the differences in the interaction cross-
















































































































































































































































































































































































































































































































































































































































































Figure 2.5: DER distribution due to Ta2O5 NP in a 10 MV (top row), 150 kVp (middle row),
and 125 kVp (bottom row) photon radiation field. Layers 1-3 are defined in Figure 2.1a.
The mean energy of the 125 kVp and 150 kVp incident photon fields are 60 keV and 73 keV
respectively. The K-edge for gold occurs at around 80 keV. The K-edge for other NP
materials are shown in Table 1.1.
The DER is much more strongly observed in both of the kilovoltage beams, compared to the
10 MV photon radiation field. However, experimental measurements with MV photon fields
















































































































































































































































































































































































































































































































































































































































































Figure 2.6: DER distribution due to CeO2 NP in a 10 MV (top row), 150 kVp (middle row),
and 125 kVp (bottom row) photon radiation field. Layers 1-3 are defined in Figure 2.1a.
than what is predicted by simulation [39, 41, 81]. This may be due to the biological and
chemical mechanisms not accounted for in the physical dose enhancement simulation.
The simulations show there is potentially an ability to select optimised beam energy to obtain
the maximum DER. Through the use of simulated results, beam energy could be selected to
target the maximum of the interaction cross-section of a NP material placed within a tumour,
whilst normal tissue damage is by comparison lower.
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Table 2.1: Total DER in all cells, in each cell layer, and in the cell immediately downstream
of the NP aggregate.






R 125 kVp 2.34 ± 0.01 1.90 ± 0.01 1.74 ± 0.01 2.18 ± 0.01
150 kVp 2.37 ± 0.01 1.90 ± 0.01 1.77 ± 0.01 2.15 ± 0.01







R 125 kVp 1.97 ± 0.02 1.62 ± 0.01 1.49 ± 0.01 1.83 ± 0.01
150 kVp 2.04 ± 0.02 1.64 ± 0.01 1.52 ± 0.01 1.83 ± 0.01







R 125 kVp 2.87 ± 0.03 2.26 ± 0.02 2.07 ± 0.02 2.63 ± 0.02
150 kVp 2.80 ± 0.02 2.18 ± 0.01 2.07 ± 0.01 2.52 ± 0.02







R 125 kVp 2.21 ± 0.02 1.85 ± 0.02 1.69 ± 0.01 2.09 ± 0.02
150 kVp 2.27 ± 0.02 1.88 ± 0.01 1.72 ± 0.02 2.10 ± 0.02







R 125 kVp 7.50 ± 0.15 5.80 ± 0.08 5.38 ± 0.11 7.20 ± 0.16
150 kVp 7.07 ± 0.17 5.29 ± 0.12 5.27 ± 0.11 6.48 ± 0.14
10 MV 1.13 ± 0.04 1.03 ± 0.03 1.05 ± 0.02 1.05 ± 0.02
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2.2.2 Secondary Electron Spectra and LET
The high DER observed in the cells around the high-Z NP spheres is due to electrons
knocked out from the high-Z NP materials. The kinetic energy and resulting LET of sec-
ondary electrons entering all cells in the array were analysed with and without the NP in-
cluded and with respect to different NP materials. Figure 2.7 shows the LET of secondary
electrons created within the NP region, with respect to the type of NP and Figure 2.8 shows
the LET of those electrons which then escape the NP volume. There is a significant increase
in high-LET secondary electron production observed in both the 125 kVp and 150 kVp sim-
ulations in the NPs compared to water. The increased production of secondary electrons is
less significant in the 10 MV simulation.
The LET of emitted electrons in Figure 2.8 effectively show the characteristics of the sec-
ondary electrons created within the NP which are not self-absorbed by the NP before escap-
ing the volume. The number of escaping electrons is clearly much smaller (relative to the
case of a water sphere) in the 10 MV compared to both of the kilovoltage simulations.
Figure 2.9 shows the kinetic energy spectra of electrons entering all of the cells for each























































































































































































Figure 2.8: LET of secondary electrons created within the NP and escaping the NP with
each incident photon beam.
Kinetic Energy (keV)






















































































Figure 2.9: Kinetic energy spectra of secondary electrons entering all cells in the array with
each incident photon radiation field.
trons. These figures show the enhanced number of secondary electrons, compared to water.
Electrons counted in this situation include those created within the NP volume as well as















































































































At creation in NP
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At creation in NP
Leaving NP
Entering cells
(b) 10 MV radiation field
Figure 2.11: LET of secondary electrons originating within the Au NP, escaping the Au NP,
and entering all cells in the array in each radiation field. Points without minimum error bars
have errors which go below zero.
Figures 2.9 and 2.10 show, in the kinetic energy and resulting LET respectively, clear en-
hancement of electrons entering into the cells of the population due to different NP materials
in the two kilovoltage beams. It can be observed that in the case of the megavoltage photon
field there is no significant enhancement. This happens because at MeV energies Compton
scattering dominates and the cross-section is independent from the atomic number and so
the LET does not change. The photon interaction cross-sections are shown in Figure 1.4.
Figure 2.11 shows for the case of the Au NP a direct comparison of the secondary electron
spectra created within the NP, leaving the NP and the total spectra entering all cells, per
incident photon.
In both the 125 kVp and 10 MV photon field examples, the high-LET secondary electrons
produced in the NP (blue curves) are, to a large degree, absorbed within the NP. This can be
seen in the lower number of secondary electrons leaving the NP (red curves). The total spec-
trum of secondary electrons entering cells includes all sources, including those scattered in
from surrounding water medium. In the case of the 10 MV photon radiation field, there is








































































































Figure 2.12: LET of secondary electrons created inside the NP with three incident photon
radiation fields incident on NPs or water.
with a higher proportion of electron entering cells due to interactions of the higher energy
photons in the medium. This indicates that in general secondary electrons in the megavolt-
age photon radiation field will act over a larger range compared to those in the kilovoltage
case. Figure 2.11b shows on the same plot the secondary electron spectra created in and
escaping the NP and the increased lower-LET electrons entering cells. This shows that the
higher-LET secondary electrons produced in the NP are likely to be absorbed that there is
a greater number of lower-LET (high kinetic energy) secondary electrons entering the cell
population as a whole.
Figure 2.12 shows that the number of higher LET electrons produced in the NP is increased
for all materials studied with the lower energy photons in the 125 kVp and 150 kVp spectra
compared to 10 MV incident photon spectrum. A comparison of the LET of electrons
entering cells with 125 kVp, 150 kVp, or 10 MV incident beam shows the effect of the
beam energy on selectivity of enhancement from NPs in the kilovoltage photon irradiation.
It can be observed that in the kV beams the additional electrons have higher LET for all the
NP materials under study. In the 10 MV photon field the lower LET (higher kinetic energy)
electrons are more prominent than the high-LET, low range electrons and there is minimal
enhancement observed comparing the electron spectra with and without NPs.
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Figures 2.11 and 2.12 show LET of secondary electrons at various points in the simulation
geometry. These figures demonstrate the mechanism of dose enhancement in the cells.
Not all secondary electrons produced in and emitted from the NP materials will reach the
surrounding cells. The higher LET, low kinetic energy secondary electrons will have a lower
range, a lower probability to escape the NP, and a lower probability to reach the surrounding
cells compared to higher energy electrons. The range of secondary electrons depends on
their kinetic energy and on the material through which they are transported. The range of
low energy electrons in different materials is shown in Table 2.2 and Figure 2.13 with data
obtained from Berger et al. (2005).
Table 2.2 and Figure 2.13 demonstrate that the low energy part of the spectrum will have a
lower probability to escape the high-Z NPs if they are created at a distance greater than 1 µm
from the surface. These low energy electrons will also travel less than 10 µm in the water
medium before they are absorbed meaning the effect of these electrons will remain localised























Figure 2.13: Continuous-slowing-down approximation (CSDA) range of low energy sec-
ondary electrons in NP materials, and water, with respect to electron kinetic energy. Data
obtained from Berger et al. (2005)
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Table 2.2: Range of low energy secondary electrons in NP materials, and water, with respect













10 2.52 0.41 0.74 0.74 0.82
20 8.57 1.17 2.25 2.31 2.39
30 17.6 2.24 4.40 4.56 4.59
50 43.2 5.13 10.3 10.8 10.6
100 143.1 15.8 32.3 34.2 32.8
2.2.3 Effect of Atomic Deexcitation
Atomic deexcitation (AD) processes (Auger electron emission and fluorescence) are acti-
vated in the simulations. The effect of the secondary electrons produced from AD processes
was quantified by running paired simulations with and without the AD processes. The re-
sulting secondary electron spectra were then analysed and subtracted from one another in
order to extract the component of the spectra attributable to AD processes. Counts falling
within error of zero, or within error of the original spectra are disregarded. Similarly, the
effect on the DER was calculated. Figure 2.14 shows the spectra of secondary electrons that
originated from AD processes.
Atomic deexcitation electrons have low kinetic energy and therefore interact and deposit
dose close to the point of creation. This means that on the micron-scale of the cell array
simulated in this study the effect of AD electrons is effectively swamped by higher energy
secondary electrons. The effect of Auger electrons has been observed on the nanoscale [40];
however, this is not quantified in the present study due to the micron-size of the cell volumes




































































Figure 2.14: Kinetic energy and LET of secondary electrons originating from AD.
2.3 Discussion
These simulations demonstrate the effect of incident photon beam spectra on the dose en-
hancement capabilities caused by the difference in interaction cross-sections between high
and low energy photons, as described in detail in Chapter 1. Lower energy photons, as
found predominantly in the 125 kVp and 150 kVp X-ray spectra, are more likely to interact
by means of the photoelectric effect (shown in Figure 1.4). At higher photon energies (up to
10 MeV in the spectrum studied in this project) Compton scattering becomes the dominant
type of interaction. Therapeutic photon spectra (including the one referred to in this simula-
tion) are not monoenergetic, and the mean energy of photons is lower (around 2 MeV for the
10 MeV case) and therefore photoelectric interactions are not an insignificant component of
the photon interactions in the NP material.
Figure 1.5 shows the increased mass absorption coefficients of photons in gold compared to
water for the cases of pure gold, and a 1% solution of gold in water. Using the mass absorp-
tion coefficient ratios an estimate can be made of the increased photon absorption expected
in a solution containing gold. An increase in the mass absorption coefficient in a 1% gold
solution is estimated from this data to be 33%, 26% and 0.2% for the 125 kVp, 150 kVp,
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and 10 MV fields, respectively. This demonstrates the theoretical advantage of high-Z NP
induced enhancement of photon interactions being most prevalent for lower energy photons
(less than a few hundred keV). The contrast in the order of magnitude of the observed dose
enhancement in the cell simulation in the kilovoltage and megavoltage photon beams (from
Table 2.1, it is about 130% compared to 1%, respectively) is in agreement with this estimate
from the mass absorption coefficient ratio.
The simulation results in this chapter demonstrate a higher overall dose enhancement com-
pared to the theoretical estimate of increased photon absorption. This is due to the larger
mass of gold modelled as a spherical NP in the simulation rather than a homogeneous 1%
gold solution in water. The average effect of the increased probability of photon absorp-
tion is not the quantity calculated in this simulation as the aim was to examine the effect
of NP material in close proximity to modelled cells and the micron-scale effects rather than
the effect of a homogeneous solution of NP in water. The difference in dose enhancement
observed also promotes the importance of the study of realistic NP geometries and NP inter-
nalisation into cells or coating of cells (rather than homogeneous solution approximations)
when measuring and calculating dose enhancement in this type of situation, on the scale of
the cell.
Both the estimate based on the increase in the absorption of photons and the simulation study
presented in this chapter predominantly account for the effect of primary photons interacting
in the region of interest. The simulation does not take into account the total effect of all
electrons (e.g. Compton scattered) which are scattered into the region of interest, which may
form a significant portion of the dose deposited in the region close to the NP. The fact that
radiosensitisation of cells is observed under higher energy irradiation in experimental studies
[21, 32] indicates that there is an increase in the number of damaging particles reaching
cells which is not accounted for by the modelling of the photon and secondary electron
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interactions in this study.
In the case of the kilovoltage photons the increase in photoelectrons is a dominant factor.
However, the simulations show that local dose enhancement from increased secondary elec-
trons produced in the NP is a less significant component in the megavoltage photon field.
The simulations have shown a significant increase in secondary electrons with relatively
high-LET entering cells in the population in the case of the kilovoltage photon radiation
fields however there was no significant increase observed in the megavoltage photon radi-
ation field. The small increase in secondary electrons produced within the high-Z NPs in
the 10 MV field is not translated into an increase in secondary electrons entering cells in
the array due to the majority of created electrons being reabsorbed within the NP itself (as
demonstrated in Figure 2.8c). The effect on DER of the distance from the high-Z material
is further examined and discussed in Chapter 3.
2.4 Conclusion
The study of dose enhancement by ceramic nanoparticles in kilovoltage and megavoltage
photon radiotherapy beams incident on a modelled cell population has been investigated by
means of Geant4 simulations with results being presented in this chapter. The micron-scale
simulations presented in this chapter show that ceramic oxide NPs enhance the secondary
electron production and dose deposition in cells.
The fundamental physical interaction of incident photon radiation within high-Z NPs is in-
creased compared to water, with the highest increase observed in the kilovoltage primary
photon field, compared to the megavoltage field. This outcome is to be expected when the
photon interaction cross-sections for each photon energy range are compared. The prefer-
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ential dose enhancement in the kilovoltage photon fields is due to the strong dependence of
the photoelectric effect interaction cross-section with increasing atomic number of the NP
material where photoelectric interactions dominate at photon energies below about 100 keV
(see Figures 1.4 and 1.5 in Chapter 1). In the simulation study presented in this chapter, the
physical dose enhancement is observed to be in agreement with these theoretical interaction
probabilities.
All ceramic oxides studied (Bi2O3, Ta2O5 and CeO2) showed dose enhancement in com-
parison to water, and were most effective in the kilovoltage photon field. This is in agree-
ment with cell studies described in the Chapter 1 literature review. In the case of CeO2,
the literature describes a radio-protecting free radical scavenger with dose-enhancing high-
Z properties which act in a contradictory manner. The Geant4 simulations in this chapter
have shown that dose deposition is enhanced in the presence of CeO2 and this demonstrates
the need, when using this material as a radio-protector, to take into account the high-Z en-
hancement capabilities of this NP material, especially in the kilovoltage energy range where
photoelectric interactions are most important.
Briggs et al. (2013) reported a decrease in the radio-protection effect of CeO2 NPs in cells
with both 10 MV and 150 kVp photon irradiations. This cell survival study on the radiore-
sistant 9L rat brain gliosarcoma cells reported an increase in the cell killing effect of the
radiation in the kilovoltage X-ray field. This observed effect is postulated to be attributable
to a change in the enhanced secondary electron production at this energy in particular, due to
the relatively high-Z of CeO2 (Zeff = 54). The Geant4 simulations presented in this chapter
support this suggestion, as they have shown the dose enhancement effect of CeO2 NPs to
be significant, compared to other known radiation enhancing NPs such as gold and Ta2O5.
The effect is especially prominent in the kilovoltage photon fields, which corresponds to the
experimental results previously reported by Briggs et al. (2013).
2.4. Conclusion 65
The role of the shape and distribution of NPs on calculated dose enhancement within a
simulation is further investigated in Chapter 3.
Chapter 3
Characteristics of Ceramic Oxide
Nanoparticles
This chapter will describe studies of particular types of ceramic oxide nanoparticles and their
distribution amongst cells. The dose enhancement effect of Ta2O5 and Bi2O3 NP materials
is studied in detail in terms of the concentration and distribution of NPs. The effect of
the NP distribution and shape is investigated by means of a modification of the simulation
formalism explained in Chapter 2.
3.1 Enhancement by Bi2O3: Dependence on NP Shape
Unlike gold NPs, which are predominantly spherical in shape [39], Bi2O3 NPs tend to ex-
hibit a flatter morphology [33], and can be described more precisely as NP “plates” or as
having a platelet morphology. Figure 1.7 in Chapter 1 shows the platelet morphology of
Bi2O3 NPs fabricated in the study published in the journal article Stewart et al. (2016) (see
Appendix A). The Bi2O3 NP plates tend to lie flat on top of cells in the experimental cell
culture.
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This Monte Carlo simulation study was aimed to investigate the physical mechanisms be-
hind the results of the cell experiments conducted at IHMRI at the University of Wollon-
gong, with respect to the shape of the NP aggregate in the cell culture.
3.1.1 Methods: the Geant4 simulation application
The same simulation application described in Section 2.1 was used with only the NP shape
changed. Several different geometries were selected for this study - a sphere (analagous to
Au NP), a plate (for Bi2O3 NP) of increasing thickness, and a cube to model the effect of a
bulk of NP. The dimensions of the shapes under study are: a sphere with 10 µm diameter, a
10 µm × 10 µm × 10 µm cube, a 10 µm × 10 µm × 1 µm plate, and a 10 µm × 10 µm × 5 µm
plate. Figure 3.1 shows the different geometries and NP aggregate positioning in the cell
array with the photon radiation field incident from the left.
The simulated 125 kVp and 10 MV radiation fields and the physics component are the same
as in the previously described simulation application, in Section 2.1. A total of 6 × 106
and 3.5 × 106 primary photons were incident on the phantom in order to achieve sufficient
statistical results in the kV and MV beam simulations, respectively.
The DER was calculated as per Equation 2.1. A weighted dose enhancement ratio (DERw)
was also used to evaluate the effect of NP shape with respect to the total mass of NP placed
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(a) Sphere (X-Y cross-section) (b) Sphere (c) Plate (1 µm, centred)
(d) Plate (1 µm) (e) Plate (5 µm) (f) Cube (10 µm)
Figure 3.1: Shapes of Bi2O3 NP aggregate under study and placement within cell array.
Note that the beam is incident in the positive z-direction, shown here in Fig.3.1b.
3.1.2 Results
The dose enhancement produced by the Bi2O3 sphere, cube, and plate placed in the cell
array was calculated in terms of DER shown in Equation 2.1. The DER in each cell in
cell layer 3, “downstream” of the NP, are shown in 2D maps in Figure 3.2 in the 125 kVp
photon field. The top row of the 2D maps shows for each cell the calculated DER whereas
the bottom row shows the DERw, scaled to the mass of NP in the geometry according to
Equation 3.1, in order to examine the dose enhancement per unit mass of NP dependence






































































































































































































































































































































































































































































































































Figure 3.2: DER maps of cell layer 3 in 125 kVp radiation field with Bi2O3 NP material in
different geometrical configurations a: Sphere, b: Cube and c: Plate (placed at the edge of
cell layer 3, as shown in Figure 3.1d). Bottom row shows DERw scaled to mass of Bi2O3 in
the different shapes.
on the geometry.
It can be observed in the 125 kVp photon field that the DER obtained in the case of a cube is
larger than that of the sphere and plate configurations, however, the DERw scaled to the mass
of NP, the plate geometry is superior in terms of dose enhancement. This is due to the higher
surface area to volume (SA:V) ratio in the case of the plate (2.4 × 106 m−1), compared to the
surface area to volume ratios of the cube and sphere (both equal to 0.6 × 106 m−1). The
results for the 10 MV incident beam simulation are not shown as the 2D DER maps showed
no significant enhancement of the megavoltage beam.
Table 3.1 shows the DER due to each NP shape with respect to depth of cell layer and
incident photon radiation beam energy. The total DER in the cell population is reported as
3.1. Enhancement by Bi2O3: Dependence on NP Shape 70
Table 3.1: DER with respect to NP aggregate shape in kV and MV photon radiation fields.
Layer 1, 2 and 3 refer to cell layers defined in Figure 2.1a.
125 kVp
DER Sphere Cube Plate
Layer 1 (1.83 ± 0.01) (2.60 ± 0.02) (1.15 ± 0.01)
Layer 2 (2.63 ± 0.02) (4.20 ± 0.02) (1.40 ± 0.01)
Layer 3 (2.09 ± 0.02) (3.06 ± 0.02) (1.87 ± 0.01)
Total (2.18 ± 0.01) (3.27 ± 0.02) (1.48 ± 0.01)
10 MV
Layer 1 (1.004 ± 0.006) (1.02 ± 0.01) (1.00 ± 0.01)
Layer 2 (1.004 ± 0.007) (1.02 ± 0.01) (1.00 ± 0.01)
Layer 3 (1.007 ± 0.004) (1.021 ± 0.004) (1.00 ± 0.01)
Total (1.005 ± 0.004) (1.02 ± 0.01) (1.002 ± 0.005)
well as the average DER in each cell layer, including layer 3 immediately downstream of
the NP Bi2O3 NP aggregate. It can be observed that the DER obtained in the case of a cube
is larger than that of the sphere and plate configurations. However, when the enhancement is
scaled to the mass of NP the advantage of a plate geometry becomes clear. Table 3.2 shows
the DERw scaled with respect to NP mass, for three NP shapes simulated in the 125 kVp
and 10 MV photon fields.
The data in Tables 3.1 and 3.2 clearly show higher DER in the kilovoltage case, compared to
insignificant enhancement in the megavoltage photon field simulation. The DER is observed
to be higher in the kilovoltage case, compared to the megavoltage with a total DER of (2.18 ±
0.01), (3.27 ± 0.02), and (1.48 ± 0.01) around the Bi2O3 sphere, cube and plate respectively
in the kilovoltage beam compared to (1.005 ± 0.004), (1.02 ± 0.01), and (1.002 ± 0.005)
for Bi2O3 sphere, cube and plate with the 10 MV beam. The increasing DER corresponds
to increasing mass of Bi2O3 NP placed within the geometry.
When the enhancement is scaled to the mass of NP (per g NP) the weighted dose enhance-
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Table 3.2: DERw with respect to NP aggregate shape weighted to total NP mass in kV and
MV photon radiation fields. Layers 1, 2 and 3 refer to cell layers defined in Figure 2.1a.
DERw 125 kVp
(/gNP) Sphere Cube Plate
Layer 1 (1.77 ± 0.01)×108 (1.80 ± 0.01)×108 (1.64 ± 0.01)×108
Layer 2 (3.51 ± 0.02)×108 (3.59 ± 0.02)×108 (4.53 ± 0.03)×108
Layer 3 (2.34 ± 0.02)×108 (2.31 ± 0.01)×108 (9.82 ± 0.07)×108
Total (2.53 ± 0.01)×108 (2.56 ± 0.01)×108 (5.34 ± 0.02)×108
10 MV
Layer 1 (0.00854 ± 0.00005)×108 (0.0175 ± 0.0001)×108 (-0.0403 ± 0.0002)×108
Layer 2 (0.00745 ± 0.00004)×108 (0.0273 ± 0.0002)×108 (0.0421 ± 0.0003)×108
Layer 3 (0.0152 ± 0.0001)×108 (0.0236 ± 0.0002)×108 (0.0578 ± 0.0003)×108
Total (0.01042 ± 0.00004)×108 (0.0228 ± 0.0001)×108 (0.0195 ± 0.0001)×108
ment ratio (DERw) in the 125 kVp field becomes (2.53 ± 0.01)×108g−1,
(2.56 ± 0.01)×108g−1, and (5.34 ± 0.02)×108g−1 for the sphere, cube, and plate geometries,
respectively. The very low DER calculated in the 10 MV fields results in DERw that are
insignificant and orders of magnitude smaller than in the 125 kVp case shown. It is clear
from the scaled DERw shown in Table 3.2 that the plate is the most effective geometrical
configuration, with respect to NP mass. This is due to the increased proportion of sec-
ondary electrons able to escape the NP, enter surrounding cells, and deposit extra dose in
those cells. The plate has a SA:V ratio which is four times higher than that of the cube or
the sphere. Consequently, a higher proportion of electrons (from these simulation results,
approximately five times) created within the plate go on to escape the NP volume in the
simulation compared to either the cube or sphere.
Figure 3.3 shows in the 125 kVp field for all geometries simulated the DER and DERw with
respect to radial distance from the centre of the NP aggregate, in layer 2 (shown in Figure
3.1). Figure 3.3a shows the DER is highest in the case of the 10 µm sided cube followed by









































Figure 3.3: DER and DERw in layer 2 with respect to radial distance from the aggregate
centre in 125 kVp photon radiation field with Bi2O3 NP material in different geometrical
configurations.
the 5 µm wide plate and 5 µm radius sphere with the lower DER observed for the 1 µm wide
plates placed either in the centre of the array, or against layer 3 (bottom layer) of cells. These
results indicated that the DER is most effected by the total size (or mass) of NP aggregated
in the centre of the cell population.
Figure 3.3b shows that when scaled with respect to NP mass in the cell array, the narrow
1 µm plate geometry is the most effective geometry per unit mass due to the high surface
area to volume ratio previously described. The results show in the cell volumes close to
the NP aggregate the DERw is higher in proximity to the centred plate compared to the off-
centre plate. This is due to the fact that dose is calculated only in the spherical cells in the
array and so the centred plate has an advantage being in direct contact with, and centred on,
neighbouring cells in layer 2.
The change in DER and DERw with respect to radial distance from the aggregate centre in
cell layer 3 (below the NP aggregate) for the 125 kVp field are shown in Figure 3.4. In a
realistic cell population, the NPs tend to settle on top of a single layer of cells, as described
in the literature review section. Therefore, it is valuable to also examine the DER in layer 3









































Figure 3.4: DER and DERw in cell layer 3 with respect to radial distance from the aggregate
centre under 125 kVp photon radiation field with Bi2O3 NP material in different geometrical
configurations.
of cells below the NP aggregate. Figure 3.4 shows the dose enhancement (DER and DERw)
in this cell layer. Again, before scaling to mass of NP, the 10 µm sided cube has the highest
DER, however the 5 µm wide plate has a similarly high DER effect. The 1 µm wide plates
are observed to result in a lower dose enhancement, with preferential enhancement found
when the thin NP aggregate plate is in close proximity to the cell layer. When the dose
enhancement is calculated with respect to NP mass in the aggregate the plate geometry is
again the most efficient enhancer, in terms of DERw.
Figure 3.3 shows the high DER in close proximity to the NP drops significantly at distances
of 20 - 30 µm from the NP material, in layer 2. Figure 3.4 shows the same drop-off in layer
3, behind the NP aggregates. Comparing the radial dependence of DER observed around a
1 µm plate centred in the geometry to the identical plate placed against layer 3 demonstrates
the dose enhancement effects of both plate positions are similar in cells at and beyond a
radial distance of 20 µm. In the cells closest to the NP aggregate the 1 µm plate placed in
closer proximity to the cells in layer 3 results in a higher DER compared to the same plate
placed at the centre, 5 µm from the cell layer.
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The radial dependence of the DER in the case of the 10 MV photon radiation field is shown
in Figure 3.5. As indicated previously by the DER data presented in Tables 3.1 and 3.2 the
DER in the megavoltage radiation field is much lower than in the kilovoltage case. This is
again reflected in the plot of DER with respect to radial distance. The DER is highest in
the cells closest to the NP aggregate for all geometries studied, however in contrast to the
kilovoltage case, the DER increases after initially dropping off from the initial maximum.
This is due to the difference in the quality of the secondary electron spectra generated from
the megavoltage photon field. Figure 2.12c in the previous chapter showed the LET of sec-
ondary electrons entering all cells in the population with respect to photon radiation field
spectra. In the case of megavoltage photon spectra, there are more low-LET electrons enter-
ing the cells, compared to in the kilovoltage photon radiation fields. High-LET electrons, by
their very definition, are more likely to deposit their energy close to their origination point
due to their lower range. Electrons with energy greater than about 50 keV can have a range
which is greater than the cell at the furthest distance from the NP aggregate in the cell pop-
ulation (see Figure 2.13). The CSDA range of, for example, a 1 MeV electron in water is
more than 4 mm. The mean kinetic energy of secondary electrons entering cells in the pop-
ulation within a 10 MV photon radiation field is approximately 2.2 MeV. These electrons
can have a range that is greater than 10 mm and will therefore deposit much of their energy
at a large distance from the point of interaction with a NP. The secondary electrons from the
kilovoltage photons will, in contrast, deposit their energy more locally and so a larger dose
enhancement is observed in cells close to the high-Z NP aggregates in this case.
The kinetic energy spectra as well as the linear energy transfer (LET) of secondary electrons
entering the cells in the array were analysed to assess the change in the quality of the sec-
ondary electrons due to the presence of each NP aggregate geometry. Figure 3.6 shows the
effect of Bi2O3 NP geometry on the secondary electron spectra and LET with each photon
radiation field under study.




























Figure 3.5: Radial dependence of the DER in a 10 MV photon radiation field with respect


























































































































Figure 3.6: Kinetic energy and LET spectra of secondary electrons entering all cells with
incident 125 kVp, (a) and (b), and a 10 MV photon radiation fields, (c) and (d). Bi2O3 NPs
in the three geometrical configurations are compared to water (hollow circle).
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Figures 3.6c and 3.6d show the secondary electron spectra and LET are not significantly
enhanced by the placement of the Bi2O3 NP in the 10 MV photon beam. This is in contrast
to the kilovoltage case (Figure 3.6a and 3.6b) where it is clear there is enhancement of the
secondary electron production with the greatest increase in number of secondary electrons
observed in the case of the cube geometry, followed by the sphere and plate.
These secondary electron spectra support the DER reported in Figure 3.2, and Table 3.1 for
the 125 kVp and 10 MV photon fields. The enhancement of secondary electron production
is dependent on the geometry, with the cubic geometry providing the highest number of
secondary electrons due to the absolute increase in the mass of Bi2O3 NP material placed in
the cell array. When the increase in DER is calculated with respect to mass of NP (DERw),
it is clear that the plate geometry is the most efficient radio-enhancer, with respect to mass
of NP. This is due to the increased chance of secondary electrons to be absorbed within
the NP aggregate itself with increasing geometrical size. The plate geometry allows more
electrons to escape the surface as the thickness of the plate is 1 µm, which is less than the
range in Bi2O3 of a 12 keV electron [106], meaning most of the electrons will be able to
escape the NP aggregate. By contrast, the range of a 50 keV electron in Bi2O3 is 10.6 µm
which means electrons with energy lower than this, created in the centre of the cube will
have a low probability of escape.
Secondary electrons can also be analysed in terms of those entering cells either in front of or
behind the NP aggregate. Essentially this is a means of identifying the effect of forward- or
back-scattering of electrons in addition to the total of all scattered electrons in the phantom
which then enter the cells of interest. Figure 3.7 shows the LET of secondary electrons scat-
tered forward or back from the NP aggregate. The calculated LET show a slight preference
for forward scattering of electrons in the case of sphere or cube NP aggregates. The figure
shows that for the case of the Bi2O3 NP plate, positioned at the surface of cell layer 3 (see









































































Figure 3.7: LET of secondary electrons entering cells behind (circles) and in front of
(crosses) the NP aggregate.
Figure 3.1d) there is a stronger influence of electrons scattered forward than backward due
predominantly to the fact that back-scattered electrons must travel through at least 9 µm of
water before reaching layer 1 cells.
Atomic deexcitation simulated in this study only accounted for about 1% of the DER cal-
culated, which is within the calculated error margins. The effect of AD processes would
only be on cells local to the NP material, and predominantly on a nanoscale, due to the low
energy and low range of the AD secondary electrons. The effect of AD electrons on the dose
enhancement is observed to be small in this simulation due to the use of micron sized vol-
umes to score the total dose to cells in the array. Auger electrons have a significant impact
at the nanometre scale, close to the surface of the NP. However, this effect is less significant
on the cellular level, as modelled in this part of the project. A simulation examining dose
enhancing effects of Auger electrons and nanoscale damage to cells or DNA would require
the implementation of event-by-event simulation models, such as Geant4-DNA. However in
this study, only the macroscopic effect of the high-Z Bi2O3 NP, on the level of the cell is
studied.
The next section of this chapter (Section 3.2) looks in more detail at the effect of the proxim-
ity to a sensitive volume the NP material has on dose enhancement, including, in particular,
the dose enhancement attributable to atomic deexcitation electrons.
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3.1.3 Summary
The Geant4 simulations demonstrated that in the kV photon field Bi2O3 had considerable
dose enhancement properties locally with a dependence on NP geometry. The dose en-
hancement was shown to be significant (DER around 2-3 in the cell population, depending
on geometry) in the 125 kVp photon field compared to a very small dose enhancement
calculated in the 10 MV field. This is due to the strong increase in photoelectric effect
cross-section (which has strong dependence on Z) in the keV photon energy range whereas
Compton scattering dominates in the MeV energy range. This means that more photons are
likely to interact by Compton scattering in the 10 MV photon radiation field, resulting in
a difference in the secondary electron spectra, shown in Figure 3.6. In the 10 MV photon
field studied there was no significant dose enhancement observed for any of the Bi2O3 NP
morphologies. The simulation results for Bi2O3 under a kilovoltage beam are supported by
the experimental data published by Alqathami et al (2013) reporting a dose enhancement
factor of around 1.9 [23] although it is not possible to directly compare this experimental
dosimetric study with the simulation conditions.
The simulation study shows that the geometry of the Bi2O3 aggregate affects the DER and
the kinetic energy spectrum of secondary electrons. In particular the plate geometry is the
most effective per unit NP mass because more electrons, originated in the plate, can reach
the surrounding cells with a lower probability of being self-absorbed by the NP. This is due
to the higher surface area to volume ratio, a measure of the geometrical advantage of each
shape. With a higher surface area available per unit mass of NP, the likelihood of electrons
escaping the bulk volume is increased.
The highest DER was observed in the cells surrounding the NP because of the low range of
secondary electrons. In the 10 MV photon radiation field the radial dose distribution shows
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that the dose enhancement ratio does not drop off in the same way as the kilovoltage with a
slight increase in DER shown at the edge of the cell population. This is due to the difference
in the secondary electron spectrum in the 10 MV photon radiation field compared to the
kilovoltage photon field. The local DER observed remains very small compared to those
found in the kilovoltage case.
3.2 Comparison of Ta2O5 NPs distributed in Shells or in
Homogeneous Solution
A simulation study was performed to evaluate the effect of the geometrical distributions of
Ta2O5 NPs in cell cultures. This study aims to investigate the physical effect of varying
thickness of NP shell and geometrical distribution within a cell array on the DER and sec-
ondary electron spectra in cells. Shell thickness was shown experimentally to be related
to increasing the delivered NP concentration and this behaviour is further investigated by
means of Monte Carlo simulation in this project.
3.2.1 Motivation for the study
Cytotoxicity experiments conducted by researchers within the University of Wollongong’s
TNT research team, and published in Brown et al. (2013 and 2017) showed that exposure of
the 9L cells to a higher concentration (500 µg/ml) of Ta2O5 NPs does not significantly in-
crease the toxicity. In particular, photon irradiations using 150 kVp and 10 MV X-rays have
shown that irradiated 9L cells, exposed to a 10-fold increase in Ta2O5 NP concentration,
do not correspondingly indicate a significant decrease in cell survival, as may be expected
[22, 32].
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(a) control (b) 50 µg/ml (c) 500 µg/ml
Figure 3.8: Confocal microscopic image of elliptical 9L gliosarcoma cells with Ta2O5 NPs;
control (a), after exposure of concentration 50 µg/ml (b), and 500 µg/ml (c).
Subsequent confocal microscopic images of the cell population with a Ta2O5 solution in-
dicate that some NPs begin to form a “shell” around the cell nucleus. Figure 3.8 shows
representative confocal microscopic images of 9L cells with Ta2O5 NPs. The Ta2O5 NPs
are observed to form “shells” in the confocal image of the 500 µg/ml concentration (Figure
3.8c), compared to the 50 µg/ml concentration (Figure 3.8b). These confocal images were
acquired by co-authors of a paper published and provide the motivation for the Monte Carlo
simulation study [109].
Confocal images show that increasing the Ta2O5 concentration triggers the formation of
shells of NP material around cell nuclei with an increasing shell thickness, while leaving, on
average, a higher number of cells bare or with a limited number of NPs internalised. This
phenomenon also translates to a lower number of cell nuclei surrounded by NP shells, sepa-
rated, on average, by bigger distances. This means that some colonies of the cell population
have a small concentration of NPs, whereas other colonies have several neighbouring cells
with Ta2O5 shells, with high local concentration of NP material, as shown in Figure 3.8.
The hypothesis is that in the cell colonies characterised by high local Ta2O5 concentration,
the NP shell contributes to physically protect the cell and/or cell nucleus from the otherwise
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expected impact on cell survival, deriving from the combined NP exposure and irradiation.
Increasing the thickness of the Ta2O5 NP shell will increase the probability of photon inter-
action and subsequent secondary electron production. However, an increased Ta2O5 shell
thickness also increases the energy loss of any secondary electrons traversing the shell and
possibly produces self-absorption of low energy and Auger electrons generated within the
shell. This could translate to produce the saturation effect where adding more NP material
does not produce higher dose enhancement.
This study investigates the physical effect on the dose enhancement of varying the NP shell
thickness and distribution within a cell colony (called µ-phantom in the following sections),
characterised by a high local NP concentration. The simulation model is based on the local
NP distribution observed in the cell population, in the confocal images shown in Figure
3.8. The Geant4 Monte Carlo simulations provide insight into the physical mechanisms that
led to the experimental cell survival curves obtained by the TNT group at the University of
Wollongong.
3.2.2 Methods: the Geant4 simulation application
The simulation application is based on the same aforementioned simulation set up, as de-
scribed in Section 2.1, with the dimensions and spacing of the cells being modified in this
study. Figure 3.9 shows that the diameter of each cell was reduced to 8 µm in order to
approximate a cell nucleus, and the cell spacing was increased to 14 µm to allow for sur-
rounding the cells with up to 3 µm thick NP shells without causing geometry overlaps. The
8 µm diameter water spheres in this case are effectively modelling the cell nuclei of the 9L
gliosarcoma cells studied experimentally. The cell nuclei and shell spacing has been set
arbitrarily as currently the average distance between shells is not quantified experimentally.
The simulation set up resembled the configuration of clonogenic assay experiments carried
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Figure 3.9: Geometry of the modified cell array, Y-Z plane.
out to determine the cell survival curves. A 70 × 70 × 70 µm3 array of cells (called here cell
nuclei in a µ-phantom) was modelled, corresponding to experimental observations of differ-
ent NP shell distributions in cellular colonies (see Figure 3.8), which are limited portions
of the entire irradiated cellular population. The cell nuclei were placed within the water
phantom as previously described in Section 2.1.
The 150 kVp photon radiation field was incident with the same dimensions as described pre-
viously and with the energy shown in Figure 2.2b. The physics interaction models selected
remain the same as in the simulation application described previously, in Section 2.1.
The dose was calculated in the cell nuclei of the µ-phantom, in different NP shell configura-
tions. The kinetic energy spectra and LET of the secondary electrons, produced by the kVp
beam in the µ-phantom and in the NP shells, entering the cell nuclei have been calculated
to evaluate the change in radiation quality responsible for the cell damage. The LET was
calculated on the basis of the electron energy, using data from Berger et al (2005). The
effect of AD processes was examined as well.
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The dose enhancement ratio (DER) was evaluated as described in Equation 2.1, with and
without Ta2O5 NPs distributed in the µ-phantom. The dose enhancement was examined
with respect to increasing the NP concentration in the µ-phantom, compared to the dose
without the NP present.
This study allowed the comparison of different concentrations of NPs and varying distribu-
tions within a cell population, in terms of energy deposition and kinetic energy (and LET)
of secondary electrons. Two different types of NP distribution geometry were modelled:
1. shells of NP material placed around cells (shell distribution) and
2. a homogeneous distribution (homogeneous distribution) of NP material in water around
the cells
Configuration 1) and 2) have the same total concentration of NP material.
The cell array geometry with the Ta2O5 NPs distributed in shells about the cell nuclei is
shown in Figure 3.10 from a beams-eye-view of the µ-phantom. Several configurations of
shells were investigated in this study, from a maximum of 9 shells placed around the 9 central
cell nuclei of layer 2, shown in red in Figure 3.10a and then 8, 4 and a single shell (Figures
3.10b, 3.10c, and 3.10d, respectively). In Figure 3.10 shells have a thickness of from 1 µm
to 3 µm as labelled. These shell distributions were selected to model the behaviour observed
in clonogenic assay experiments, where some cells were observed to have no NP uptake,
some sections had only a few isolated cell nuclei with shells, whereas other sections had
many cells with shells close together in the colony. The DER in the central cell nucleus of
layer 2 and in the total cell nuclei array in the µ-phantom was investigated for different shell
distribution in order to study the effect of a NP shell touching the cell nucleus, the effect of
nearby shells and the combination of these effects.
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(a) Nine 1 µm shells (b) Eight 2 µm shells
(c) Four 2 µm shells (d) Single 3 µm shell
Figure 3.10: Configurations of geometry of cell array with Ta2O5 NP shells on cell nuclei in
layer 2 (Fig. 3.9) from a beams-eye-view of the X-Y plane
A first study was conducted to investigate the influence of the NP shell thickness on the dose
enhancement. The simulation configuration depicted in Figure 3.10d was adopted. The NP
shell around the cell nucleus was increased between 1 and 7 µm. The DER was calculated
in the central cell nucleus and compared for increasing shell thickness. This study was
performed to determine the thickness of the NP shell where a “saturation effect” can start
to be observed. The average range of secondary electrons originated by a 150 kVp beam
in Ta2O5 is less than 5 µm, therefore electrons which deposit energy in the cell nucleus are
those produced in a spherical layer of the NP with thickness equal to or less than their range
in Ta2O5. This means that the dose enhancement capability of thicker NP shells is impeded
by internal absorption of electrons, which translated in a saturation effect of the DER when
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1 6.5 16.2 29.7
4 26.0 64.7 118.7
8 51.9 129.4 237.4
9 58.4 145.5 267.1
increasing the NP shell thickness.
A second study was performed to compare the DER calculated with a distribution of NP
shells in the µ-phantom (presented in Figure 3.10), as observed experimentally (shown in
Figure 3.8), and, alternatively, with a homogeneous distribution of NP material in water,
with the same simulated concentration. This study allows the comparison of the DER due
to NP distribution on the micron scale and the tendency of the NPs in the cell culture to
congregate in shells around the cell nuclei, compared to being uniformly distributed among
cells. Liquid water was used to model the interior of each cell volume in all simulations.
The shell thickness was set equal to 1 µm, 2 µm or 3 µm in each configuration investigated,
to obtain higher concentrations of NPs in the cell population. Such shell thicknesses were
selected on the basis of the microscope observations such as the one depicted in Figure 3.8.
Table 3.3 reports the calculated equivalent local concentration of Ta2O5 in water for each
simulated number of shells and shell thicknesses. The local NP concentrations calculated
within the µ-phantom are high due to the localisation of material in a small volume of water.
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3.2.3 Results
3.2.3.1 DER in Single Cell Nucleus with Shell
Dose enhancement due to a Ta2O5 NP shell placed on the central cell nucleus in the µ-

































NP Concentration (mg/mL) 
Figure 3.11: DER in central cell nucleus of the µ-phantom with increasing shell thickness
of 1 to 9 µm (expressed as local NP concentration) of Ta2O5 NP shell around the central
cell nucleus, and equal numbers of incident photons. Data points are labelled with the shell
thickness (in µm).
The results of the simulation show the calculated DER increases quickly and then the in-
crease slows down for larger shell thickness. The initial increase in the DER is due to the
increasing quantity of high-Z Ta2O5 NP material in close proximity to the cell nucleus,
however, the rate of increase of DER is reducing with thicker NP shells because of self-
absorption of secondary electrons originated in the NP ceramic at a distance from the surface
larger than their range.
At the same time the thickness of the NP shell does not affect the global photon fluence
reaching the “active shell” close to the cells, from which the originated electrons will reach
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the cell nucleus. Further increasing the shell thickness will eventually lead to decreasing
DER due to photon attenuation as well.
The DER increases by 3 for each unit mg/ml increase in NP concentration, when varying the
NP shell thickness from 1 µm to 2 µm. This increase is only 0.1 per mg/ml NP concentration
when the NP shell thickness varies from 5 µm to 6 µm, which is an insignificant enhance-
ment when the error margins are taken into account. This means that the effectiveness of
the NP to enhance dose in the cell nucleus is reduced with increasing concentration of NP,
eventually resulting in no further enhancement at all and finally decreasing DER.
The effect on the DER in cell nuclei without a shell, but in close proximity to a cell nucleus
with a NP shell is revealed by examination of the DER with respect to distance from the cen-
tre of the µ-phantom, with increasing shell thickness on the central cell nucleus. Figure 3.12
shows the radial dependence of dose enhancement ratio for increasing shell thickness on
the central cell nucleus. The radial distances shown in this and the next figures are dictated
by the placement of the cell nuclei in the µ-phantom at distances of 14 µm from centre to
centre. The figure shows a sharp drop in dose enhancement in the cell nuclei located around
the shell (distance from centre ≥ 14 µm) compared to the DER in the central cell nuclei
(distance from centre = 0 µm).
Due to increased absorption of secondary electrons produced within greater thickness of NP
material the increased DER observed in the cell nuclei with the thickest layers begins to
plateau. This means for example that a larger increase in DER is observed when the shell
thickness is increased from 1 µm to 2 µm compared to 5 µm to 6 µm. This effect is quantified
by calculating the percentage increase in DER with respect to distance of cell nucleus/nuclei
from the centre of the µ-phantom. Figure 3.13 shows this behaviour of the DER with respect
to changing shell thickness. The figure shows the increase in the DER (as a %) at each radial
























Figure 3.12: DER due to a single, central Ta2O5 NP shell with respect to distance from the
centre of the µ-phantom. Note the radial distances are dictated by the cell positions and the
Y-axis is on a logarithmic scale.
distance from the central cell nucleus compared for increasing shell thickness.
Figure 3.13a shows the average effect of increasing the shell thickness by 1 µm increments
(e.g. from 1 µm to 2 µm, compared to 2 µm to 3 µm and so on). Higher energy electrons
are more likely to escape the Ta2O5 shell and also to reach the furthest cell nuclei without
being absorbed by the water medium which means the relative effect of increasing the shell
thickness by 1 µm is of a similar magnitude at greater distances from the central cell nucleus
about which the NP shell is placed. A large difference is seen at 0 µm (i.e. within the central
cell nucleus) due to the close proximity of the Ta2O5 NP material to the volume in which
the DER is calculated.
Figure 3.13b then compares the average effect of increasing the shell thickness by 1 µm up
to 5 µm increments averaged over all shell thickness increases studied. This figure shows the
effect of increasing shell thickness is observed to be large in the closest neighbouring cell
nuclei as well as the central cell around which the shell is placed. The effect at a distance
of 14 µm (i.e. in the closest neighbouring cell nuclei) of increasing the shell thickness from





















































(b) Average effect of increasing shell thickness
in +1 µm up to +5 µm increments.
Figure 3.13: Relative increase in DER due to increased thickness of a single, central Ta2O5
NP shell, with respect to radial distance from the centre of the µ-phantom.
1 µm to 6 µm (i.e. +5 µm), is an increase in the DER of 373%, compared to a 149% increase
in the central cell nucleus. This increase in the DER with increasing shell thickness is less
pronounced at greater radial distances from the central cell nucleus, dropping from 209%
at around 20 µm to 94% at 28 µm, as shown in Figure 3.13b. The behaviour observed can
be attributed to the combined effect of increased secondary electron production balanced
against increased absorption of secondary electrons within NP shells of increasing thickness.
The kinetic energy spectra and corresponding LET of electrons entering the central cell nu-
cleus are shown in Figure 3.14. The figure shows results for Ta2O5 shell thickness varying
between 1 µm and 7 µm. The number of secondary electrons per incident photon increases
with the shell thickness up to approximately 5 µm. For shell thickness greater than 5 µm
(corresponding to the average range of secondary electrons) the number of secondary elec-
trons does not increase significantly.
The mean kinetic energy of the secondary electrons is (31 ± 1) keV. These electrons would
have a range of about 18.7 µm in water and 4.5 µm in Ta2O5. This means that for shell
thickness greater than this range in Ta2O5 the enhancement is expected to be reduced due




































Figure 3.14: Secondary electron kinetic energy spectra (a) and LET (b) entering central
cell nucleus with increasing shell thickness of Ta2O5 NP shell around central cell nuclei per
incident photon.
to electron absorption by the NP shell. It is important to note that these spectra are from
electrons entering only the central cell nucleus about which the NP shell is placed.
3.2.3.2 Effect of Spatial Distribution of Shells
Figure 3.15 shows the DER in a 150 kVp photon radiation field, in the four alternative spatial
distributions of NP shells represented in Figure 3.10. It can be observed that - for the NP
shell thicknesses under study - the DER increases with increasing thickness of Ta2O5 NPs
and with the number of shells. Most dose enhancement occurs within the cell nuclei about
which shells are placed, significant enhancement is still seen in neighbouring cell nuclei,
with biggest dose effect in those closest to the NP shells. This means that NP shells have a
dose enhancement effect over a short range (the average range of secondary electron is less
than 20 µm in water) however there are longer range effects resulting in a dose enhancement
ratio above 1 at larger distances from the NP shells. For example, in the case of the NP shell
surrounding the central cell nucleus only, the average DER in the furthest cell nuclei is (1.34
± 0.01) for 3 µm shell thickness. This compares to an average DER of (3.47 ± 0.02) in the
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eight cell nuclei surrounding the central cell nucleus.








































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.15: DER 2D distribution in layer 2, with a single shell (top row), 4 shells (second
row), 8 shells (third) or 9 shells (bottom)
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Figure 3.16 reports the DER calculated in the different NP shell configurations under study,
for different local concentrations (corresponding to different NP shell thicknesses), inte-
grated over the cell nuclei in the entire µ-phantom. The non-linear trend observed in Figure
3.16 is similar to that shown in Figure 3.11 and indicates that even though the high-Z Ta2O5
NP material creates an increased number of secondary electrons entering the cell nuclei,
the number of secondary electrons with sufficient energy to escape the NP is reduced with
an increasing thickness of the NP shell, thus reducing the rate at which the overall DER
increases with NP concentration.
Figure 3.16: Total DER in cell array per incident photon due to NPs distributed in shells of
various shell thickness (concentration) and distribution. The three points corresponding to
increasing local NP concentration for each shell distribution correspond to increasing shell
thicknesses of 1, 2 or 3 µm.
3.2.3.3 Secondary electron kinetic energy spectra and LET
Figure 3.17 shows the kinetic energy spectra and LET of secondary electrons entering into
the central cell nucleus of layer 2 in the µ-phantom, varying the Ta2O5 NP shell thickness in
the cases of NP shell distributions under study (Figure 3.10), with reference to the case of
no NP material in the µ-phantom. The 9, 8 and 1 shell distributions are compared in Figure
3.17 in order to see the effect of a local shell, the effect of nearby shells and the combination
of these.

















































































































































Figure 3.17: LET of electrons entering the central cell nucleus in the array with Ta2O5
NPs distributed in shells around 9 (a), 8 (b), 4 (c) or a single cell nucleus (d) in the array,
compared to configuration without NPs (Water). The different NP shell configurations are
also directly compared for the 3 µm thick shell case (e).
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Range in 267.1 mg/ml
Ta2O5 Solution (µm)
10 2.51 0.74 2.33
20 8.57 2.25 7.84
30 17.56 4.40 16.0
40 29.19 7.09 26.5
50 43.20 10.29 39.1
150 281.7 62.0 252.6
The mean kinetic energy of secondary electrons created within the Ta2O5 NP shells is around
1.5 keV. Electrons with kinetic energy less than 10 keV have a range of less than 1 µm in
Ta2O5 as shown in Table 2.2 and Figure 2.13, reporting the range of electrons with varying
kinetic energy in water, solid Ta2O5 NP and homogeneous Ta2O5 solution [106]. This results
in a large proportion of the low energy electron spectra being absorbed by the Ta2O5 shell
and not contributing to the DER in the nearby cell nuclei. The mean kinetic energy of sec-
ondary electrons escaping the NP shell was found to be around 33 keV, increasing slightly
with larger shell thickness. This happens because higher energy electrons can escape the NP
shell with increasing shell thickness. Low energy electrons produced in the region close to
the inner surface of the shell will enter the cell nucleus, or be absorbed by the shell.
The increased frequency of high-LET electrons observed in the presence of Ta2O5 compared
to water produces a dose enhancement within close proximity of such high-Z NPs. This ef-
fect is observed when comparing the LET spectra in the central cell nucleus without a Ta2O5
NP shell in close proximity (8 shell case) and with a NP shell directly on the central cell (9,
or 1 shell cases) in Figure 3.17e. Secondary electrons entering cell nuclei are increased in
number with increasing thickness of Ta2O5 shells for the kilovoltage spectrum under study.
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Table 3.5: Number of secondary electrons entering cell nuclei in the array with increasing






1 µm 2.48 ± 0.01
1 2 µm 3.61 ± 0.02
3 µm 4.50 ± 0.02
1 µm 12.38 ± 0.05
8 2 µm 20.6 ± 0.1
3 µm 26.6 ± 0.1
1 µm 13.75 ± 0.05
9 2 µm 22.8 ± 0.1
3 µm 29.2 ± 0.1
Table 3.5 shows the increase in the number of electrons traversing cell nuclei in proximity
to increasing thickness and varying distributions of NP shells, compared to water. It is clear
from these ratios that the number of electrons entering the cell nuclei in the array is increased
with increasing mass of Ta2O5 in shells within the array.
3.2.3.4 Effect of NP Distributed in Shells or Homogeneous Solution
Figure 3.18 shows the DERs obtained with the NP shell configurations depicted in Fig-
ure 3.10 and with a homogeneous distribution of NP material in water. The NP shell config-
uration and the homogeneous solution have the same total concentration of NP material. It
can be observed that the DER depends significantly on which model of the NP distribution
is selected (shells or solution in water).
The DER increases with increasing concentration of Ta2O5 in both NP shell and solution
configurations. In the case of the homogeneous solution the DER increases linearly with
increasing mass of Ta2O5 in water. Instead, in the case of a NP shell distribution, the DER
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Figure 3.18: Total DER in the µ-phantom per incident photon due to a homogeneous solu-
tion of Ta2O5 NPs in water (filled symbols) compared to the average dose due to the same
ceramic compound arranged as NP shells (unfilled symbols) of various thickness (corre-
sponding to different local concentration) and geometrical distribution.
increases and then saturates with an increase in mass of Ta2O5 shell as shown in Figure 3.16.
In the case of a homogeneous NP solution, generated secondary electrons do not have to
traverse a NP shell in order to deposit dose within the cell and are therefore attenuated only
by the homogeneous NP solution which translates to a linear effect on the DER with respect
to NP material concentration.
Figure 3.19 reports the kinetic energy spectra of secondary electrons entering in the central
cell nucleus in the µ-phantom in the case of NP shells surrounding 9 cells (Figure 3.10a)
and in the corresponding NP homogeneous solution in water, with the same concentration.
It is observed that more electrons enter the central cell nucleus with the Ta2O5 NPs in shell
configuration compared to an equivalent solution of NP. This happens because the NP shell
of Ta2O5 material surrounding the cell nucleus provides a source of low energy electrons
close to the nucleus, in contrast to the a homogeneous NP solution in water producing a

































Figure 3.19: Electron spectra (a) and LET (b) entering central cell nucleus in the µ-phantom
with NP distributed in shells (hollow symbols) or in solution (filled symbols) around the
cells compared to water.
uniform source of electrons throughout the water medium surrounding the cells. This also
explains why the total DER in Figure 3.18 is higher in the NP shell case compared to homo-
geneous solution.
3.2.3.5 Effect of Atomic Deexcitation
The influence of AD processes on the DER was investigated by performing simulations with
and without the AD processes activated. The kinetic energy of AD electrons is constrained
by the low energy production threshold of 100 eV. The difference between the DERs calcu-
lated with and without the deexcitation is attributed to the effect of the deexcitation electrons.
Table 3.6 summarises the results and shows that the AD processes accounted for between
about 3% and 7% of the DER at cellular level. The DER due to AD processes is predom-
inantly observed in the cell surrounded by the NP shell and for thinner NP shells. This is
explained by the fact that Auger electrons are very low energy and therefore have a short
range and can be easily self-absorbed in thicker NP shells. Auger electrons contribute to
the DER locally to the NP shell as expected. This means that if in an experimental, in vitro,
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Table 3.6: Percentage of DER within the central cell attributed to AD processes, for each
NP shell configuration and thickness under study.
Shell
Distribution
1 µm 2 µm 3 µm
1 (7.23 ± 0.03)% (5.55 ± 0.03)% (4.98 ± 0.01)%
8 (4.56 ± 0.04)% (4.00 ± 0.04)% (2.73 ± 0.01)%
9 (7.03 ± 0.04)% (5.38 ± 0.02)% (4.75 ± 0.01)%
Kinetic Energy (keV)

























Figure 3.20: Kinetic energy spectrum of secondary electrons produced by AD processes,
entering the central cell nucleus with a 3 µm thick Ta2O5 NP shell surrounding the cell
itself.
situation a particular cell does not have a large uptake of Ta2O5 NP forming a shell about
the nucleus, it will experience significantly lower DER from low energy AD electrons than
neighbouring cells with internalised NP shells.
Figure 3.20 shows the spectra of AD electrons entering the central cell nucleus per incident
photon for the 9 shell configuration. This spectrum is calculated by subtracting the spec-
trum calculated from the simulation without AD processes from that with AD processes.
Electrons falling within error of zero are disregarded.























1 µm no AD
2 µm
2 µm no AD
3 µm
3 µm no AD
Figure 3.21: Effect of AD on the LET of secondary electrons entering the central cell nucleus
in the 9 shell configuration. LET with AD processes activated (filled symbols) is compared
to LET with no AD activated (unfilled, red symbols).
It can be seen from Figure 3.20 that AD processes have most effect on the low energy part
of the spectra, below 10 keV with peaks in the spectra enhanced around 6 keV and below
1 keV. The mean kinetic energy of secondary electrons is slightly decreased (approximately
1 keV lower) by the inclusion of AD processes in the simulation. This effect is small and
indicates Auger electrons with low energy will have the most effect on short ranges from the
NP surface.
Figure 3.21 shows the effect of AD processes on the LET of secondary electrons entering
the central cell nucleus with respect to increasing shell thickness. The figure shows that the
AD has the most effect on the LET of secondary electrons in the case of a 1 µm thick NP
shell. The second effect of AD is to increase the number of high LET electrons, as expected.
The number of secondary electrons with LET of 12 keV/µm entering the central cell nucleus
increases by 30% with AD processes in the 1 µm case, compared to only 25% and 24% in
the 2 µm and 3 µm cases respectively. This is due to the shorter range of low energy, high
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LET, AD electrons which have increased probability of absorption in the thicker shells.
The proportion of dose enhancement observed to be due to AD in Table 3.6 agrees that the
thinner shell provides more AD electrons’ dose enhancement in all configurations.
3.2.4 Summary
This work was motivated by the experimental observation that Ta2O5 NPs tend to congregate
as shells with different thicknesses in colonies of cancer cells. Based on this observation,
different scenarios of cells covered with NP shells were investigated in cellular colonies of
limited size, in terms of local DER obtained under a 150 kVp irradiation, by means of Monte
Carlo simulations.
The local DER becomes saturated with an increasing concentration of NPs and shell thick-
ness for each considered scenario of shell pattern in the µ-phantom. The local DER reaches
saturation when the NP shell thickness is larger than 5 µm. The local DER in individual
cells in the µ-phantom is significantly increased when the Ta2O5 NPs are simulated in re-
alistic shells configurations rather than in the commonly accepted homogeneous solution
distribution between all cells with the same concentration of NPs.
Considering a realistic scenario of NP concentration used in experiment in a range of 50
to 500 µg/ml, the conclusion is that only a very small partial volume of the cell culture,
which is modelled with the µ-phantom, has a significant local concentration of NPs. This
leads to a low DER for most cells in the entire cell population, while obtaining a large local
DER, which is not changing essentially the DER averaged over the entire cell population.
This conclusion is supported by the simulation results, showing that the enhancement of
secondary electrons by Ta2O5 NP shells has the most effect on cells in close proximity to the
high-Z material and by the DER measured experimentally for cell cultures irradiated with
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150 kVp X-ray beam, with NP concentration varying between 50 and 500 µg/ml.
Demonstrated DER in µ-phantom with Ta2O5 NPs and the experimental observation that
such NPs congregate in shells around cells prompt us that these NPs can be excellent for
targeting micrometastasis, based on a single or small number of cells, provided the ability
to selectively deliver them to the targeted cancerous cells. In this case even much smaller
concentration than 260 mg/ml can potentially provide a DER of about 4-5, based on this
study.
3.3 Discussion
It has been shown in this chapter that the shape and distribution of NP material within a
micro-volume phantom are important factors to consider when modelling the physical dose
enhancement of radiotherapy by NPs. The study of different Bi2O3 NP geometries showed
the effect of aggregate shape on the DER in the cell population whilst the study of the
shell-forming behaviour of Ta2O5 NPs was studied and shown to have a large effect on dose
enhancement, compared to NPs in solution.
The study of Bi2O3 NP aggregated in the cell array showed the increased effectiveness of
the Bi2O3 platelet morphology [33], with respect to total aggregate mass, compared to more
bulky geometrical configurations. The study also showed again the increased effect in the
keV photon energy range compared to the MeV photon energy range. Although Bi2O3NPs
have been shown to have sensitizing effects under both kilovoltage and megavoltage photon
irradiation, the simulations showed preferential enhancement in the kV field. This does not
mean that the NPs are not expected to be enhancing in the MV, rather that a more com-
plex combination of physical, chemical and biological effects should be considered to be
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at play in the cell population. The Geant4 simulation presented in this chapter has mod-
elled the local physical dose enhancement due to increased secondary electron production
only. The complex relationship between secondary electron production, and free radical for-
mation [110] is an aspect which could be further investigated by Geant4 simulations using
the Geant4-DNA (with recently included chemical modelling of water radiolysis) very low
energy extensions of Geant4 to model free radical products in water.
The simulation of Ta2O5 NP material distributed in shells around cell nuclei in a cell popula-
tion demonstrates the high local dose enhancement ratio present in the cell array compared
to when NP material is distributed in a homogeneous solution between cells in the simu-
lation. Different NP materials are taken up by cells or distributed within cells in different
ways, depending on the NP type, size, morphology and aggregation. These properties and
behaviour, when known and understood can potentially be exploited to gain advantage from
certain types of NP, in order to optimise the enhancement of radiotherapy. This has been
demonstrated in the case of the shell-forming Ta2O5 NP in this chapter’s Geant4 simulation
study as the saturation effect with increasing NP concentration has been investigated.
Although the simulation geometry in ref [85] is vastly different from that presented in this
chapter, the reported saturation effect with increasing concentration and shell thickness ob-
served in a cell population study is in agreement with the trend observed in ref [85] for the
case of clustered gold NPs in solution.
Results presented in this chapter have shown that it will be important for future simulation
work to carefully model the realistic distribution of NPs within cell populations in order to
accurately model the effect of high-Z NP induced dose enhancement including the produc-
tion of secondary electrons and possibility of self-absorption of electrons, depending on the
dimensions of the NP material. The uptake by cells of NPs and also the distribution within
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cells should be carefully modelled, as the results in this chapter demonstrate the strong de-
pendence of local dose enhancement on NP distribution. A simple model of a homogeneous
NP solution in water is not sufficient, on the level of the cell or the cell nucleus, to provide
an accurate calculation of the dose enhancement in a cell population.
Chapter 4
Dose Enhancement by Nanoparticles in
Proton Therapy
This chapter presents studies at the nanoscale level of the dose enhancement due to different
types of NPs in proton therapy by means of Geant4 Monte Carlo simulations. The work
presented in this chapter is based largely on articles published in the peer reviewed journals
Physica Medica and The European Physical Journal D, which are also included in this thesis
as Appendix C and Appendix D. The contribution made as second author on the paper of
Verkhovtsev et al. (2015b) is the Geant4 study described in this chapter.
4.1 Ceramic Oxides in Proton Therapy
4.1.1 Methods
Simulations were performed using Geant4, versions 9.6-patch 2 and 10.1 in order to check
the consistency of the results through the Geant4 software’s evolving life cycle [67, 68].
Figure 4.1 shows the simulation configuration in the case of a 4 MeV pencil proton beam
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incident on the water box. This energy is selected to show the interactions of a low energy
proton reaching the NP. The track structure of secondary electrons, shown in red, is more
detailed in the liquid water surrounding the NP sphere due to the physics models adopted
here, the Geant4-DNA Package (see Chapter 1, Section 1.4.3) modelling particle interac-
tions event-by-event.
The simulation consisted of a monoenergetic proton beam with energy spanning from 5 MeV
to 90 MeV, incident normally on a 200 µm liquid water phantom, comparable to a 20 ×
20 × 20 cell population adequate to study the dose enhancement locally to the NP. The
NP is modelled with a sphere of 100 nm diameter, set in the centre of the water phantom. A
smaller diameter NP (20 nm) is simulated as well, for comparison. The material of the NP
was defined as gold (Au), tantalum pentoxide (Ta2O5), cerium oxide (CeO2), bismuth oxide
(Bi2O3) or liquid water for a comparison with no NP present in the phantom. Materials were
defined by composition of elements in Geant4, using the densities shown in Table 4.1.
The proton energies were selected to model a proton radiation field typical of the Spread Out
(a) Schematic view of simulated water
phantom geometry with zoomed inset
showing NP at centre.
(b) Schematic view of simulated nanoparticle with
a sample track of a 4 MeV incident proton. The
proton trajectory is shown in blue, and secondary
electron tracks are red.
Figure 4.1: Schematic views of the simulation set-up.
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Table 4.1: NP material data: atomic number (Z), mean excitation energy (I) [106], and
density (ρ).
NP Material Z I (eV) ρ (g/cm2)
Au 79 790 19.32
CeO2 ZCe = 58,ZO = 8 407.6 7.215
Ta2O5 ZTa = 73,ZO = 8 523.7 8.20
Bi2O3 ZBi = 83,ZO = 8 706.9 8.90
Bragg Peak region of a hypothetical prostate cancer treatment. For example, the depth-dose
profile of a 160 MeV proton beam shows a Bragg Peak at a depth of approximately 180 mm
[111, p. 569]. The average proton energy in this peak is less than 20 MeV. The average
energy of protons is 90 MeV at a depth about 70 mm shallower than the Bragg Peak. At a
depth of 150 mm, or 10 mm from the peak, the average proton energy is 50 MeV.
Figure 4.2 shows the depth-dose profile in a water phantom from a beam of 280 MeV in-
cident protons. The peak is at approximately 45.5 cm depth. The three proton energies
investigated in these simulations, 5 MeV, 50 MeV and 90 MeV, would be found at the distal
end of the Bragg peak, about 1.8 cm, and 6 cm from the peak respectively. The study of this
range of incident beam energies allows the understanding of whether enhancement would
be preferentially in the target or more uniform across the beam’s path, potentially impacting
on healthy tissue.
Protons were originated on one side of the phantom and directed towards the NP as a circular
source beam of diameter equal to the NP diameter (here called broad beam), or alternatively
as a pencil beam with no lateral dimensions (here called pencil beam), directed only towards
the NP.
The Geant4-DNA Very Low Energy Extensions [89] were adopted to model in detail parti-
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cle interactions down to electron volt scale, in the liquid water phantom. The Low Energy
electromagnetic physics package, based on Livermore evaluated data libraries or the Pene-
lope approach, was selected to describe particle interactions in the NP. Secondary electron
production and transportation within the NP region is limited to those secondaries with ki-
netic energy greater than 100 eV. Atomic deexcitation (fluorescence, Auger electrons, and
PIXE) was modelled as well. The physics processes and models adopted in the NP and in
the surrounding water medium are summarised in Table 4.2.
The step in Geant4 is - by default - the distance between two interactions. A particle track is
composed of multiple steps through the geometry, as the particle interacts with the medium
and crosses boundaries between different materials. Physics models based on condensed
history approach used within the NP region result in larger tracking steps as multiple in-
teractions are simulated in a single step. Because of the limited size of the NP, the step
was limited to 0.1 nm to calculate the energy deposition with higher spatial accuracy. It
is important to note this is only a software solution dictated from the fact that track struc-
ture physics models for NP materials are not available in Geant4. In the water phantom,
Figure 4.2: Depth dose curve for a 280 MeV proton beam incident on a water phantom.
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surrounding the NP, the Geant4-DNA track structure models describe the electromagnetic
particle interactions.
Test simulations performed with 5 MeV proton beam incident on a each NP examined the
effect of AD processes, including fluorescence, Auger electrons and PIXE, on dose enhance-
ment. Production cuts are implemented in Geant4 in order to control the low energy limits
of particle transport. A defined production cut is the low energy threshold, below which
particles are not created. If a particle has an interaction which will result in the release of a
secondary particle of kinetic energy lower than the production cut, this secondary will not
be created and the energy is instead deposited at the point of interaction. Production cuts can
be defined in terms of particle range, which will be converted internally in Geant4 to energy
cuts, depending on the medium in which the particle travels, or as a low energy threshold
regardless of material. The threshold of production of secondary electrons in the NP was set
to 100 or 250 eV, corresponding to the recommended low energy limit of the Penelope and
Livermore-based physics models respectively.
Since Geant4 version 10.00 the proton ionisation model generates secondary electrons with
an inherent energy threshold equivalent to the I of the specific material where in previous
versions the threshold corresponded to the cut or the validity of the physics models (e.g.
100 eV in the case of Penelope models). This cut, for example in gold at 790 eV (the mean
excitation energy for gold) applies to proton ionisation models and was introduced because
the models are not confirmed below this energy level and are therefore assumed to not be
accurate1. Table 4.1 shows the mean excitation energy data obtained from NIST for the NP
materials under study. Any secondary electrons with energy below this threshold are not
created and their energy is treated in the simulation as being locally deposited energy at the
point of interaction of the proton.
1Private communication with Vladimir Ivanchenko, coordinator of the EM Physics Component of Geant4,
8 November 2015
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Secondary electrons were created in the NP above an energy threshold set in the Physics
List (100 eV in the Penelope physics case, and 250 eV for Livermore), when originated by
electron ionisation. In the context of the present study these limitations mean that there
may be some underestimation of dose deposited close to the NP surface. Results of the
simulations show that the maximum range in water of a 100 eV electron is around 30 nm.
This means that for electrons created within the NP with energy less than 100 eV which are
not transported in the simulation the range would not be more than this distance from the
NP surface. This energy threshold is therefore not expected to have a large impact on the
overall dose distribution but should be taken into consideration when examining the results
of this simulation.
In the latest versions of Geant4 (version 10 and above), AD electrons originated with en-
ergy below 100 eV cut are transported in the high-Z NP regardless of the simulation cuts by
using the UI command /process/em/deexcitationIgnoreCut true to effectively ignore the cut
and transport electrons down to 0 eV in the special case of AD processes. Although the rec-
ommended low energy limit of physical validity of the Penelope physics models is 100 eV
to describe electron, positron and gamma interactions, it is possible to transport Auger elec-
trons with energy below this recommended threshold, with the understanding that the results
carry this inherent inaccuracy throughout. However, in order to obtain a first understanding
of the effect of very low energy electrons on the energy deposition in the proximity of the
NP, the limit of validity is surpassed. This choice was dictated by the current lack in Geant4
of detailed event-by-event physics models addressed to energies below 100 eV in the NP
materials under study.
The proton track structure was studied in terms of radial dependence of energy deposition
in slices around the proton tracks. Energy deposition was calculated in cylindrical shells
(see Figure 4.3, slices 1-4) with 100 nm thickness and 10 nm width, centred with the proton
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Table 4.2: Physics processes implemented by region.




















Rayleigh scattering (Penelope), Photoelectric effect (Penelope),
Compton scattering (Penelope), gamma conversion (Penelope)
direction of incidence. The energy deposition was then scaled by the mass of the water of
the corresponding cylindrical shell to obtain the dose. Radial dose distributions around the
NPs are compared to the dose distribution around a water sphere which models the case of
no NP present. The ratio of the NP and water dose distributions is calculated in order to
analyse the dose enhancement due to the NP.
The dose deposited in a 1 µm radius cylinder of 400 nm length (in four slices shown in
Figure 4.3) is calculated with each NP type under study compared to water. This is used
to compare the relative enhancement of local dose deriving from each NP material under
study compared to liquid water. The secondary electron spectra produced within each NP
and escaping from it are compared, varying the NP material and incident proton energy.




Slice 1 Slice 2 Slice 3 Slice 4 
400nm 
1µm 
Figure 4.3: The energy deposited is calculated with respect to radial distance around the
proton beam direction, in 100 nm thick cylindrical slices out to 1 µm.
4.1.2 Results
4.1.2.1 Dose distribution enhancement by NPs
Figure 4.4 shows the radial dose distribution in 100 nm wide bins. The radial dose distribu-
tion was calculated in slices 1, 2, and 3 (shown in Figure 4.3) and scaled to the number of
primary protons in the broad beam. The ratio of dose calculated with and without the NP is
reported as well.
The relatively short range of secondary electrons produced from the incident proton beam
and enhanced by the presence of NPs results in most energy being deposited close to the
primary proton tracks, in close proximity to the NP. The majority (more than 99%) of the
energy is deposited within the first 300 nm from the beam centre in the water slices (Fig-
ure 4.4a and 4.4c). The first bin in slice 2 (Figure 4.4b) contains the NP (50 nm radius), and
so has an artificially high dose enhancement ratio compared to the bins in water only. More
than 95% of energy is deposited from the NP edge out to 300 nm in slice 2, containing the
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Figure 4.4: Dose deposited in 100 nm bins in slice 1 (A), slice 2 (B), and slice 3 (C) with
a 5 MeV proton beam incident on a Au NP (open circles) and in water (solid circles), per
incident proton. Linear scale with dose ratio (top row) and logarithmic scale (bottom row)
are both shown.
NP. The dose is reduced from (16.5 ± 0.2) Gy in the first bin outside of the Au NP in slice 2
to (1.80 ± 0.05) Gy in the bin above 300 nm, which is a drop of 89%. The logarithmic scale
plots show that dose drops off quickly with increasing radial distance from the broad proton
beam, however the distribution is still enhanced due to the presence of the NP out to 1 µm.
The detailed study of radial dose distribution is examined below 300 nm in the following
sections as this is the region of most interest in the study of dose enhancement of primary
proton tracks.
Radial dose distributions in 10 nm wide bins in slice 2, containing the NP (see Figure 4.3) for
5 MeV, 50 MeV and 90 MeV incident broad proton beams are shown in Figure 4.5 as well
as the calculated dose enhancement ratio. The radial dose distribution local to all four NPs
studied was enhanced for all the broad proton beam energies under study. A comparison
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of the dose enhancement ratios shown in the inset allows direct comparison of positions
along the Bragg peak, although absolute dose deposition varies widely between the studied
energies.
Dose enhancement occurs at each beam energy studied, showing there is no significant
preference for enhancement in the Bragg peak. All NP materials studied showed some level
of dose enhancement with gold showing most enhancement in the plots of radial distribution
of deposited dose. The X-ray radioprotector material, CeO2, shows enhancement of a similar
scale to the radiation enhancing Ta2O5 in the proton beam. The Bi2O3 NP shows relatively
high dose enhancement, but was still not as effective as the Au NP.
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Figure 4.5: Radial distribution of deposited dose in slice 2 with respect to proton beam
energy and NP material, compared to dose in water (solid circles), per incident proton.
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Figure 4.6: Radial dose distribution with respect to slice and for each energy of proton beam
incident on a Au NP in water, per incident proton.
The distribution of the energy deposition enhancement with depth is shown in Figure 4.6.
All three energies have most dose in slice 2, perpendicular to the NP. The 5 MeV and 50 MeV
distributions also show increased dose in slice 3, downstream of the NP, followed by slice 1
upstream. The 90 MeV has a similar distribution upstream as downstream.
The figures show higher deposited dose in the radial distribution in the slice containing the
NP compared to the slices upstream or downstream of the NP. This happens because the low
energy electrons produced in the NP deposit energy laterally and locally to the NP.
4.1.2.2 Effect of NP Material on Dose Enhancement
A comparison of the radial dose distribution for different NP materials is shown in Fig-
ure 4.7. The radial dose is shown in each of the four slices (see Figure 4.3) around the
NPs. The dose is enhanced laterally to the NP as well as upstream and downstream of the
NP for each of the materials investigated. Enhancement of radial dose distribution is most
pronounced in the slice lateral to the NP for Au, CeO2, Ta2O5 and Bi2O3 NPs. Significant
enhancement is obtained up to 100 nm behind the NP for the Au, CeO2, Ta2O5 and Bi2O3
NPs. Dose enhancement upstream of each NP (slice 1) is due to enhanced backscattering of
low energy electrons from the high Z NPs. The Au NP offers the greatest dose enhancement
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of the materials studied. This is due to the higher density of gold (19.3 g/cm3) compared
to Ta2O5 (8.2 g/cm3), CeO2 (7.2 g/cm3), or Bi2O3 (8.9 g/cm3). The proton stopping power
equation (see Equation 1.4) is dependent on the density of the medium and inversely depen-
dent on the square of the velocity of the incident particle [28].
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Figure 4.7: Radial dose distribution from a 5 MeV proton beam incident on NPs, and in
water in slice 1 (A), slice 2 (B), slice 3 (C), and slice 4 (D), per incident proton.
Table 4.3 shows the overall dose enhancement in water due to presence of the NPs under
study, integrating the radial dose over slices 1, 2 and 3 of the water phantom, shown in
Figure 4.3, up to a radius of 1 µm, in the simulation set up. The dose is calculated omitting
bins within 50 nm radius in slice 2, as these contain the NP, and then compared to dose with
water in the NP volume. Similar results were obtained with 50 MeV and 90 MeV proton
beams. The average dose enhancement, for all the proton energies considered, is (28 ± 2)%
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and Dwater are doses calculated with and without the NP, integrated over the water cylinder
represented in Figure 4.3. The statistical uncertainty is below 1%.
NP Material
% relative difference
5 MeV 50 MeV 90 MeV
Au 26 27 31
Ta2O5 16 16 17
CeO2 14 15 17
Bi2O3 17 17 20
for Au NP, (17.9 ± 0.2)% for Bi2O3, (16.6 ± 0.6)% for Ta2O5 NP, and (15 ± 1)% CeO2 NP.
Atomic deexcitation accounted for less than 1% of the dose enhancement from gold in this
volume and particular size of NPs, as low energy electrons deposit energy very close to the
NP surface and so create enhancement on a smaller scale. The treatment of AD processes
in Geant4 is discussed in more detail in Section 4.1.2.4.
4.1.2.3 Spectra of secondary electrons from different NP materials
The number of secondary electrons produced within the NP and escaping from it was cal-
culated. Figure 4.8 shows the secondary electron spectra created with the different NPs,
compared to water. These are the total secondary electron spectra from all interactions, and
do not take into account whether or not the electrons will escape the NP or not. Figure 4.9
then shows the secondary electron spectra emitted from the four different NPs, compared to
water.
The number of secondary electrons increases with the placement of a Au, Bi2O3, Ta2O5
and CeO2 NP, compared to water, as expected. The Au NP is characterised by the highest
number of secondary electrons emitted, compared to Bi2O3, Ta2O5 and CeO2, however the
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Figure 4.8: Spectra of secondary electrons created within each NP, for 5 MeV, 50 MeV and
90 MeV incident protons, per incident proton.
Kinetic Energy (keV)



























































































































































































Figure 4.9: Spectra of secondary electrons created within and then escaping each NP, for
5 MeV, 50 MeV and 90 MeV incident protons, per incident proton.
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lower densities of Bi2O3, Ta2O5 and CeO2 with respect to Au allows a greater proportion of
secondary electrons created within the NPs to escape.
Figures 4.8 and 4.9 both show that the low energy electrons dominate the spectrum. Ap-
proximately 50%, 60% and 70% of the escaping secondary electrons having kinetic energy
of less than 1 keV with a proton beam incident on a Au, Ta2O5 and CeO2 NP, respectively.
These values are averaged over the proton energies studied and compare to approximately
90% of secondary electrons with kinetic energy of less than 1 keV escaping from the NP
filled with water. The difference in the low energy spectra with and without NP occurs due
to the internal cut in the proton ionisation models implemented in Geant4, combined with
the high-Z NPs absorbing some of the secondary electrons produced.
Due to the majority of electrons having kinetic energy below 1 keV, secondary electrons
escaping the NP predominantly deposit energy locally. The range of a 10 keV electron (ap-
proximate maximum energy of secondary electrons generated by a 5 MeV incident proton)
in water is 2.5 µm whereas in gold it is only around 410 nm [106]. Most secondary electrons
have much lower energy than this and would therefore have even shorter range in gold, lead-
ing to an increased number of these electrons being absorbed by the NP when the beam is
incident on the centre of the particle.
A test simulation was performed to calculate the maximum range of electrons in the Geant4-
DNA water. An isotropic electron source was placed at the centre of a water phantom and
the radius at which energy was deposited was simulated in spherical shells. Figure 4.10
shows the results for 100 eV and 1 keV isotropic sources.
The results showed all energy deposition by the 1 keV electrons is deposited within a
(150 ± 10) nm radius sphere around the source. The 100 eV electrons, on the other hand,
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Figure 4.10: Location of energy deposition from an isotropic electron source in water, in
spherical radial bins.
have a maximum range of just (31 ± 1) nm. This means that most energy from secondaries
emitted from the NP is deposited within a short range of the NP surface.
It is observed that (31± 1)% of electrons created within the gold NP escape the NP compared
to (58.0 ± 0.6)% and (57.9 ± 0.3)% escaping Ta2O5 and CeO2 NPs, respectively. This
proportion becomes (92.1 ± 0.2)% when the NP is substituted with a water sphere of the
same dimensions, due to the longer range of low energy electrons in water compared to the
material of the NP.
The average number of electrons produced and subsequently leaving the NP as a ratio to the
number of electrons leaving a water sphere, across all proton energies under investigation,
was (2.7 ± 0.4), (1.3 ± 0.1), (1.5 ± 0.1), and (1.8 ± 0.1) with a Au, Bi2O3, Ta2O5 and CeO2
NP, respectively. This shows the combined effect of the increased number of interactions
counteracted by the lower range of secondary electrons with increasing density of the NP.
The highest-Z NP, the Au NP provides the highest enhancement ratio however when com-
paring the ceramic oxide NPs, the CeO2 NP shows the advantage of the number of escaping
electrons due to a low density combined with a relatively high-Z and lower mean excitation
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Table 4.4: Number of electrons, per incident proton, produced with broad 5 MeV proton
beam.
Total Escape AD electrons
% of AD spectra
< 200 eV
Au 5.58 ± 0.05 1.63 ± 0.02 0.00746 35.5
Bi2O3 1.65 ± 0.02 0.82 ± 0.01 0.00805 23.6
Ta2O5 1.71 ± 0.01 0.98 ± 0.01 0.02504 70.3
CeO2 1.99 ± 0.02 1.14 ± 0.01 0.05597 74.7
H2O 0.728 ± 0.004 0.671 ± 0.003 - -
energy (see Table 4.1).
4.1.2.4 Effect of Atomic Deexcitation on Dose Enhancement
The inclusion of AD processes in the physics processes has only a minor effect on dose
enhancement in this study. Atomic deexcitation electrons are originated with discrete en-
ergy spectrum up to approximately 8 keV, however more than 70% fall below 1 keV. The
previously described simulation of the range in water of 100 eV electrons from an isotropic
source showed that all energy is deposited within 30 nm radius sphere. This means that most
energy from low energy AD electrons is deposited close to the NP surface, within 30 nm. In
this simulation study the dose enhancement in the first 30 nm beyond the Au NP surface is
approximately 5% when AD is modelled.
Table 4.4 shows the number of secondary electrons and AD electrons produced for each NP
type under study as well as the proportion of the AD spectra which falls below 200 eV.
Figure 4.11 shows the kinetic energy spectra of electrons produced from AD processes in the
simulation of 5 MeV protons incident on NP. The spectra of atomic deexcitation (AD) elec-
trons was determined by running the simulations for each NP type studied with and without
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atomic deexcitation processes activated in the physics models. The spectra of secondary
electrons was taken at the point of creation within each NP. In order to isolate the spectra of
atomic deexcitation electrons from the total spectra, the spectra without AD activated was
subtracted from the spectra obtained with AD active. The spectra were corrected to omit
counts within error of zero or values within error of the original spectra.
Kinetic Energy (keV)



















































































































Figure 4.11: Auger electrons from 5 MeV protons incident on NP
The mean kinetic energy of the total spectra created within each NP are shown in Table 4.5.
It is clear from the table that the mean energy is not changed significantly by the inclusion
of AD processes, with most values falling within error of each other, or very close.
The Auger electrons form a small part of the total number of electrons emitted from the
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Table 4.5: Mean kinetic energy of electrons (in eV) from 5 MeV proton beam
Au CeO2 Ta2O5 Bi2O3
with AD 570 ± 6 701 ± 6 814 ± 7 849 ± 7
w/o AD 569 ± 3 715 ± 5 829 ± 7 864 ± 7
Radius (nm)










































































Figure 4.12: Radial dose distribution in slice 1 (A), slice 2 (B), and slice 3 (C) with (circles)
and without atomic deexcitation (crosses, no AD) for 5 MeV protons incident on Au NP,
compared to water (black circles).
NPs, thus not contributing significantly to the energy deposited in the water around the NP
and have only contributed to the dose on the nanoscale. The total dose enhancement within
the previously described 1 µm radius, 300 nm long water cylinder (slices 1-3 in Figure 4.3)
increases from (25.3 ± 0.3)% to (26.0 ± 0.3)% in the case of a Au NP with 5 MeV incident
protons when including AD. Figure 4.12 shows the radial dose distribution calculated with
and with AD processes. The effect is small because of the low number of Auger electrons
produced compared to ionisation electrons, and the short range of their effect.
4.1.2.5 Effect of beam size on NP dose enhancement
Figure 4.13 shows the radial distribution of the ratio of dose calculated with and without the
NP with the broad beam proton source (100 nm diameter beam) compared to a pencil beam
(no lateral dimensions).
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It can be observed that the broad beam configuration is characterised by a higher dose en-
hancement in slice 2. This happens because secondary electrons are produced along the
proton tracks. In the broad beam case, a larger number of electrons are produced close to
the NP surface and, therefore, they have higher probability to escape from the NP. In the
pencil beam case protons instead pass through the centre of the NP and thus produce elec-
trons which must traverse a longer path in the NP before escaping and depositing dose in
the surrounding water medium.
The ratio of the number of secondary electrons produced within a Au NP, compared to water,
for various beam configurations indicates the effect of the distance of interaction from the
surface of a NP. In the case of a pencil beam incident directly on the centre of the NP, the
number of secondary electrons escaping the NP is increased (compared to water) by the
ratio (2.26± 0.01). In the case of the broad beam which covers the entire NP cross-sectional
area, this ratio is higher (2.43±0.02). When a larger, 500 nm radius, source is used, the ratio
remains essentially the same at (2.4 ± 0.4), however due to the lower number of protons
directly incident on the NP, the statistical uncertainty is higher.
A simulation test was done with a beam of protons passing close to, but not directly im-
pacting the NP. The resulting increase in secondary electrons emitted from the NP is due
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Figure 4.13: Radial DER expressed as a ratio of dose calculated with and without the Au
NP, with respect to beam geometry. Slices defined as shown in Figure 4.3.
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therefore to the secondary interactions of electrons with the NP. The ratio of secondary elec-
trons escaping the Au NP, compared to water, in this case is increased to (4.7 ± 0.4). This is
due to the fact that as the particle source is always external to the NP and so the secondary
electrons are more likely to be produced close to the surface where the originating secondary
electron enters the NP.
The position (in terms of radial distance from the centre of the NP) of the creation point
of secondary electrons which are not absorbed within, and therefore escape, the NP varies
depending on NP material, and proton beam configuration. Figure 4.14 shows the radial
distance from the centre of the NP at which secondary electrons, which then go on to leave
the NP, are created.
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Figure 4.14: Radial position within NPs from which escaping electrons are generated with
respect to beam geometry (broad or pencil) and NP types. The beam configuration is a broad
beam incident on the water volume in (a) and all NPs presented in (b). Incident protons are
5 MeV in all cases.
Compared to the case of the water-filled NP, there is a higher proportion of electrons escap-
ing closer to the surface of the Au NP in the case of the broad proton source incident on
the NP. The average radial depth within the NP at which escaping electrons are created is
(12.5 ± 0.1) nm, (10.6 ± 0.1) nm, and (20.9 ± 0.1) nm for the water, Au with broad and Au
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with pencil beam, respectively. The depths in the other NP materials are (12.0 ± 0.1) nm,
(11.9±0.1) nm, (11.7±0.1) nm from CeO2, Ta2O5 and Bi2O3 respectively. The dependence
on NP material is due to the different elemental composition of each NP material and there-
fore the range of electrons within each NP. The high-Z gold results in more self-absorption
of electrons created close to the NP centre and therefore a higher proportion of electrons es-
caping from closer to the NP surface. The highest density NP, gold has preferential escaping
of electrons produced within 10 nm of the NP surface.
Similar results are obtained with the broader proton source, extending beyond the NP, as
expected, as there remains a uniform distribution of protons incident on the NP surface, but
with lower statistical probability of direct hit. The case of the pencil beam incident directly
on the centre of the NP shows a higher proportion of the escaping secondary electrons are
generated within a 25 nm radius from the NP centre. This is evidence of the bias introduced
with a directly incident proton source as the likelihood of interaction at the centre of the NP
is increased, and therefore the likelihood of an escaping electron having been created deep
within the NP is greater.
The results of this simulation study indicate the importance of beam geometry in the design
of any simulations of NP induced dose enhancement in proton therapy and the interpretation
of results of simulation studies. These results demonstrate the enhancement when there are
direct proton hits on the NP, and subsequent secondary electron interactions.
4.1.2.6 Effect of NP size on dose enhancement
A simulation of a smaller, 20 nm diameter, NP was performed with a Au NP and a 5 MeV
incident proton beam of the same diameter. The percentage dose enhancement in the three
slices (1, 2, and 3) around the Au NP (omitting bins from 0 - 10 nm, containing the NP in
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slice 2) is (11.2±0.1)% compared to (26.0±0.3)% with the 100 nm diameter particle, shown
in previous results (see Table 4.3).
Figure 4.15 shows the radial distribution of deposited dose and dose enhancement ratio in
three slices around the 20 nm Au NP. The radial distributions of deposited dose surrounding
a 20 nm NP can be compared to Figure 4.5a on page 115 presenting the dose enhancement
due to a 100 nm diameter Au NP. The lower dose enhancement observed locally to the Au
NP is due to the fact that there are in total fewer proton interactions in the smaller diameter
NP, resulting in reduced probability of an increased production of secondary electrons.
Figure 4.16 shows the secondary electron spectra generated with respect to NP size, com-
paring 20 nm and 100 nm diameter NPs with corresponding water volumes. Examination of
the generated secondary electron spectra show a lower number of secondaries generated in
the smaller diameter NP. The number of secondary electrons produced within the Au NP,
per primary proton, was calculated to be (5.58 ± 0.05) and (0.60 ± 0.01) in the 100 nm
and 20 nm diameter NPs respectively.
When a pencil beam is incident on a NP of each size studied, the number of secondary
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Figure 4.15: Radial dose distribution about a 20 nm Au NP (hollow circles) compared to
water (black circles) with 5 MeV incident protons. Dose per incident proton is presented in
slice 1 (A), slice 2 (B) and slice 3(C). The ratio of the dose with NP to dose with water is
shown in the inset figures.
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Figure 4.16: Kinetic energy spectra of secondary electrons generated within a 20 nm Au NP
with 5 MeV incident protons. Frequency per incident proton is presented with logarithmic
scales.
electrons produced, per incident proton is increased from (1.01 ± 0.01) to (9.29 ± 0.05)
from the 20 nm to 100 nm diameter NPs (an increase similar to that found in the broad beam
case). This again comes down to the fact that, for the smaller NP, the incident protons have
a maximum of 20 nm of NP material in which to interact and create secondary electrons,
whereas the larger NP has 100 nm of NP material (or five times) for the protons to interact
in, although this is not a linear increase.
Another factor which plays a role is the proportion of secondary electrons produced within
a NP which are able to escape the NP. With increasing NP size, the probability of electrons
produced close to the centre of the NP is reduced due to the limited range of electrons in the
high-Z NP materials. This translates to a lower number of electrons, per incident proton in
the broad beam, escaping the NP, corresponding to (1.63 ± 0.02) and (0.36 ± 0.01) from
the 100 nm and 20 nm diameter NPs respectively. The frequency of escaping electrons, per
primary proton in the pencil beam, was (2.27 ± 0.01) and (0.545 ± 0.004) from the 100 nm
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and 20 nm diameter NPs respectively (a similar level of increase compared to that found in
the broad beam case).
The proportion of secondary electrons created within a 100 nm diameter gold NP which go
on to leave the NP volume is around 30%. This value increased to approximately 60% for a
smaller, 20 nm diameter NP. This effect occurs due to the increased proportion of secondary
electrons able to be generated close to the NP surface, rather than deep in the NP volume,
described by the increased surface area to volume ratio (SA:V). With an increase in NP
radius from 10 nm to 50 nm (5-fold increase) the SA:V decreases in the same proportion.
In water spheres of the same dimensions the escaping proportion of secondary electrons is
increased from 92% to 97% with decreasing diameter.
4.1.2.7 Geant4 regression test for NP studies
As Geant4 and Geant4-DNA are constantly evolving software it is important to perform
regression testing to evaluate how the results of a specific study change with the version of
Geant4. This section present a regression test in one specific case. A 5 MeV proton beam
was incident on a 100 nm diameter Au NP in the test case. The subsequent radial dose
distribution was calculated as well as the total DER in a 300 nm long, 1 µm radius cylinder
around the NP. Figure 4.17 shows the radial distribution of deposited dose from a 5 MeV
proton beam incident on Au NP with respect to program version.
The radial distributions in Figure 4.17 show that with the later version of Geant4 the differ-
ence in dose distribution between water and Au NP is reduced. This can also be seen in the
reduced total DER calculated between versions. Version 10.1 gives a DER in the cylinder
of (1.26 ± 0.01) compared to (1.32 ± 0.01) in the previous version.
The secondary electron spectra of all electrons created within the NP region is analysed
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in terms of the type of interaction originating the secondary electrons and those electrons
escaping the NP region.
The secondary electron spectra in version 10.1 are different from the previous due to the in-
ternal cuts in the proton ionisation model discussed in Chapter 1. The spectra of secondary
electrons change between versions of Geant4 due to changes in the physics cross-sections.
Simulations were performed with the later version 10.1, and dose enhancement was com-
pared for the updated models in this version. The proton ionisation cross-section imple-
mented in version 10.1 are different from previous versions in that a low energy threshold is
implemented intrinsically in the cross-sections and do not allow electron ionisation below
the mean excitation energy of a material. The restriction of proton ionisation models to the
creation of secondaries only above the mean excitation energy of materials was not intro-
duced before version 10, therefore more low energy electrons are created in simulations run
on early versions of Geant4.
Figure 4.18 shows a comparison of the secondary electron spectra between versions of
Geant4. It is clear from the plot that the cross-sections result in the same secondary elec-
tron spectra above the internal 790 eV cut, however there are differences below this cut, and
Radius (nm)





















































Figure 4.17: Radial dose distribution in slice 1 (a), slice 2 (b), and slice 3 (c) with respect to
program version for 5 MeV protons incident on Au NP, compared to water (circles).
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Figure 4.18: Spectra of secondary electrons created within the Au NP with 5 MeV incident
protons, comparing Geant4 v9.6p02 and v10.1, per incident proton.
below 100 eV. In the latest version of Geant4, atomic deexcitation electrons are seen to be
produced below the 100 eV low energy limit of Penelope models, set in the Physics List.
As expected, the proportion of secondary electrons produced with kinetic energy below
1 keV is higher in simulations with the previous version of Geant4. Approximately 90%
of the escaping secondary electrons having kinetic energy of less than 1 keV regardless of
NP type. This would have an effect on dose enhancement close to the NP surface (within
150 nm).
The low range of low energy electrons (seen in Figure 4.10 on page 121) means that the
secondary electrons omitted from the spectra when using the updated physics models of
version 10 would only contribute dose to those bins within 150 nm of the NP surface. This
effect can be observed in the results analysing the effect of beam geometry on the dose
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Table 4.6: Dose enhancement in a water cylinder surrounding an Au, Ta2O5 or CeO2 NP
compared to water. The results using Geant4 version 9.6p02 (left top) are compared to
version 10.1 (right top). The statistical uncertainty is <1%. The percentage difference from
the v.10.1 results is shown in the lower section of the table.
NP 9.6.p02 10.1
Material 5 MeV 50 MeV 90 MeV 5 MeV 50 MeV 90 MeV
Au 32 31 32 26 27 31
Ta2O5 16 17 18 16 16 17
CeO2 14 15 15 14 15 17
% Difference between above DERs
calculated with updated program version
5 MeV 50 MeV 90 MeV
Au - 19% - 13% - 3%
Ta2O5 0% - 6% - 6%
CeO2 0% 0% + 13%
enhancement ratio.
The effect on overall dose enhancement is observed in the total dose enhancement within
slices 1-3, compared for each program version in Table 4.6. This data shows that the highest
dose enhancement comes from the Au NP, with Ta2O5 and CeO2 showing similar enhance-
ment, for both Geant4 versions.
Dose enhancement is generally lower in the version 10.1 results due to the different sec-
ondary electron spectra produced in the NPs. Fewer highly enhancing low energy electrons
are emitted from the NP due to the cut in the proton ionisation models (see Figure 4.18).
This means that compared to water, the calculation shows NPs to be less enhancing in the
later version, however enhancement by higher energy secondary electrons from proton ion-
isation and electrons released by means of electron ionisations still occurs. Due to the short
range of low energy secondary electrons the impact of the modelling difference between
program versions is shown to be limited to the region close to the NP surface where there is
a reduction in the dose deposited. For the most extreme example, in the 5 MeV beam in the
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first bin outside the NP in slice 2 the dose deposited is ≈20% higher when calculated using
the previous version of Geant4, compared to version 10.1. However, this difference does not
translate to a significance difference in dose at radial distances of more than 10 nm from the
NP surface.
4.1.3 Discussion
The number of interactions an incident proton or secondary electron encounters is increased
compared to water for all NP materials considered in this study when directly impacted by
protons. The dose enhancement in the region around a high-Z NP is due to an increased
number of secondary electrons transporting energy to the surrounding water volume. This
increase in secondary electrons is due to the increased number of ionizations in the NP.
In the case of an incident proton beam, the majority of Auger electrons have a kinetic energy
below 1 keV, in agreement with Wälzlein et al. (2014), and contribute a small fraction to the
total number of secondary electrons, as the major part is originated by proton and electron
ionisation. Increase in energy deposition by Auger electrons within 30 nm of the NP surface
was found to be approximately 5%. The greatest effect from atomic deexcitation is shown
to be in the first few tens of nm of the radial dose distribution and this agrees with the results
of Wälzlein et al. (2014), reporting high dose enhancement within the first 5 nm from the
surface of the NP.
This work shows that dose enhancement occurs in the presence of Au, Bi2O3, Ta2O5 or
CeO2 NPs with incident proton broad beams. The secondary electron emission from each of
the studied NPs, increases by factors of (2.7 ± 0.4), (1.3 ± 0.1), (1.5 ± 0.1), and (1.8 ± 0.1)
for Au, Bi2O3, Ta2O5, or CeO2 NPs respectively, indicating potential increased biological
effectiveness enhancement due to secondary electrons. As the secondary electron spectra
4.1. Ceramic Oxides in Proton Therapy 135
show, proton interactions produce a large number of high-LET electrons with energy lower
than 1 keV.
The benefit of proton therapy is due to the proton’s densely ionizing track, especially at
low energy, in the Bragg peak region. The large number of low energy electrons creates
complex damage in DNA. An increase in the production of low energy secondary electrons
due to the placement of a NP close to DNA may enhance the biological effectiveness of
proton therapy. Local dose enhancement within a cylinder (300 nm long, 1 µm radius) was
observed to be (28 ± 2)% for Au NP, (18 ± 1)% for Bi2O3 NP, (16.6 ± 0.6)% for Ta2O5 NP,
and (15 ± 1)% CeO2 NP. The local dose enhancement around the CeO2 NP indicates this
material has dose enhancement effects that are in counteraction to the free radical scavenging
properties discussed in the literature.
The dose enhancement ratio demonstrated in the present study shows a maximum value of
approximately 2 for 5 MeV protons lateral to the Au NP (slice 2 of Figure 4.3). This result
is comparable with the results of the study by Wälzlein et al. (2014) although there are
differences in the geometrical set-up of the simulations.
The importance of beam geometry in the simulation design is clear as dose enhancement is
vastly increased when protons impact directly on NPs. This is an important consideration
when relating simulation results to realistic experimental situations. In reality, the concen-
tration of NPs in a cell population of tumour tissue and distribution within these are widely
variable and so there will not necessarily be a high probability of a proton interacting with a
NP directly.
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4.2 Dose Enhancement by Carbon NPs
In addition to dose enhancement by metallic or ceramic oxide NPs in radiotherapy the en-
hancement by means of carbon NPs is a recent area of research interest [58, 59]. The
enhanced production of secondary electrons from metallic, ceramic oxide or carbon NPs is
expected to result in increased damage to cells and DNA. The understanding of the basic
physical interactions of protons with carbon NPs and production of low energy secondary
electrons will allow a basis for continuing research in this direction. This chapter exam-
ines the secondary electron production from a C60 NP with incident proton beam comparing
different simulation and analytical modelling techniques.
Plasmons are collective excitations of electrons in metals. Plasmon excitation and electrons
produced in their decay are an important mechanism of dose enhancement by metallic NP
in ion therapy [112]. Plasmon excitation cross-section data for the C60 molecule in this
project was developed and calculated by Alexey Verkhovtsev from MBN Research Center,
Frankfurt am Main, Germany by means of the plasmon resonance approximation (PRA).
A Geant4 Monte Carlo simulation study to calculate secondary electron creation in, and
emission from, carbon NPs was developed as part of this PhD project. The results obtained
were compared with analytical methods of calculating low energy secondary electron yield
from a carbon NP. Results obtained by means of this Geant4 Monte Carlo simulation were
compared to results obtained by the analytical calculation (see Appendix C).
The calculation based on the dielectric formalism was performed by Pablo de Vera from
Departament de Física Aplicada, Universitat d’Alacant, Alicante, Spain and Department of
Physical Sciences, The Open University, Milton Keynes, UK.
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(a) Structure of C60 molecule - image created
using VESTA software.
(b) Illustration of the molecule positions in a
face-centred cubic structure of C60 molecules.
Figure 4.19: Diagrams of C60 molecule geometry and arrangement of molecular positions
in a face-centred cubic structure.
Figure 4.19 shows the geometry and elementary lattice structure of particles simulated and
modelled in this chapter based on a form of carbon (C60). Each C60 molecule (Figure 4.19a)
occupies a position in a face-centred cubic structure (Figure 4.19b). In the Monte Carlo sim-
ulation an approximation of this structure is necessary, as described further in the Methods
below.
In the published work [101], the interaction of protons with metallic NPs or carbon NPs
(C60) is studied in detail by means of Monte Carlo simulations using Geant4 and compared
to calculations performed by collaborators modelling the decay of plasmon excitations and
calculations based on dielectric formalism. The Monte Carlo simulation consisted of place-
ment of an approximated carbon or water NP in a water phantom. The secondary electron
yield per incident proton was calculated and this part of the collaborative work is detailed in
this section of this thesis.
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4.2.1 Methods
The low energy electron production in a carbon NP calculated using the PRA was compared
to results from the Geant4 simulation developed in this PhD project. The PRA calculation
is based on an isolated C60 molecule so is extended to the case of a large solid carbon NP
with C60 molecules in a fullerite structure [101]. The Monte Carlo simulation described in
Section 4.1 in this chapter was modified to model the carbon NP for this project.
In order for Geant4 to calculate secondary electron production in a material it is necessary
to include the density and composition of the material in the simulation set up. The density
of the fullerite was calculated from the mass of a single carbon atom (mC = 12 u) and the







Geant4 does not model the individual molecules or the lattice geometry explicitly, how-
ever, the 50 nm diameter NP modelled would consist of approximately 92,000 of the C60
molecules shown in Figure 4.19a.
As described in the first part of this chapter, the secondary electrons created in the NP with
a 1 MeV incident proton were analysed with respect to their kinetic energy.
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4.2.2 Results
Secondary electron yield within the 50 nm C60 particle and an equivalent volume of liquid
water are compared in Figure 4.20. The number of electrons per unit energy produced from
an incident 1 MeV proton is shown in these graphs. Some electrons produced within the C60
or H2O volumes will naturally be absorbed within the volume. Figure 4.20 does not take
into account the effect of this self-absorption, however, the proportion self-absorbed in each
volume is generally small.
Further details of the plasmon resonance approximation and calculations based on the di-
electric formalism are available in the published paper and other literature [101, 113, 114].
The proportion of these secondary electrons created within each material and then escaping
the NP volume are shown in Table 4.7. A comparison of the effect of the selection of physics
models (Geant4-DNA vs. Livermore) is included for the case of the liquid water sphere.
Figure 4.20: Number of electrons per unit energy produced by irradiation of a 50 nm carbon
NP by a single 1 MeV proton (black), and in the equivalent volume of liquid water (blue).
Open circles illustrate the data obtained in this PhD project by means of Monte Carlo simu-
lations using the Geant4-DNA simulation tool. The black curves represent the data obtained
by the PRA approach. Solid and dashed blue curves represent the results obtained with the
dielectric formalism by Scifoni et al. (labelled ref. [48], see ref. [113]) and de Vera et al.
(labelled ref. [49], see ref. [114]), respectively. Figure reproduced from ref [101].
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The proportion of secondary electrons created within the liquid water sphere (with Geant4-
DNA models implemented) and escaping is significantly lower than the other cases. This is
due to the higher number of electrons created with kinetic energy less than the 250 eV cut
implemented in the other cases being more like to be self-absorbed within the water sphere.
4.2.3 Discussion
The collaborative work presented in this chapter is an important comparison of methods to
calculate secondary electron yield from carbon NPs. The work performed as part of this
thesis contributed the Geant4 Monte Carlo simulation results in the case of carbon NPs, and
water NPs. These simulations were compared in the paper (see ref. [101]) with analytical
models.
The results show enhancement of secondary electron emission from a carbon NP, compared
to water. This is an important result as it shows the potential for use of carbon NPs in the
enhancement of proton therapy. A thorough understanding of the mechanisms of enhance-
ment in NP enhanced radiotherapy, including proton therapy is an important aspect of study
in the push towards implementation of NP enhancement in a clinical setting.
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The results of this work show the potential importance of low energy electron contributions
from NPs which are not currently modelled in Geant4, due to limitations of cross-sections
available. Geant4 Monte Carlo simulations are currently limited in their ability to model
secondary electron production at very low energies (below ~100 eV) in NP materials. A
potentially useful area of future study is the implementation of plasmon excitations within
low energy models in Geant4.
4.3 Conclusion
The work in this chapter shows that the fundamental concept of dose enhancement by NPs
in proton therapy is evident on a nanoscale and therefore biological effectiveness of proton
therapy may be increased due to this localized increased secondary electron density.
The results in Section 4.1 showed that more than 95% of dose deposition occurs within
300 nm of the proton beam and NP centre. Most dose enhancement was observed in the
slice containing the NP, with some enhancement also observed upstream and downstream
of the NP in the proton beam.
All proton energies studied showed similar levels of dose enhancement, indicating no spe-
cific advantage is achieved in or close to the Bragg peak region of the dose distribution. The
lower energy protons (5 MeV and 50 MeV) showed enhancement upstream and downstream
of the NP however this was less significant in the higher energy proton case.
The highest dose enhancement was observed for the Au NP followed by Bi2O3. The Ta2O5
and CeO2 NPs showed a similar level of dose enhancement. This result is due to the depen-
dence of the proton stopping power equation (Equation 1.4) on the density and the inverse
square of the velocity of the incident particle. The average dose enhancement due to the
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Au NP is (28 ± 2)%. This compares to (17.9 ± 0.2)%, (16.6 ± 0.6)%, and (15 ± 1)% from
the Bi2O3, Ta2O5, and CeO2 NPs, respectively.
The proportion of the secondary electron spectra with kinetic energy less than 1 keV in-
creased with decreasing NP density from 50% in the Au NP to 90% in the H2O NP. This
demonstrates the effect of the self-absorption of secondary electrons within higher density
NPs. The overall secondary electron yield from NPs compared to water is highest from
Au-NP: (2.7 ± 0.4) times that of water. The ceramic oxides result in an increase in the total
yield of secondary electrons of (1.3 ± 0.1), (1.5 ± 0.1), and (1.8 ± 0.1) times the yield from
a water NP for the Bi2O3, Ta2O5, and CeO2, respectively.
The results showed that the increase in energy deposited observed within 30 nm of the ce-
ramic oxide NPs was approximately 5 % due to the action of Auger electrons. This observed
result is in agreement with studies by other researchers (see ref [82]). Less than 1% of the
total dose enhancement effect is attributed to atomic deexcitation to the short range of these
secondary electrons.
The simulation studies showed that secondary electrons are mostly emitted from close to the
NP surface, due to the high probability of self-absorption of low energy electrons created
deeper within the NP. The smaller NP modelled (20 nm diameter) showed a lower overall
dose enhancement effect than the 100 nm diameter particle, (11.2 ± 0.1)% v.s. (26 ± 0.3)%.
However, the secondary electron yield increases from (2.43 ± 0.02) to (2.6 ± 0.1) times the
yield from water when the NP diameter is decreased from 100 nm to 20 nm. This is due
to the increased proportion of electrons produced within the smaller volume being able to
escape the nanosphere without being self-absorbed in the particle.
The production and transportation of free radicals in water was not modelled in this study.
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This is a limitation of this work as the action of free radicals may contribute a non-trivial part
of the damage from proton therapy resulting in cell death. However, it can be noted that the
increase in low energy secondary electrons, whilst contributing to increased direct damage
in clustered hits to DNA, would also likely result in an increase in water radiolysis. This
increase in free radicals would further enhance the efficacy of a proton beam in proximity to
a NP, in the absence of radical scavenging, such as the action of CeO2.
The short range of the low energy electrons emitted from the NP would necessitate the
NP being relatively close (within a µm scale) to critical structures within the cell to induce
direct DNA damage. For this reason, coupled with sub-µm dimensions of fabricated NPs,
nanodosimetric track structure simulations are an important investigation tool to understand
the physical effects of NP dose enhancement in radiotherapy, however event by event particle
tracking is currently not implemented in Geant4 in solid state materials, excluding silicon.
Given the limitations of the physics models adopted when describing particle interactions
in the NPs, the results of this project are intended to provide a basic physics understanding
beyond the mechanism of dose enhancement produced by NPs and a first comparison of
ceramic oxide NP materials with respect to gold. The results shown in this study should be
refined in the future with inclusion of more sophisticated physics models for a more detailed
description of particle tracks in NP materials.
In the final part of this chapter the secondary enhancement yield due to a carbon NP was
calculated using the same Monte Carlo simulation set up. This calculation was compared
to analytical techniques performed by collaborators on the paper in Appendix C. The plas-
mon resonance approximation approach demonstrated the enhanced production of very low-
energy secondary electrons in the carbon-NP compared to water. This highlights the possi-
bility of carbon based nano-structures to be developed with the proposed aim to produce a
radiation sensitizing effect similar to metallic NPs [101].
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The evaluation of the physics models of Geant4 has shown an impact on the calculation of
dose, DER, and secondary electron spectra therefore it is something to be taken into con-
sideration in future simulation studies. Further work in this project, and ongoing research
in this field, will need to include the modelling of the production and transport of free rad-
icals, which has been recently released in Geant4 [115, 116]. This will provide an insight
into the broad observed effect of NP enhancing cell killing in proton therapy. Hadronic
interactions should also be modelled in the next stage of the study to evaluate the effect
of these interactions in the NP dose enhancement. The plasmon excitation decays should
also be modelled in a full simulation [112] to study their possible effect on the nanoscale
dose enhancement. The low energy part of the spectra would play an important role in dose




This thesis has described a body of work examining the fundamental techniques for assess-
ing the physical dose enhancement due to ceramic oxide NPs in several radiation therapy
fields. Four NP materials were the focus; Ta2O5, CeO2, Bi2O3, and gold for comparison.
The fundamental concept of the escalation of radiation dose delivered to cells and/or DNA
in conventional therapy as well as proton therapy by means of ceramic oxide NPs has been
studied by means of Monte Carlo simulation on the micron- and nano-scale. Carbon (C60,
fullerite) was also investigated for it’s potential to increase low-energy secondary electron
yield in proton therapy.
This thesis has presented the results of several Monte Carlo simulations developed during
this PhD project which investigate the dose enhancement of radiation therapy by NPs on the
cellular level, and on the scale of the DNA. Chapter 2 introduced the Monte Carlo simulation
code and presented results comparing dose enhancement in kilovoltage and megavoltage
photon beams for the various ceramic oxide NPs. In Chapter 3 this formalism was extended
to examine the effect of ceramic oxide NP aggregate geometry. Dose enhancement in proton
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therapy was studied on the nanoscale in Chapter 4.
5.2 Dose Enhancement in X-ray Radiotherapy
Chapters 2 and 3 in this thesis presented investigations of the use of novel ceramic oxide
NPs to improve the clinical outcome of conventional kilovoltage and megavoltage photon
radiation therapy. The fundamental dose enhancement due to ceramic oxide NPs in terms
of the dose to cells in an experimentally relevant configuration has been investigated in this
project. The different physical interactions of several radiation therapy types with NPs has
been modelled using Geant4 Monte Carlo simulations.
The results in Chapter 2 showed that gold NPs have a greater enhancement effect in the
kV and MV photon fields, compared to the ceramic oxides studied. However, DERs due to
the ceramic oxide NPs were shown to be significant compared to the well known radiation
enhancing material, gold, on the micron scale in a cell model with incident photon fields.
Of particular interest from this chapter are the results showing that the radio-protector CeO2
NP also has significant dose enhancement properties. The gold NP showed a total DER in
the 125 kVp photon field of (2.34 ± 0.01) followed by the Bi2O3 NPs with a calculated
DER of (2.18 ± 0.01). This compares to total DER of (1.90 ± 0.01) and (1.74 ± 0.01) in
the presence of Ta2O5 and CeO2 NPs, respectively.
Results presented show the enhancing effect of ceramic oxide (and gold) NPs is greatest in
the kilovoltage photon fields, compared to the megavoltage radiation field. Simulation re-
sults showed that beam energy has a large influence on the magnitude of dose enhancement,
due to the increased photoelectron absorption probability at lower photon energies, present
in kilovoltage radiation fields. The DER drops from around 2 in the kV photon fields to
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close to 1 (i.e. no enhancement) with all NPs studied under MV photon irradiation. This is
due to the difference in the photon attenuation cross-section at higher photon energies.
The first part of this study compares only the dose enhancement effect due to the effective
Z of each NP and so does not take into account the vastly different distributions within cell
populations that each NP will have in realistic experiments.
The different NPs studied have different uptake properties, different aggregate shape and
behaviour. The detailed Monte Carlo studies presented in Chapter 3 show the importance
of taking factors such as these into account when designing a simulation to model dose
enhancement by NPs in radiation therapy. As discussed in Section 3.1, the shape of the NP
aggregate was shown to be important when calculating dose enhancement. Results show that
the platelet morphology of Bi2O3 NPs approximated in the cell array is the most efficient
(per unit NP mass) radiation enhancer in the 125 kVp and 10 MV photon radiation fields.
When DER was scaled to the mass of the NP, the simulations showed that the plate geometry
(with a higher surface area to volume ratio) has increased efficiency of enhancement per unit
of NP mass. The total DERw in the 125 kVp field was calculated to be (5.34 ± 0.02)×108 /g
compared to around 2.5 × 108 /g in the case of the cube or sphere shape. This effect is due
to the variable surface area to volume ratio from different NP morphologies. An increased
surface area to volume ratio increases the likelihood of electrons created within the bulk of
the NP to be able to escape to the surface of the particle.
Section 3.2 in Chapter 3 presented results demonstrating the importance of careful mod-
elling of NP distribution on the cellular level by comparison of dose enhancement in cell
nuclei with NP distributed in shells compared to the more traditional method of modelling
NP in a homogeneous solution. It is observed that the dose enhancement increased sharply
with increasing shell thickness before reaching a plateau at 5 µm aggregate shell thickness.
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This is due to the increasing influence of secondary electrons being reabsorbed within the
NP shell and not contributing to dose deposition in the cell nucleus.
A high level of dose enhancement is observed in cell nuclei in close proximity to NP shells,
compared to dose enhancement with an equivalent local homogeneous solution of NP in
water. For example, the total DER in the cell array due to a 3 µm shell on the central cell
nucleus was calculated to be (2.96 ± 0.01) compared to (2.18 ± 0.01) in the case of an
equivalent homogeneous solution in the volume. This effect is local and shows a saturation
in dose enhancement to cell nuclei with increasing shell thickness, resulting from increasing
local concentration of NPs applied.
The studies reported in Chapter 3 show there is a large difference in the local effect when NP
material is distributed in shells compared to solution and this work has been published in a
peer-reviewed journal article (refer Appendix B). This detailed modelling can help to explain
non-linear sensitisation enhancement observed in cell studies by showing a saturation of the
physical dose enhancement for shells greater than a described thickness.
5.3 Proton Radiation Therapy
The dose enhancement in proton therapy due to NPs was investigated with nanoscale simu-
lations of the track structure around high-Z NPs. The radial dose distributions with respect to
NP type, NP size, and proton beam energy were calculated and compared on the nanometre
scale using event-by-event Monte Carlo tracking code Geant4-DNA in Chapter 4.
Results showed that the dose is deposited predominantly very close to the primary proton
track and enhancement effects are therefore highest here in the region close to the NP. More
than 95% of dose was observed to be deposited within the first 300 nm of the NP surface.
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The radial distribution of deposited dose drops off sharply beyond the NP surface. The dose
is enhanced compared to water in the first 10 nm bin outside the NP by 45% for the Au, 32%
for the Bi2O3, 29% for the Ta2O5 and 26% for the CeO2 NPs. The results presented showed
that for dose enhancement to be most effective in the goal of increasing the damage to the
DNA, NPs must be located within the cell, in close proximity to cell nucleus, or within the
cell nucleus.
By comparing the dose enhancement in three proton beam energies the simulation study
did not demonstrate any dose enhancement advantage of placing NPs in the Bragg Peak
region, compared to the higher proton energy. Therefore targeting tumour cells with radio-
enhancing NPs is an important factor to increase impact on tumour control without causing
additional damage to health tissues.
The gold NP demonstrates the highest dose enhancement due to the effect of proton stopping
power in the NP material. The simulations showed a total dose enhancement of (28 ± 2)%
from the Au NP, (17.9 ± 0.2)% from the Bi2O3 NP, (16.6 ± 0.6)% from the Ta2O5 NP,
and (15 ± 1)% from the CeO2 NP. Atomic deexcitation was shown in Chapter 4 to account
for less than 1% of the dose enhancement in the calculation volume. This is increased to
5% within the first 30 nm of the NP surface due to the short range of the low energy atomic
deexcitation electrons.
Results demonstrated the importance of the beam configuration and NP geometry in the
design of a nanoscale simulation. The study presented in this thesis focused on the develop-
ment of the Monte Carlo simulation to model directly incident protons on ceramic oxide and
gold NPs. In reality the direct hit of a NP with a primary proton is unlikely to occur and so
the modelling of secondary electrons incident on the NP to contribute to radiosensitisation
would be an interesting area to investigate further.
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The effect of the decay of plasmon excitations on the secondary electron yield originating
from a carbon NP, due to an incident proton beam typical of the Bragg peak position in pro-
ton therapy was compared to Geant4 Monte Carlo simulation in Chapter 4. This work was
performed in collaboration the MBN Research Center in Frankfurt, Germany and the Monte
Carlo simulation study was developed as part of this PhD project. The results demonstrated
an increase in the calculated secondary electron yield from a carbon NP, compared to liquid
water however significant very low energy electron production in a carbon-NP is not cur-
rently modelled in Geant4. The results of this collaborative work showed the potential for
proton therapy to be enhanced by carbon NPs as well as the potential importance of low en-
ergy electron contributions from NPs which are not currently modelled in the Geant4 Monte
Carlo code.
5.4 Future Work
Several Monte Carlo simulation studies in this PhD project have demonstrated the physical
dose enhancement mechanism of ceramic oxide NPs in different radiation therapy modali-
ties.
The ongoing adaptation of the Monte Carlo simulations developed during this PhD project
has allowed the investigation of dose enhancement by NPs in a wider range of specialised
radiation therapy techniques, for example the case of Microbeam Radiation Therapy [42].
The careful modelling of NP distributions within cell populations and within tumour tissue
has been shown to be significant and important for the calculation of physical dose enhance-
ment on the level of the cell and DNA. This work is ongoing.
Future work in this project will require the extension of the Monte Carlo simulations to also
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describe chemical products and their diffusion on the nanoscale [92, 115]. The diffusion
of radiolytic products will be important when NPs are internalised by cells and/or cell nu-
cleus. These processes have been shown experimentally [66] to play a significant role in the
enhancement of DNA damage and cell killing in radiation therapy. The latest releases of
Geant4 include the low energy extension - Geant4-DNA, which now also has the capability
to model the physico-chemistry of nanoscale processes and the incorporation of these mod-
els into the simulation developed in this thesis is an important next step to further develop
this work.
In addition to the modelling of these chemical products of radiation interactions, the ra-
diobiological behaviour of cancer cells with the application of ceramic oxide NPs, and the
connection between dose delivered, dose enhancement, and cell survival curves will be an
important avenue of further research.
Hadronic interactions should also be included in the simulation physics models to evaluate
the effect of these interactions and improve the modelling of enhancement of dose by NPs.
The continual evolution of the Geant4 simulation toolkit will mean there will be increasingly
detailed and accurate physics models becoming available for applications in nanoparticle en-
hanced radiation therapy. As improvements and extensions are released the work presented
in this thesis can be further refined in some cases to include superior modelling of the low
energy interactions in high-Z materials such as gold, and ceramic oxides, as well as the
extension to include chemical products of water radiolysis processes.
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a b s t r a c t
This study provides the first proof of the novel application of bismuth oxide as a radiosensitiser. It was
shown that on the highly radioresistant 9L gliosarcoma cell line, bismuth oxide nanoparticles sensitise
to both kilovoltage (kVp) or megavoltage (MV) X-rays radiation. 9L cells were exposed to a concentration
of 50 lg.mL1 of nanoparticle before irradiation at 125 kVp and 10 MV. Sensitisation enhancement ratios
of 1.48 and 1.25 for 125 kVp and 10 MV were obtained in vitro, respectively. The radiation enhancement
of the nanoparticles is postulated to be a combination of the high Z nature of the bismuth (Z = 83), and the
surface chemistry. Monte Carlo simulations were performed to elucidate the physical interactions
between the incident radiation and the nanoparticle. The results of this work show that Bi2O3 nanopar-
ticles increase the radiosensitivity of 9L gliosarcoma tumour cells for both kVp and MV energies. Monte
Carlo simulations demonstrate the advantage of a platelet morphology.
 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
1. Introduction
External X-ray Radiation Therapy is a common treatment for
many cancers, which has been used extensively for many years.
Despite the improvement of this cancer modality [1,2], there are
still unwanted side effects which need to be addressed [3].
One possible solution to improve the efficacy of X-ray radio-
therapy exists in the use of metal nanoparticles (NPs) as individual
radiosensitising agents. Investigations into gold NPs [4–7] and
Platinum [8,9] NPs were performed to quantify the biocompatibil-
ity of the proposed nanomaterials. The metallic NPs were shown to
be radioenhancing under kilovolt (kVp) and megavolt (MV) radia-
tion fields, however, they presented two problems. First, there was
no guarantee that these nanomaterials would be biocompatible on
the nanoscale. Studies into pure metal NPs showed that the size
and morphology of the nanoparticle often resulted in varying
degrees of toxicity [10,11]. Metal NPs with diameters below 5 nm
can freely diffuse into the nucleus and interact directly to DNA,
resulting in necrosis [9,10]. Second, the metals used for radiosensi-
tisation require a high atomic number (high Z), and are also heavy
metals. It was shown that these NPs induced toxicity as the treat-
ment concentrations increased.
To solve these two issues, high Z nanoceramics, such as the
promising tantalum pentoxide Ta2O5 [12], have started to be inves-
tigated. The Ta2O5 nanoparticle aggregates demonstrated the
required radiosensitisation provided by the heavy Ta metal, and
also the necessary biocompatibility thanks to the oxide form.
Bismuth is a better candidate for high Z radiosensitiser research
since it is one of the heaviest naturally occurring elements of the
periodic table [13]. Bismuth oxide and other bismuth-based com-
pounds are also known to be biocompatible [14]. They have been
extensively used in many medical and cosmetic applications for
many years [15]. In addition, Stewart et al. [16] showed that bis-
muth oxide nanoparticles could be tailored with different oxygen
contents, inducing cell proliferation or toxicity. Another paper by
Bogusz et al. [17] highlighted that a theranostic system based on
bismuth oxide nanoparticles would be highly effective in the treat-
ment of cancer.
This research is aimed to investigate the novel application of
high Z bismuth oxide nanoparticles as radiosensitisers for cancer
therapy. The bismuth oxide nanoparticles were synthesised and
irradiated with clinical 125 kVp and 10 MV X-ray beams. The cell
http://dx.doi.org/10.1016/j.ejmp.2016.10.015
1120-1797/ 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
⇑ Corresponding author at: Centre of Medical Radiation Physics (CMRP), Univer-
sity of Wollongong, Northfields Avenue, Wollongong, NSW 2522, Australia.
E-mail address: moeava@uow.edu.au (M. Tehei).
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clonogenic and internalisation assays were then performed. Monte
Carlo simulations performed complemented the experimental
work providing insight into the physical mechanisms behind dose
enhancement and the effect of the particle morphology on these
physical mechanisms.
2. Methods and materials
2.1. Experimental
2.1.1. Synthesis
The bismuth based compounds were fabricated at the Institute
of Superconducting and Electronic Materials (ISEM). The biocom-
patible Bi2O3 nanoparticles were synthesised via the precipitation
route [16,18]. Bismuth Nitrate (99.9%, Sigma-Aldrich, Australia)
was dissolved in 70% Nitric acid (50–70% Merck, Australia), and
then 30% Ammonium Hydroxide (Sigma Aldrich, Australia) was
added in small increments until a white precipitate appeared. This
was extracted using a centrifuge and washed with deionised (DI)
water. The precipitate was transferred to a beaker of DI water
and stirred continuously for 5.5 h at 100 C. The precursor was
extracted and washed as before then annealed under argon for
4 h in a tube furnace at 530 C.
2.1.2. X-ray diffraction (XRD)
The Bi2O3 was examined using an Enhanced Mini-Materials
Analyser (EMMA) X-ray Diffractometer at 40 kV and 25 mA. The
X-ray diffractometer scanned between 20 and 80 at a step rate
of 2.00min1 and step size of 0.02. The mean crystalline size
was determined using the Scherrer equation, while the material
phase was extracted from the ICDD database using the Traces soft-
ware [19,20].
2.1.3. Surface area
The surface area of the nanoparticles was examined using the
methylene blue test due to negative effects induced by the drying
process of Brunauer Emmet Teller (BET) gas adsorption surface
area method. Bismuth oxide (100 mg) was dispersed in 50 mL
deionised (DI) water and 12 mg of Methylene Blue (MB) added.
After stirring and leaving overnight, a sample was taken from the
stock and diluted accordingly for UV–vis analysis. The absorption
at 665 nm of the MB solution was measured using a Shimatzu
3600 NIR UV–vis Spectrophotometer (Shimadzu, Kyoto, Japan).
After examination, 4 mg of MB was added to the stock with 5 mL
of DI. This was repeated for three days until the ideal concentration
was determined. The concentrations were converted to weight
ratios of the adsorbed MB: Bi2O3 and the added MB: Bi2O3. The
ratio values were plotted against each other to produce the Lang-
muir curve and the ion replacement concentration point was used




:AV  AMB  1ms ð1Þ
where mMB is the weight of MB added, 319.87 g.mol1 is the MB
molecular weight, AV is Avogadro’s number (6.023*1023 mol1),
AMB is the accepted surface area of a single adsorbed MB molecule
(130 Å2) [21] and ms is the weight of the Bismuth oxide.
2.1.4. Cell internalisation
Cell internalisation was performed at the Illawarra Health and
Medical Research Institute (IHMRI). A LSRII (BD, Franklin Lakes,
NJ, USA) Fluorescence Activated Cell Sorting (FACS) flow cytometer
was used in order to determine the degree of internalisation of the
nanomaterials into the cultured 9L cells. This was done as part of
an oxidative stress assay [16]. The cells were brought to 90% con-
fluence in T12.5 cm2 flasks (Falcon, Corning). Twenty-four hours
before the procedure, 2  104 cells were transferred to 5 mL flow
cytometer tubes and freshly prepared NP solution was added to
the designated NP sample tubes, filling to 0.5 mL total volume at
50 lg.mL1. After 24 h the tubes were agitated to dislodge the cells
and were analysed with a flow rate of 60 mL.min1 until 10 000
events were recorded. The degree of internalisation of the nanoma-
terials was determined with FACSDiva software, assessing both
forward and side scatter intensities [17,22].
2.1.5. Media preparation
The 9L gliosarcoma cells were maintained in a T75cm2 flask
with completed Dulbecco’s Modified Eagle Medium (c-DMEM)
(DMEM from GIBCO, supplemented with 10% Fetal Bovine Serum
(FBS) and 1% Penicillin and Streptomycin) and incubated at 37 C
with 5% (v/v) CO2 [12].
2.1.6. Determination of Bi2O3 k-edge and optimum kVp radiation
To optimise the dose enhancement effects of the bismuth oxide
the correct filter and beam energy needed to be calculated. This
optimal energy was the closest to the maximum photon mass
absorption energy for the bismuth oxide compared to water, max-
imising the secondary photoelectric particle production. Using the
Xmudatv1.0.1 program the photo attenuation coefficients for
water and bismuth oxide were generated based on total mass
energy absorption. The ratio between the two curves was graphed
as a function of energy [12].
2.1.7. Irradiation with kVp and MV beams
All irradiation experiments were carried out at the radiation
oncology department of the Prince of Wales Hospital (Randwick,
NSW, Australia). Beam energies of 125 kVp and 10 MV were gener-
ated by a Nucletron Oldelft Therapax DXT 300 Series 3 Orthovolt-
age unit (Nucletron B.V., Veenendaal, The Netherlands) and an
Elekta AxesseTM LINAC (Elekta AB, Kungstensgatan, Stockholm,
Sweden), respectively.
Cell culturing and clonogenic assays were performed at IHMRI.
The 9L cell culture was brought to 90% confluence a day prior to
irradiation. 50 lg.mL1 of Bismuth oxide NPs was prepared via
sonication with a double step Branson 250 Digital sonifier at 70%
amplitude for 3  10 min runs. The suspension was added to the
cell culture medium of the treated samples for 24 h while the
untreated controls were not. For kVp experiments, 9L cells were
irradiated in T12.5 cm2 flasks (BD FalconTM) with 6 mm of medium.
For MV experiments, T12.5 cm2 flasks were completely filled with
Hank’s Balanced Salt Solution (HBSS). No air bubbles were present
inside the flask to ensure that electronic equilibrium was obtained
at cell monolayer depth. All doses (1, 2, 3, 5, & 8 Gy) were delivered
in single fractions at room temperature. Tissue culture flasks were
laid horizontally and surrounded sides and back by a 30x30x10
cm3 solid water phantom to ensure backscattering effects were
taken into account. The flasks were then irradiated with the source
perpendicular (z-axis) to the flasks. Irradiated flasks of the same
dosage were irradiated together to reduce individual dose varia-
tion. Non-irradiated control samples, with and without bismuth
oxide NPs, were handled under the same conditions as the irradi-
ated samples [12]. The experiments were performed in triplicate
with multiple repetitions.
2.1.8. Clonogenic cell survival assay
Clonogenic assay was used as the radiobiological endpoint to
assess the effects of 50 lg.mL1 concentration of bismuth oxide
NPs on cell survival, compared to control (no NPs). After irradia-
tion, cells were sub-cultured at low density into 100 mm diameter
Petri dishes (Sigma) with 10 mL c-DMEM and incubated for 15
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doubling times. Following this, each dish was washed with 5 mL
PBS (with calcium and magnesium ions) and fixed and stained with
5 mL of a (25% crystal violet, 75% ethanol) solution. Colonies con-
sisting of no less than 50 cells were counted (n) and compared with
initial seeding values (I) to obtain the plating efficiency (PE)
[12,16], expressed as:
PE ¼ n=I ð2Þ
For each group, the surviving fraction (SF) is determined as the
ratio of the PE of the irradiated sample (PEx) by PE of the non-
irradiated control (PEc):
SF ¼ PEx=PEc ð3Þ
2.1.9. Cell survival analysis
Survival curves were fit according to the linear quadratic model
(LQM) using the associated error bars of each point as weighting
factors. The LQM describes cell surviving fraction (SF) mathemati-
cally as a function of absorbed dose (D). The fit parameters, a
(Gy1) and b (Gy2), are indicative of cell radiosensitivity and
repair effectiveness, respectively [7]. They are derived from the
LQM Eq. (4):
SF ðDÞ ¼ expðaD bD2Þ ð4Þ
We quantified the degree of dose enhancement introduced by
the NPs by means of the Sensitisation Enhancement Ratio (SER),
defined as the ratio of doses giving 10% cell surviving fraction.
SER represents a radioenhancement based on the radiobiological
endpoint from the LQM curves, and is dependent upon the deliv-
ered dose [5].
2.2. Monte Carlo simulation
Simulations were performed using Geant4 (version 9.6 patch 2),
a Monte Carlo code modelling particle transport through matter
[23], at the Centre for Medical and Radiation Physics (CMRP). The
simulation set-up was modelled to retain the essential characteris-
tics of the experimental configuration necessary to investigate the
physical mechanisms behind the results of the cell experiments
and to investigate the effect of the shape of the NP aggregate on
the energy deposition enhancement.
The geometry consisted of a cell population modelled as an
array of spherical water cell volumes with 10 lm diameter (shown
in Fig. 1), placed in a water phantom at a depth of 6 mm and
25 mm for kVp and MV beams, respectively, to obtain electronic
equilibrium. The dimensions of the phantom reflect the sizes of
the real phantom used in the experiments. Geant4 Low Energy
electromagnetic physics was used with Penelope models to
describe the interactions of particles down to 100 eV in the cell
population. Atomic deexcitation processes (including both fluores-
cence and Auger electron emission) were activated in the
simulation.
The NP aggregate was modelled as a sphere of 10 lm diameter,
a cube with 10 lm sides or a plate with dimensions
10 lm  10 lm  1 lm, placed at the centre of the cell popula-
tions, as shown in Fig. 1.
The energy spectra of 125 kVp and 10 MV X-ray beams were
simulated using SpekCalc v 1.1 [24] and provided by ARPANSA
[25], respectively. A 100 lm  100 lm beam of photons was inci-
dent normally on the phantom edge, along the Z axis (see Fig. 2).
A total of 6  106 and 3.5  106 primary photons were incident
on the phantom in order to achieve sufficient statistical results in
the kVp and MV beam simulations, respectively.
The energy deposited in each cell was calculated with and with-
out the NP. In this study, the dose enhancement factor (DEF) was
defined as a ratio DNP/DC⁄, where DNP and DC⁄ are the doses calcu-
lated with and without the Bi2O3 NP aggregate placed in the cell
array, as shown in Fig. 1. Water substituted Bi2O3 in the simulation
configuration without the NP. The DEF represents the physical dose
enhancement due to the interactions of incident photon beam and
the NP, and is independent of delivered dose.
The DEF was calculated for the different shapes of the NP nano-
material under study. This factor depends on the mass and shape of
the NP aggregate. In order to isolate the effect of the increasing
mass of the NP aggregates, the DEF was scaled with respect to
the NP aggregate mass. The scaled DEF, referred to as DEFS, was cal-
culated as DEF/mNP where mNP is the mass of the NP aggregate
placed in the cell population. In order to evaluate the effect of
the NP aggregate shape (in terms of increasing surface area to vol-
ume ratio), the DEF and DEFS were compared.
The spectra and the Linear Energy Transfer (LET) of secondary




The bismuth oxide nanoparticles were characterised as alpha
phase [26] by the XRD spectrum. The Scherrer equation was
applied to the three peaks (1 2 0), (2 0 0), and (2 2 1) which
showed the Bi2O3 nanoparticles had a size range of range of 50–
70 nm. This can be observed in Fig. 3, denoted by the transparency
of the platelets.
Figure 1. Cross-section in y–z plane of cell population with the NP modelled as a sphere (A), cube (B) or a plate (C) with the photon beam incident on the cell layer from the
left along the Z axis. D: Cross-section in x–y plane through layer 2 of cells arrayed around 10 lm diameter sphere of Bi2O3.
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3.1.2. Surface area
The optimal MB concentration for the 100 mg of bismuth oxide
nanoparticles was determined to be 0.26 ± 0.02 mg.mL1. Using
the cation replacement point, the surface area of the NPs was deter-
mined to be 48.7 ± 4.5 cm2.g1. There is currently no literature value
for comparison. Correct sonication played a crucial role in this pro-
cess due to the tendency of the nanoparticles to aggregate.
3.1.3. Cell internalisation
The comparison of side scatter (SSC) v.s. forward scatter (FSC)
light values at 24 h showed a dramatic increase in the side scatter
of the NPs samples over the control. The SSC is proportional to the
cell granularity and can be used to examine the cellular uptake of
the nanoparticles [27]. The relative increase in scatter is 7 times
higher than the controls indicating that a large quantity of
nanoparticles had been taken into the cells, as denoted by the dra-
matic change in scatter distribution (Fig. 4).
3.1.4. kVp energy determination
The maximum differential absorption energy is around 40 keV
with the K-edge being located at 91 keV (Fig. 5). These values were
then examined against the available spectra for the kVp orthovolt-
age unit at Prince of Wales Hospital and it was determined that fil-
ter 4 would be the most suitable. Filter 4 is an additional filtration
of 0.1 mm Cu and 0.25 mm Al; in combination with an X-ray tube
potential of 125 kVp orthovoltage beam, it produces photons with
an effective energy of 46.7 keV (Fig. 2).
3.1.5. Intrinsic toxicity, survival curves, and radiosensitivity
parameters
The Bi2O3 NP used in this experiment underwent argon anneal-
ing and were found to have no cytotoxicity on 9L cells as previ-
ously described [16]. The first radiation energy examined was
125 kVp, which corresponds to the calculated optimum energy of
Bi2O3 (see Fig. 5), and is used for treatment of superficial cancers.
The extracted a and b parameters from the linear quadratic curves
were 0.075 ± 0.040 Gy1 and 0.017 ± 0.006 Gy2 for the control
sample and 0.355 ± 0.003 Gy1 and 0 Gy2 for the cells with
Bi2O3. This lead to an SER of 1.48 for the Bi2O3 NP at 125 kVp,
demonstrating that the material is a highly effective radiosensitiser
(Fig. 6).
The effect of bismuth oxide nanoparticles was also examined
with 10 MV radiation to investigate how effective it would be for
treating deeper seeded cancers, like brain cancer (Fig. 7). The
extracted a and b parameters from the linear quadratic curves
were 0.150 ± 0.030 Gy1 and 0.013 ± 0.005 Gy2 for the control
sample and 0.256 ± 0.054 Gy1 and 0.009 ± 0.007 Gy2 for the cells
with Bi2O3. The analysis of the curves produced an SER of 1.25 for
the Bi2O3 nanoparticles.
3.2. Results of the simulation study
3.2.1. Effect of NP aggregate geometry in dose enhancement
The physical dose enhancement produced by the Bi2O3 sphere,
cube, and plate placed in the cell population was calculated in
terms of DEF and DEFS as explained in the Methodology section.
Fig. 8 shows the DEF and DEFS in cells with respect to radial dis-
tance from NP centre in cell layer 3, downstream of the NP, and cell
layer 2, containing the NP, in the 125 kVp X-ray field.
Table 1 shows the total DEF and DEFS obtained when consider-
ing the three alternative Bi2O3 NP aggregate geometries. It can be
observed that the DEF obtained in the case of a cube is larger than
Figure 2. 150 kVp (A) and 10 MV (B) photon energy spectra, provided in terms of relative frequency per incident photon [26].
Figure 3. High resolution – transmission electron microscopy (HR-TEM) image of
Bi2O3 nanoparticles platelets.
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that of the sphere and plate configurations, however, when the
DEFS is considered, the plate geometry is superior in terms of dose
enhancement. This is due to the higher surface area to volume ratio
in the case of the plate (2.4  106), compared to the surface area to
volume ratios of the cube and sphere (both equal to 0.6  106).
Since the in vitro conditions assume a monolayer of cells at the
time of irradiation, the cells in the bottom layer (layer 3 in Fig. 1)
below the NP aggregate are also shown in Table 1.
3.2.2. Secondary electron spectra
The kinetic energy and LET spectra of secondary electrons
entering all the cells in the population were analysed to assess
the change in the quality of the secondary electrons due to the
presence of each NP aggregate shape. The results are shown for
the kVp and MV beam in Fig. 9 where the spectra are shown per
incident photon on the water phantom. It can be observed that
the secondary electron spectra and LET are not significantly
enhanced by the Bi2O3 NP in the 10 MV photon field. This is in con-
trast to the kilovoltage case where there is a clear enhancement of
the secondary electron production. In particular, the greatest
increase in number of secondary electrons is observed in the case
of the cube geometry, followed by the sphere and plate.
These secondary electron spectra results agree with the DEF
reported in Table 1 for the 125 kVp and 10 MVphotonfields, respec-
tively. The enhancement of secondary electron production is depen-
dent on the geometrywith the cube geometry providing the highest
number of secondary electrons due to the absolute increase in the
mass of Bi2O3 NP material placed in the cell population.
Figure 4. Nanoceramic internalisation, Side scatter (SSC) of 9L cells without (A) and with (B) nanoceramic.
Figure 5. Ratio of mass energy absorption coefficient of Bi2O3 relative to water.
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When the DEFs is calculated, it is observed that the plate geome-
try is themost efficient enhancer. This is due to the increased chance
of secondary electrons to be absorbedwithin the NP aggregate itself
with increasing geometrical size and lower surface area to volume
ratio. The plate geometry allows more electrons to escape the sur-
face, as the thickness of the plate is only 1 lm, and the range of
which is less than the range in Bi2O3 of a 12 keV electron [28],mean-
ing most of the electrons will be able to escape the NP geometry. By
contrast, the range of a 50 keV electron in Bi2O3 is 10.6 lm which
means that electrons originate in the cube with energy lower than
this value will have a reduced probability of escaping.
4. Discussion
The MB surface area method provided two advantages over the
BET. The first was that the suspension was a closer match for the
liquid cell environment, closer simulating the actual particle size
found during testing. The second was that in suspension, the full
surface area could be measured as the nanoplatelets aggregate
when dried and lose access to the majority of their surface area.
Cell internalisation measurement showed that the nanoparti-
cles were highly internalised after 24 h (Fig. 4). However, due to
the physical parameters of the nanoparticles, the Bi2O3 NPs should
not penetrate the nucleus and interfere with the DNA resulting in
NP induced apoptosis, as is the case of nanoparticles with diame-
ters smaller than 5 nm [10].
Both Geant4 simulations and in vitro experiments were essen-
tial for this study. The simulations provided insight into the phys-
ical processes behind physical dose enhancement in the cells,
whereas in vitro measurements allowed the study of the synergy
among physical, chemical, and biological mechanisms when
enhancing radiotherapy treatment by means of nanoparticles.
The Geant4 simulations demonstrated that in the kVp X-ray
field, Bi2O3 had considerable physical dose enhancement proper-
ties, with a dependence on the NP aggregate geometrical shape,
related to Surface Area to Volume ratio (SA/V). The dose enhance-
ment was shown to be significant (DEF around 2–3 in the cell pop-
ulation studied, depending on the geometry of the nanoparticle
aggregate) in the 125 kVp photon field compared to no significant
dose enhancement calculated in the 10 MV field. This is due to the
strong increase in photoelectric effect cross-section in the kVp
energy range for high Z materials, whereas, electron pair produc-
tion dominates at 10 MVwith contributions from Compton scatter-
ing. This effect is caused by the strong Z-dependence
(approximately power 3–4) of the photoelectric effect compared
to pair production (above 1.022 MeV), which has mass attenuation
coefficient approximately proportional to Z, and Compton scatter-
ing, which is not strongly Z-dependent [29]. This means that the
higher energy photons in the 10 MV spectra are unlikely to
strongly contribute to radiation dose enhancement. The megavolt-
age simulation study found no significant enhancement for any NP
morphologies studied. The simulation results for Bi2O3 under a
kilovoltage beam are in agreement with the experimental data
published by Alqathami et al. [30].
The cell survival curves (Figs. 6 and 7) showed that the bismuth
oxide has an SER of 1.48 and 1.25 in kVp and MV beam, respec-
tively. The highest SER values for Au NPs is an enhancement of
1.41 obtained at 150 kVp on a less radioresistant cell line. The
SER reduced when the Au NPs were examined in more resistant
cells [5]. Tantalum oxide has shown an SER of 1.33 on 9L cells at
10 MV [12]. The DEF observed in the simulated cell population
was 1.87 ± 0.01 in the layer of cells below the Bi2O3 NP plate in
the 125 kVp X-ray field. This is a DEF calculated in a small number
of cells close to the NP aggregate in this simulation and cannot be
compared directly to the experimental SERs observed. However,
the High-Z dose enhancement properties of Bi2O3 NPs are an
important factor influencing increased SER and the calculated
DEF from the Monte Carlo simulation reflects this.
The effectiveness of any nanoparticle system in radiation fields
is due to a number of factors including cell line, radiation energy,
particle morphology, subcellular localisation, and concentration.
The 9L gliosarcoma cells used in this study are known to be more
radio-resistant and more hypoxic than most of other cancerous
cells. Oxygen levels in cells have been shown to alter the effective-
ness of radiation therapy, as oxygen is responsible for indirect
damage through radiation induced radicals [31]. Therefore, obser-
vations on 9L cells should be amplified on less radio-resistant and
hypoxic cells.
The surface chemistry of the nanoparticles also has an impor-
tant effect on the effectiveness of the radiosensitiser as indirect
damage is the major mechanism behind cancer apoptosis in radia-
tion therapy [32]. It has been shown that nanoparticles can
Figure 6. Survival curves of 9L untreated and treated with 50 lg/ml of Bi2O3
nanoparticles and exposed to 125 kVp X-ray radiation doses. Surviving fractions
were normalised against the non-irradiated controls, averages taken from a sample
size of 3 and errors given ±1 standard deviation from the mean.
Figure 7. Survival curves of 9L cells untreated and treated with 50 lg/ml of Bi2O3
nanoparticles and exposed to 10 MV X-ray radiation doses. Surviving fractions were
normalised against the non-irradiated controls, averages taken from a sample size
of 3 and errors given ±1 standard deviation from the mean.
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demonstrate catalytic behavior under radiation fields becoming
radiocatalysts. In the case of our NPs, it is hypothesized that the
energy of the photons excite the NPs, causing them to act as radio-
catalysts and split water molecules into HO and H radicals [33].
This produces additional ROS which increases the effectiveness of
the radiosensitiser and would not be predicted in simulations.
The morphology (SA/V) of the radiosensitising NPs also plays an
important role in their effectiveness. The Monte Carlo simulations
were designed to model the experimental set up, as stated in Sec-
tion 2.2, with the incident X-ray beam along the Z-axis. Each 10 lm
diameter cell within the array was measured and the average DEF
taken for the entire population. Comparatively, the internalisation
assay demonstrated high levels of NP internalisation 24 h after NP
exposure within the biological cell monolayer (Section 3.1.3.), with
the incident X-ray beam passing along the z-axis, perpendicular to
the cell monolayer (Section 2.1.7). The Monte Carlo simulations
demonstrated that the platelet morphology of Bi2O3 NP aggregates
leads to more effective radiation damage, especially in kVp photon
field, due to a larger SA/V ratio compared to the other morpholo-
gies as demonstrated by ourMonte Carlo simulations in Section 3.2.
Therefore, according to the local effect model the platelet morphol-
ogy leads to a more preferential dose spike distribution in the indi-
vidual cellular environments for the same weighted concentration
of NPs.
The apparent disparity between the Monte Carlo simulations
and the in vitro survival curves can be explained through a compar-
ison of the analysis techniques [34]. DEF calculations are the phys-
ical ratio of energy deposited with a NP aggregate compared to a
pure water phantom. This produces DEF values which are indepen-
dent of therapeutic dose for a given X-ray energy, i.e. 125 kVp or 10
MV. Alternatively, the SER is a radiobiological endpoint based on a
quadratic exponential equation (Eq. (4)), with the radioenhance-
ment being dependent upon the dose for a given X-ray energy, as
seen in Figs. 6 and 7, and does not scale linearly.
The Local Effect Model (LEM) for radiation enhancement assists









Figure 8. Radial DER (A & C) and DERS (B & D) in layer 3 (A & B) and layer 2 (C & D) in 125 kVp photon radiation field with Bi2O3 NP material in different geometrical
configurations (Sphere, Cube, Platelet).
Table 1
DER and DERS due to each NP aggregate configuration with 125 kVp and 10 MV incident photon fields. DER is calculated for the entire cell population and for the cells in layer 3 of
the cell population (below the NP aggregate) to represent the monolayer of cells seen in cell survival experiments.
Sphere Cube Plate
125 kVp
Total cell population DER 2.18 ± 0.01 3.27 ± 0.02 1.48 ± 0.01
DERS (gNP1) (4.67 ± 0.02)  108 (3.68 ± 0.02)  108 (16.58 ± 0.07)  108
Cells in layer 3 DER 2.09 ± 0.02 3.06 ± 0.02 1.87 ± 0.01
DERS (gNP1) (4.48 ± 0.03)  108 (3.44 ± 0.03)  108 (21.1 ± 0.2)  108
10 MV
Total cell population DER 1.005 ± 0.004 1.020 ± 0.007 1.002 ± 0.005
DERS (gNP1) (2.16 ± 0.01)  108 (1.15 ± 0.01) x108 (11.26 ± 0.05)  108
Cells in layer 3 DER 1.007 ± 0.004 1.021 ± 0.004 1.00 ± 0.01
DERS (gNP1) (2.16 ± 0.01)  108 (1.147 ± 0.005)  108 (11.29 ± 0.06)  108
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context. It states that the dose enhancement of a single particle is
effective only to a small subvolume of the total, i.e. the cytoplasm
of a cell with an internalised NP. As shown in the Monte Carlo sim-
ulations, 50 keV electron has a range of up to 10.6 lm, meaning the
subvolume affected by the NP under radiation is confined to the
inside of a cell, given the average diameter of a eukaryotic cell is
approximately 20–50 lm. Each subvolume produces a slight vari-
ation in the dose determined by the NP’s interaction with the inci-
dent radiation field (dose spike distribution) [32]. While the
amplitude and shape of the local dose spikes is different in the
kVp and MV photon fields due to the LET of the radiation fields
[35], both lead to a large SER. The physical dose enhancement is
the cumulative effect of these NP-radiation field interactions, and
produce the observed SER in combination with the previously
mentioned radiocatalytic and SA/V factors.
5. Conclusion
This work provided the first in vitro study of the radiosensitising
capacity of bismuth oxide nanoparticles on the highly radioresis-
tant 9L gliosarcoma cells. The XRD and MB analysis showed that
the nanoparticles have a platelet morphology with a thickness of
50–70 nm and a surface area of 48.7 ± 4.5 cm2.g1. The Bi2O3 NP
were irradiated with 125 kVp and 10 MV X-ray beams, producing
SERs of 1.48 and 1.25 respectively. These values are resultant from
a combination of the high Z of the bismuth, radiocatalytic activity,
and the favourable dose distribution resulting from the advanta-
geous geometrical shape of the nanoparticles on the highly
radioresistance 9L cells.
Monte Carlo simulations are a valuable tool to examine the
physical dose enhancement of NP enhanced radiotherapy and the
importance of careful simulation design to accurately model NP
geometry has been demonstrated. Simulations showed that the
platelet morphology per unit of Bi2O3 mass, is the most effective
for enhancing the dose, compared to the cubic and spherical mor-
phologies. The DEF reported by the simulation study are lower
than the biological SER found by means of the cell survival exper-
iments in both the kVp and MV radiation fields due to the non-
linear dose enhancement nature of biological systems. The means
that the physical dose enhancement induced by the High-Z of
Bi2O3 is only one of multiple factors influencing the sensitisation
and this is the only factor accounted for in the simulated DEF in
the cell population compared to the experimental SER
measurements.
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a b s t r a c t
The application of nanoparticles (NPs) in radiotherapy is an increasingly attractive technique to improve
clinical outcomes. The internalisation of NPs within the tumour cells enables an increased radiation dose
to critical cellular structures. The purpose of this study is to investigate, by means of Geant4 simulations,
the dose enhancement within a cell population irradiated with a 150 kVp photon field in the presence of a
varying concentration of tantalum pentoxide (Ta2O5) NP aggregates, experimentally observed to form
shells within tumour cells. This scenario is compared to the more traditionally simulated homogeneous
solution of NP material in water with the same weight fraction of Ta2O5, as well as to a cell population
without NPs present. The production of secondary electrons is enhanced by increased photoelectric effect
interactions within the high-Z material and this is examined in terms of their kinetic energy spectra and
linear energy transfer (LET) with various NP distributions compared to water. Our results indicate that
the shell formation scenario limits the dose enhancement at 150 kVp. The underlying mechanism for this
limit is discussed.
 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Nanoparticle (NP) enhanced radiation therapy is an increasingly
popular area of research with studies showing potential increase in
the effectiveness of radiotherapy with the application of NPs to
cancerous tumour cells [1–6]. By increasing the effectiveness of
dose delivery to the tumour, the probability of tumour control
can be increased whilst minimising the dose delivered to normal
tissue if NPs are preferentially taken up by tumour rather than nor-
mal cells. The physical dose enhancement is due to the high-Z
component of the NP leading to an increased photoelectric effect
cross-section for incident photon irradiation. Increased secondary
electron production, including enhanced Auger electron emission,
in the NP translates to more energy deposition within the cell
population.
Various properties of NPs, such as size, fabrication material and
coating [7], have been shown to have an influence on dose
enhancement and increased cell death. The energy of the incident
photon beam affects the dose enhancement, as well as the photon
interaction cross-sections depending strongly on photon energy
and Z of the target material.
Gold NPs (GNPs) are widely studied due to their relative biolog-
ical compatibility combined with high atomic number (ZAu = 79).
Passive uptake of gold NPs by tumours is also an advantage [8].
The leaky vasculature of tumours results in GNPs being preferen-
tially accumulated within cancer tissue rather than in normal tis-
sue [1]. Hainfeld et al. (2010) found 1.9 nm GNPs intravenously
administered to mice with head and neck squamous cell carcinoma
model (SCCVII) leg tumours were more effective radiosensitizers at
a lower beam energy (68 keV compared to 157 keV) with the same
dose [1]. They found increased therapeutic enhancement for higher
doses at both energies when mice had received intravenous injec-
tions of GNPs.
McMahon et al. (2011) found enhanced radiosensitation of plas-
mid DNA across a range of kV X-ray beams with the use of 11.9 and
http://dx.doi.org/10.1016/j.ejmp.2016.09.006
1120-1797/ 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
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37.5 nm diameter GNPs [9]. Dose enhancement is also reported in
the case of MV photon beams where Compton scattering and pair
production are dominant [10]. The effectiveness of 6 MV and 15
MV photon irradiations of MDA-MB-231 breast cancer cells was
shown by Jain et al. (2011) to be increased by sensitizer enhance-
ment ratios (SER) of 1.29 and 1.16, respectively [10].
The concept to use ceramic compounds containing high-Z ele-
ments in NP enhanced radiotherapy as radiosensitizers in mega-
voltage irradiation has first been reported in [2]. Results with
kilovoltage irradiation are currently under review for publication
[11]. The ceramic based compounds have different aggregation
properties compared to NPs based on noble metals. They tend to
aggregate much easier, which may limit their migration so as to
localize them better in the desired target region. Due to this, the
expected radioenhancement may differ compared to GNPs. Cera-
mic NPs also have the ability to be non-toxic, radioprotectors
and/or inducers of differential biochemical activity in malignant
and non malignant cells [2,12,13]. Brown et al. (2014) showed that
radioresistant 9L rat-brain gliosarcoma cancer cells are more suc-
cessfully treated with 10 MV photon irradiation when internalising
Ta2O5 NPs [2]. Ta2O5 has a high effective atomic number, due to the
high-Z of tantalum (ZTa = 73) and a resulting sensitization enhance-
ment ratio (SER) of 1.33 was measured for a concentration of
50 lg/mL. Toxicity results are also reported elsewhere (see Ref
[2]). The presence of a high-Z material results in an increased pro-
duction of secondary electrons and subsequently increased direct
and indirect damage to the cell. A Monte Carlo based study into
any further sensitisation enhancement with higher Ta2O5 concen-
tration was therefore considered with respect to NP distribution
between and within cells, compared to the more traditionally sim-
ulated homogeneous solution of NP material in water [14].
2. Experimental motivation of the study
Cytotoxicity experiments conducted by Brown et al. (2014)
showed that exposure of the 9L cells to a higher concentration
(up to 500 lg/mL) of Ta2O5 NPs does not significantly increase
the toxicity [2]. In particular, photon irradiations using 150 kVp
X-rays [11] have shown that irradiated 9L cells, exposed to a 10-
fold increase in Ta2O5 NP concentration, do not correspondingly
indicate a significant decrease in cell survival, as may be expected.
Confocal images of the cell population with a Ta2O5 solution
indicate that some NPs are internalised and begin to form a ‘‘shell”
around the cell nucleus. Fig. 1 shows representative confocal
microscopic images of 9L cells with Ta2O5 NPs. The Ta2O5 NPs are
observed to form ‘‘shells” in the confocal image of the 500 lg/mL
concentration (Fig. 1c), compared to the 50 lg/mL concentration
(Fig. 1b).
Confocal images show that increasing the Ta2O5 concentration
triggers the formation of shells of NP material around cell nuclei
with an increasing shell thickness, whilst leaving, on average, a
higher number of cells bare or with a limited number of NPs. This
phenomenon also translates to a lower number of cell nuclei sur-
rounded by NPs, separated, on average, by greater distances. This
means that some colonies within the cell population have a small
concentration of NPs, whereas other colonies have several neigh-
bouring cells with Ta2O5 shells, with high local concentration of
NP material, as shown in Fig. 1.
Our hypothesis is that in the cell colonies experiencing a high
local Ta2O5 concentration, the NP shell contributes to physically
protect the cell nucleus from the otherwise expected impact on cell
survival. Increasing the thickness of the Ta2O5 NPs shell will
increase the probability of photon interaction and subsequent sec-
ondary electron production. However, an increased Ta2O5 shell
thickness also increases the energy loss of any secondary electrons
traversing the shell and produces more self-absorption of low
energy Auger electrons generated within the shell. This could
translate to a saturation effect where adding more NP material
does not produce higher dose enhancement.
This work intends to investigate our hypothesis behind the
results of the cell experiments, by studying the physical effect on
the dose enhancement of varying the NP shell thickness and distri-
bution within a cell colony (called l-phantom in the following sec-
tions), characterised by a high local NP concentration. The
simulation model is based on the local NP distribution observed
in the cell population, in the confocal images shown in Fig. 1.
3. Materials and methods
3.1. Monte Carlo simulation set-up
An ad-hoc Monte Carlo simulation study was performed to
characterise the dose enhancement by means of Ta2O5 NPs in the
presence of a 150 kVp photon field. The dose enhancement was
studied varying the NP shell thickness and distribution in the cell
colony. Geant4, version 9.6 patch 2 [15,16], was the Monte Carlo
code adopted.
The simulation set-up resembled the configuration of cellular
irradiation experiments carried out to determine the clonogenic
survival curves. A 70  70  70 lm3 cell population (called here
l-phantom) was modelled corresponding to experimental obser-
vations of different NP shell distributions in cellular colonies (see
Fig. 1), which are limited portions of the entire irradiated cellular
population. Cells/cell nuclei were modelled as simple water
spheres with 8 lm diameter, and were placed in 3 layers of 5  5
such spheres giving a total of 75 cells in the l-phantom. The dis-
tance between the cell centres was 14 lm to allow for surrounding
(a) (b) (c)
Fig. 1. Confocal microscopic image of elliptical 9L gliosarcoma cells with Ta2O5 NPs; control (a), after exposure of concentration 50 lg/mL (b), and 500 lg/mL (c). In the
control image M = cell membrane, N = cell nucleus, C = cytoplasm. In 500 lg/mL image (c) NPin = Ta2O5 NPs inside cell, NPout = Ta2O5 NPs outside cells.
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the spheres with 3 lm thick NP shells without encountering geom-
etry overlaps. This cell spacing has been set as an approximation
arbitrarily as currently the average distance between shells is not
quantified experimentally. The l-phantom was set in a larger
water phantom, at a depth of 6 mm along the direction of the inci-
dent photon beam, corresponding to the depth of the cells in the
cellular irradiation experiments. The water phantom has lateral
side length of 30 cm and total length in the direction of incidence
of the beam equal to 10.6 cm. The position of the l-phantom and
the phantom sizes correspond to the real configuration used in
the cell experiments conducted by the Targeted Nano-Therapies
research group at the University of Wollongong [2,11,12].
A 100 lm  100 lm beam of X-rays was incident normally on
the phantom, irradiating the entire cell population of the l-
phantom. The chosen size of the beam, which is significantly smal-
ler with respect to the 10  10 cm2 field adopted in the experi-
ments, allows to obtain a relative comparison of the dose effect
of the different NP distributions under the same irradiation condi-
tions, whilst at the same time reducing the required simulation
execution times to approximately 800–900 h on a single 3 GHz
CPU for each shell configuration. The use of small incident beam
sizes is common in Monte Carlo simulation studies to investigate
nanoparticle enhanced radiotherapy [17–19]. Leung et al. (2011)
and Li et al. (2014) employ a photon source of nanometre dimen-
sions set at a distance of 1 mm from a GNP in Monte Carlo simula-
tion studies [17,19]. Furthermore, the study by Chow et al. (2012)
uses a 100 nm diameter photon source incident on a GNP in a
water phantom of variable size [18].
The 150 kVp spectrum (Fig. 2) was simulated using SpekCalc v
1.1 and corresponds to the beam generated by a Nucletron Oldelft
Therapax DXT 300 Series 3 Orthovoltage unit (Nucletron B.V., Vee-
nendaal, The Netherlands) peak energy of 150 kV, Tungsten anode,
inherent filtration of 3 mm Beryllium, additional filtration of
1.5 mm Aluminium and 0.35 mm Copper; 1st half value layer of
0.67 mm Cu [20]. Multiple NP configurations were studied with
the simulation of 2  1010 primary photon histories in each case,
to achieve an adequate statistical uncertainty.
The Geant4 Low Energy electromagnetic physics package [21]
with Penelope physics models was selected to describe particle
interactions. This choice was dictated by the capability of Penelope
models to track secondary electrons down to 100 eV, which is the
low energy limit recommended in Sempau et al. (2003) [22], cou-
pled with shorter simulation execution times with respect to the
Fig. 2. 150 kVp photon energy spectrummodelled in the simulation study, in terms
of relative frequency per primary photon [20].
(b)(a)
(e)(d)(c)
Fig. 3. Simulation geometry: cross section of the l-phantom where three layers of 5  5 cell array with photon beam incident along z-axis from the left (a); view of cells of
layer 2 with 2 lm thick NP shells (red) coating 1 (b), 4 (c), 8 (d) and 9 (e) cells. (For interpretation of the references to colour in this figure legend, the reader is referred to the
web version of this article.)
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Geant4 Very Low Energy Extensions (Geant4-DNA) [23]. Although
event-by-event Monte Carlo codes, such as Geant4-DNA, are the
state of the art to study the effect of radiation at cellular and
sub-cellular level, Stewart et al. (2002) showed that Penelope phy-
sics models can be used to estimate physical quantities of interest
at cellular level with an agreement between 1 and 25% with event-
by-event Monte Carlo codes when calculating the mean specific
energy [24]. Atomic deexcitation, including Auger electron emis-
sion and fluorescence, were modelled in the simulation.
The total dose deposited in each of the cells of the l-phantom
was calculated with different NP shell configurations as described
in Section 3.2. By calculating the dose in micron scale cell volumes
the simulation by design avoids a potential for inaccuracies in dose
distribution introduced by sub-micron voxelized scoring volumes
on the nanoscale, which were described in [25].
The kinetic energy spectra and LET of the secondary electrons,
produced by the kVp beam in the l-phantom and in the NP shells,
entering the cells have been calculated to evaluate the change in
radiation quality responsible for the cell damage. The LET was cal-
culated on the basis of the electron energy, using data from refer-
ence [26]. The effect of atomic deexcitation was examined as well.
The dose enhancement ratio (DER) was evaluated as DNP/DWater,
where DNP and DWater are the doses calculated in the cells, with and
without Ta2O5 NPs distributed in the l-phantom, respectively. The
dose enhancement was examined with respect to increasing the
NP concentration in the l-phantom, compared to the dose without
the NP present.
3.2. Nanoparticle distributions under study
The NP material, Ta2O5, was defined in the Geant4 simulation
with a density of 8.2 g/cm3. Two different types of NP distribution
geometry were modelled: (1) shells of NP material placed around
the water spheres, modelling cell/cell nuclei (shell distribution)
and (2) a homogeneous distribution (homogeneous distribution) of
NP material in water around the spheres. Configurations (1) and
(2) have the same total concentration of NP material.
The geometry with the shell distribution is shown in Fig. 3 pre-
senting the side view (Fig. 3a) and beams-eye-view (Fig. 3b–e) of
the l-phantom. Several configurations of shells were investigated
in this study, from one single shell (Fig. 3b) to a maximum of 9
shells placed around the 9 central spheres of layer 2 (Fig. 3e). 4
and 8 shells were considered as well (Fig. 3c and d, respectively).
In Fig. 3 all of the shells have a thickness of 2 lm. These shell dis-
tributions were selected to model the behaviour observed in cellu-
lar irradiation experiments, where some cells were observed to
have no NP uptake, some section had only few isolated cells with
shells, whereas other sections had many cells with shells close
together in the colony.
The DER in the central sphere of layer 2 in the l-phantom was
investigated for different shell distribution in order to study the
effect of a NP shell touching the cell, the effect of nearby shells
and the combination of these effects.
3.3. Simulation studies
A first study was conducted to investigate the influence of the
NP shell thickness on the dose enhancement. Simulation configura-
tion depicted in Fig. 3b was adopted. The NP shell around the water
sphere was increased between 1 and 7 lm. The DER was calculated
in the central cell and compared for increasing shell thickness. This
study was performed to determine the thickness of the NP shell
where a ‘‘saturation effect” can start to be observed. The average
range of secondary electrons originated by a 150 kVp beam in
Table 1
Calculated concentration of Ta2O5 NP in the l-phantom with respect to shell
thickness and configuration.






1 6.5 16.2 29.7
4 26.0 64.7 118.7
8 51.9 129.4 237.4
9 58.4 145.5 267.1
Fig. 4. DER in central cell of l-phantom with increasing shell thickness of 1–7 lm
(expressed as local NP concentration) of Ta2O5 NP shell around the central cell itself,
per incident photon.
(b)(a)
Fig. 5. Secondary electron kinetic energy spectra (a) and LET (b) entering central cell with increasing shell thickness of Ta2O5 NP shell around central cell per incident photon.
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Ta2O5 is less than 5 lm [26], therefore electrons which deposit
energy in the cell are those produced in a spherical layer of the
NP with thickness equal to or less than their range in Ta2O5. This
means that the dose enhancement capability of thicker NP shells
is impeded by internal absorption of electrons, which translated
to a saturation effect on the DER when increasing the NP shell
thickness.
A second study was performed to compare the DER calculated
with a distribution of NP shells in the l-phantom (shown in
Fig. 3), as observed experimentally (shown in Fig. 1), and, alterna-
tively, with a homogeneous distribution of NP material in water,
with the same simulated concentration. This study allows the com-
parison of the DER due to NP distribution on the micron scale and
the tendency of the NPs in the cell culture to congregate in shells
around the cells, compared to being uniformly distributed among
cells. The shell thickness was set equal to 1 lm, 2 lm or 3 lm in
each cell configuration investigated, to obtain higher concentra-
tions of NPs in the cell population. Such shell thicknesses were
selected on the basis of the microscope observations as the one
depicted in Fig. 1.
Table 1 reports the calculated equivalent local concentration of
Ta2O5 in water for each simulated number of shells and shell thick-
(c)(b)(a)
Fig. 6. Dose enhancement ratio in each cell volume in layer 2 (see Fig. 3(b–e)) with Ta2O5 shell of 1 lm (a), 2 lm (b), and 3 lm (c) thickness of a single shell (top row), 4
(second row), 8 (third) or 9 shells (bottom).
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nesses. The local NP concentrations calculated within the l-
phantom are high due to the localisation of material in a small vol-
ume of water.
4. Results and discussion
4.1. Effect of shell thickness on dose enhancement in a single cell
Dose enhancement due to a Ta2O5 NP shell placed on the central
cell in the l-phantom, as shown in Fig. 3b, is represented against
the NP shell thickness in Fig. 4.
From the simulation results, the calculated DER increases
quickly and then the increase slows down for larger shell thick-
ness. The initial increase in the DER is due to the increasing quan-
tity of high-Z Ta2O5 NP material in close proximity to the cell.
However, the rate of increase of DER is reducing with thicker NP
shells because of self-absorption of secondary electrons originated
in the NP ceramic at a distance from cell surface larger than their
range.
At the same time the thickness of the NP shell does not affect
the global photon fluence reaching the ‘‘active shell” close to the
cells, from which the originated electrons will reach the cell
nucleus. Further increasing the shell thickness will eventually lead
to decreasing DER due to photon attenuation.
The kinetic energy spectra and corresponding LET of electrons
entering the central cell are shown in Fig. 5. The number of sec-
ondary electrons per incident photon increases with the shell
thickness (t) up to a t of approximately 5 lm. For shell thicknesses
greater than 5 lm the number of secondary electrons does not
increase significantly.
The DER increases by 3 per mg/mL increase in NP concentration
when varying the NP shell thickness from 1 lm to 2 lm. This
increase is only 0.1 per mg/mL increase in NP concentration when
the NP shell thickness varies from 5 lm to 6 lm, which is an
insignificant enhancement when the error margins are taken into
account. This means that the effectiveness of the NP to enhance
dose in cells is reduced with increasing concentration of NP, even-
tually resulting in no further enhancement at all, and finally
decreasing DER.
Fig. 5 shows the energy spectra of secondary electrons for an NP
shell thickness varying between 1 lm and 7 lm. The mean kinetic
energy of the secondary electrons is (31 ± 1) keV. Therefore, the
average electron would have a range of less than 19 lm in water
and about 4.5 lm in Ta2O5 [26]. This means that for shell thick-
nesses greater than this range in Ta2O5 the enhancement is
expected to be reduced due to electron absorption by the NP shell.
4.2. Effect of spatial distribution of shells on the dose enhancement
Fig. 6 shows the DER in the four alternative spatial distributions
of NP shells represented in Fig. 3(b–e). It can be observed that – for
the NP shell thicknesses under study – the DER increases with
increasing thickness of Ta2O5 NPs and with the number of shells.
Most dose enhancement occurs within the cells about which shells
are placed, significant enhancement is still seen in neighbouring
cells, with the greatest dose effect in those closest to the NP shells
(e.g. DER in the central cell in the case of NP shells surrounding 8
cells). This means that NP shells have significant dose effect within
approximately 20 lm. However, a DER above 1 is observed at lar-
ger distances because of electrons with kinetic energy greater than
average. For example, in the case of the NP shell surrounding the
central cell only, the average DER in the furthest cells (at a distance
of 39.6 lm from the central cell) is (1.14 ± 0.02) for 3 lm shell
thickness. This compares to an average DER of (3.47 ± 0.02) in
the eight cells surrounding the central cell.
4.3. Secondary electron kinetic energy spectra and LET
Fig. 7a shows the kinetic energy spectra and LET of secondary
electrons entering into the central cell of layer 2 in the l-
phantom, varying the Ta2O5 shell thickness in the case of the 9
shell NP distribution (Fig. 3e), with respect to the case of no NP
material in the l-phantom. The 9, 8, and 1 NP shell distributions
are compared in Fig. 7b in order to see the effect of a local shell,
the effect of nearby shells and the combination of these.
The mean kinetic energy of secondary electrons created within
the Ta2O5 NP shells is around 1.5 keV. Electrons with kinetic energy
less than 10 keV have a range of less than 1 lm in Ta2O5, as shown
in Table 2, reporting the range of electrons with varying kinetic
energy in water, solid Ta2O5 NP, and homogeneous Ta2O5 solution
[26]. This results in a large proportion of the low energy electrons
being absorbed by the Ta2O5 shell and not contributing to the DER
in the nearby cells. The mean kinetic energy of secondary electrons
escaping the NP shell was found to be around 33 keV, increasing
slightly with larger shell thickness. This happens because only
higher energy electrons can escape the NP shell with increasing
shell thickness, whilst the only low energy electrons originating
from the NP and contributing to the dose in the cell are produced
in proximity to the inner surface of the shell.
(b)(a)
Fig. 7. LET of electrons entering the central cell in the l-phantomwith Ta2O5 NPs distributed in 9 shells, compared to configuration without NPs (Water) (a). The 9, 8 and 1 NP
shell configurations are compared for the 3 lm thick shell case (b).
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4.4. Comparison of NP distributed in shells to homogeneous solution
Fig. 8 reports the DER calculated in the different NP shell config-
urations under study, for different local concentrations (corre-
sponding to different NP shell thicknesses), and with a
corresponding homogeneous distribution of NP material in water,
integrated over the cells in the entire l-phantom. The NP shell con-
figuration and the homogeneous solution have the same total con-
centration of NP material. It can be observed that the DER depends
significantly on the geometrical model of the NP distribution in
water and indicates a saturation effect which has been described
in Section 4.1.
The DER increases with increasing concentration of Ta2O5 in
both NP shell and solution configurations. In the case of the homo-
geneous solution the DER increases linearly with increasing mass
of Ta2O5 in water. Instead, in the case of a NP shell distribution,
the DER increases and then saturates with an increase in mass of
Ta2O5 shell as explained in Section 4.1. In the case of a homoge-
neous NP solution, generated secondary electrons do not have to
traverse a NP shell in order to deposit dose within the cell and
are therefore attenuated only by the homogeneous NP solution
which translates to a linear effect on the DER with respect to NP
material concentration.
Fig. 9 reports the energy spectra of secondary electrons entering
in the central cell of the l-phantom in the case of NP shells sur-
rounding 9 cells (Fig. 3e) and in the corresponding NP homoge-
neous solution in water, with the same concentration.
It is observed that more electrons enter the central cell with the
Ta2O5 NPs in shell configuration compared to an equivalent solu-
tion of NP. This happens because the NP shell of Ta2O5 material
surrounding the cell provides a source of low energy electrons
close to the cell, in contrast to a homogeneous NP solution in water
producing a uniform source of electrons throughout the water
medium surrounding the cells. This also explains why the total
DER in Fig. 8 is higher in the NP shell case compared to homoge-
neous solution.
4.5. Effect of atomic deexcitation
The influence of atomic deexcitation on the DER was investi-
gated by performing simulations with and without atomic deexci-
tation activated. The kinetic energy of atomic deexcitation
electrons is constrained by the low energy production threshold
of 100 eV recommended in these simulations [22]. The difference
between the DER calculated with and without the deexcitation is
summarised in Table 3 and shows that the atomic deexcitation
processes accounted for between approximately 3% and 7% of the
DER at the cellular level. The DER due to atomic deexcitation is pre-
Table 2







Range in 267.1 mg/mL Ta2O5
solution (lm)
10 2.51 0.74 2.33
20 8.57 2.25 7.84
30 17.56 4.40 16.0
40 29.19 7.09 26.5
50 43.20 10.29 39.1
150 281.7 62.0 252.6
Fig. 8. Total DER in the l-phantom per incident photon due to a homogeneous
solution of Ta2O5 in water (filled symbols) compared to the average dose due to the
same ceramic compound arranged as NP shells (unfilled symbols) of various
thickness (corresponding to different local concentration) and geometrical
distribution.
(b)(a)
Fig. 9. Energy spectra (a) and LET (b) of electrons entering the central cell in the l-phantom with NPs distributed in shells (hollow symbols) or in solution (filled symbols)
around the cells compared to water.
Table 3
Percentage of DER within the central cell attributed to atomic deexcitation, for each
NP shell configuration and thickness under study.
Shell distribution 1 lm thickness 2 lm thickness 3 lm thickness
1 (7.23 ± 0.03)% (5.55 ± 0.03)% (4.98 ± 0.01)%
8 (4.56 ± 0.04)% (4.00 ± 0.04)% (2.73 ± 0.01)%
9 (7.03 ± 0.04)% (5.38 ± 0.02)% (4.75 ± 0.01)%
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dominantly observed in the cell surrounded by the NP shell and for
thinner NP shells. This is explained by the fact that Auger electrons
are very low energy and therefore have a short range and can be
easily self-absorbed in thicker NP shells. Auger electrons con-
tribute to the DER in the cell surrounded by the NP shell as
expected. This means that if in an experimental situation a partic-
ular cell does not have a NP shell, it will receive a significantly
lower DER from low energy atomic deexcitation electrons than
neighbouring cells with internalised NP shells.
The spectra of atomic deexcitation electrons per incident pho-
ton entering the central cell is shown in Fig. 10a for the 9 shell con-
figuration. This spectrum is calculated by subtracting the spectra
calculated from the simulation without atomic deexcitation from
that with atomic deexcitation. Electrons falling within error of zero
are disregarded. The effect of atomic deexcitation on the LET of sec-
ondary electrons entering the central cell is shown in Fig. 10b.
It can be seen from Fig. 10a that atomic deexcitation has the
most effect on the energy spectra below 10 keV, with peaks around
6 keV and below 1 keV. The mean kinetic energy of secondary elec-
trons is slightly decreased (approximately 1 keV lower) by the
inclusion of atomic deexcitation in the simulation. Fig. 10b shows
that atomic deexcitation increases the number of high LET elec-
trons as expected, and has the most effect on the LET of secondary
electrons in the case of a 1 lm thick NP shell.
5. Conclusions
This work was motivated by the experimental observation that
Ta2O5 NPs tend to congregate as shells with different thicknesses in
colonies of cancer cells. Based on this observation, different scenar-
ios of cells/cell nuclei coated with NP shells were investigated in
cellular colonies of limited size, in terms of local DER obtained
under a 150 kVp irradiation, by means of Monte Carlo simulations.
The local DER becomes saturated with an increasing concentra-
tion of NPs and shell thickness for each considered scenario of shell
pattern in the l-phantom. The local DER reaches saturation when
the NP shell thickness is larger than 5 lm. The local DER in individ-
ual cells in the l-phantom is significantly increased when the
Ta2O5 NPs are simulated in realistic shells configurations rather
than in a homogeneous solution distribution between all cells with
the same concentration of NPs.
Zygmanski et al. (2013) showed by means of Monte Carlo sim-
ulations that increasing gold NP clustering in X-ray radiotherapy
translates to a nonlinear dose enhancement [27]. Our work differ-
entiates from Ref [27] in the type of nanoparticle aggregate consid-
ered and in the shape of the aggregate, dictated by our
experimental observations as shown in Section 2. Although the
simulation geometry in Ref [27] is vastly different from that pre-
sented in the present work, the saturation result with increasing
concentration and shell thickness observed in our cell population
study is in agreement with the trend observed for the case of clus-
tered gold NPs in solution. Our study further examines and com-
pares the effect of a completely homogeneous distribution of NP
materials as well as the magnitude of the effect of atomic deexci-
tation on the DER.
Recent advances included in the evolving physics models of
Geant4 allow for the simulation of complete Auger cascades in ver-
sion 10.2Beta, on top of the Auger electron emissions currently
simulated in the version used in the present study [28]. As a pos-
sible future extension of this study it would be interesting to inves-
tigate the effect of full Auger electron cascades in proximity of the
NP by using the most recent beta version of Geant4.
Upon considering the experimentally observed scenario of NP
internalisation for concentrations in the range of 50–500 lg/mL,
we concluded that only a very small partial volume of the total cell
culture had a high local concentration of NPs. We modelled the
experimentally observed scenario via a l-phantomwith effectively
a non-uniform uptake distribution in our radiation transport sim-
ulations. The results of the simulations show that a non-uniform
NP uptake leads to a huge local DER, but does not significantly
change the DER averaged over the entire cell population. The
non-uniform uptake model of NPs could therefore possibly explain
the lack of increase in the DER with increasing concentration
observed in cell study currently under review for publication
[11]. In this case we could conclude that the enhancement of sec-
ondary electrons by Ta2O5 NP shells has the most effect on cells in
close proximity to the shells with a saturation effect shown for
high concentrations. The small changes in survival vs dose are
obviously due to the entire cell culture and are therefore related
to the average DER as well as the local saturation effect.
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Appendix C
The following article [117] is derived from work presented in Chapter 4 of this thesis. My
role in this project was the design and development of the Monte Carlo simulation study
which forms the basis of this paper. All Monte Carlo simulations in this paper were per-
formed by me, under the supervision of my principle supervisor, Dr Susanna Guatelli.
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a b s t r a c t
Nanoparticles (NPs) have been shown to enhance X-ray radiotherapy and proton therapy of cancer. The
effectiveness of radiation damage is enhanced in the presence of high atomic number (high-Z) NPs due to
increased production of low energy, higher linear energy transfer (LET) secondary electrons when NPs are
selectively internalized by tumour cells. This work quantifies the local dose enhancement produced by
the high-Z ceramic oxide NPs Ta2O5 and CeO2, in the target tumour, for the first time in proton therapy,
by means of Geant4 simulations. The dose enhancement produced by the ceramic oxides is compared
against gold NPs. The energy deposition on a nanoscale around a single nanoparticle of 100 nm diameter
is investigated using the Geant4-DNA extension to model particle interactions in the water medium.
Enhancement of energy deposition in nano-sized shells of water, local to the NP boundary, ranging
between 14% and 27% was observed for proton energies of 5 MeV and 50 MeV, depending on the NP
material. Enhancement of electron production and energy deposition can be correlated to the direct
DNA damage mechanism if the NP is in close proximity to the nucleus.
 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Proton therapy is a highly conformal radiation therapy tech-
nique, widely used for the treatment of eye, prostate, lung and
brain tumours. With respect to conventional photon or electron
beam therapy, proton therapy has the advantage of higher treat-
ment conformity due to the proton Bragg peak as well as higher
radiobiological effectiveness (on average 1.1 as accepted currently
in clinical practice) [1,2].
Damage to tumour cells from therapeutic irradiation occurs
through direct and indirect mechanisms [3]. Direct damage occurs
when secondary electrons hit DNA within the cell nucleus whereas
indirect damage includes damage to DNA and other cell structures
deriving from free radical production, including change of chemical
properties within the cell. In proton therapy an increase in the
number of already high-LET particles in the Spread Out Bragg Peak
region will theoretically improve tumour control outcomes.
Nikjoo et al. [3] showed computationally the factors which con-
tribute to the biological effectiveness of electrons, protons and
alpha particles. This study shows that for a 4 MeV proton, 61% of
DSBs are caused by direct damage, i.e. due to low energy
d-electrons, while 39% are due to indirect damage deriving from
free radicals.
Nanoparticles (NPs) are materials or structures produced with
sizes ranging from 1 nm to 100 nm [4]. NPs are currently studied
as contrast agents, radiation protectors or sensitizers, and for drug
delivery. Nanomaterials under investigation include gold, plat-
inum, gadolinium and ceramic nanostructured particles [4–8].
The widespread investigation of gold (Au) NPs in radiation therapy
enhancement is due to the relative biocompatibility at low concen-
trations and the high atomic number (ZAu = 79). Extensive studies
have presented the dose enhancement in X-ray radiation therapy
http://dx.doi.org/10.1016/j.ejmp.2016.11.112
1120-1797/ 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
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by the application of high-Z NPs, including investigations of the
influence of particle size, methods to encourage uptake by cells,
cell specific response, energy of incident radiation and dose [9–14].
Kilovoltage photon interaction with high-Z gold NPs results in
enhanced photoelectron emission [15]. Increased emission of low
energy secondary electrons causes a localized dose enhancement
(within a short distance of the NP surface, due to the relative short
range of the low energy enhancement electrons) and increased
water radiolysis. If NPs are selectively accumulated within a
tumour through internalization within tumour cells, the localized
secondary electrons can target damage to the tumour cells.
High-Z NPs are expected to have the highest dose enhancement
under kilovoltage X-ray irradiation compared to higher energies,
due to the higher mass energy absorption coefficient relative to
water in this range. However, dose enhancement has also been
observed in megavoltage studies [7,16].
In proton therapy an increase in low energy electron production
is the result of physical proton or secondary electron interaction
with a high density NP, and these enhancement electrons will
induce further direct and indirect damage to cells. Experimental
studies show enhancement of proton and heavy ion therapy by
the means of NPs. Polf et al. [17] studied the enhancement of the
relative biological effectiveness (RBE) in prostate tumour cells
exposed to a 160 MeV proton beam (cells placed within the Spread
Out Bragg Peak region) with and without internalized gold NPs of
(44 ± 8) nm diameter compared to 60Co irradiated control cells.
These researchers found a potential 15–20% increase of the RBE
of proton therapy due to the presence of gold NPs during
treatment.
Porcel et al. [18] have shown enhanced damage to DNA in the
presence of platinum NPs irradiated by fast helium ions, carbon
ions or gamma rays. The number of SSB or DSB in plasmid DNA
with and without platinum NPs was compared for different Linear
Energy Transfer (LET) incident particles. They found that SSBs
decreased with increasing LET of incident radiation, while DSBs
increased, indicating more complex damage to DNA from higher
LET particles with more dense secondary electron track structure.
The action of water radicals was investigated by Porcel et al. [18]
by including a radical scavenger to effectively eliminate DNA dam-
age resulting from indirect action of radicals in the water. The
study showed that more than 90% of damage enhancement after
both gamma (60Co, LET = 0.2 keV/lm) and C6+ (LET = 13 keV/lm)
beam irradiations could be attributed to the action of free radicals.
Liu et al. [19] reported the effect of increasing concentration of Au
NP on the enhancement effect of hydroxyl radical production
under X-ray or carbon ion irradiation. Porcel et al. [20] have also
demonstrated the ability of gadolinium-based NPs to enhance
the cell killing in helium and carbon heavy-ion therapy.
Kim et al. [21,22] investigated the enhancement of a 40 MeV
therapeutic proton beam treating CT26 tumours in mice with the
application of gold and iron NPs with diameter of (14 ± 1.2) nm
and (10.6 ± 0.8) nm, respectively. NPs were administered intra-
venously and an increase in complete tumour regression ranging
between 37% and 62% was observed when the Bragg Peak was
located in the tumour. The production of free radicals within
tumour cells was found to be enhanced with the application of gold
or iron NPs.
In the context of dose enhancement, gold NPs have been
reported to be effective, however these NPs have also shown signif-
icant toxicity at concentration as low as 100 lg/mL [23]. High-Z
ceramic oxides now offer a prospective alternative to gold as dose
enhancers [7]. These high-Z nanoceramics used for dose enhance-
ment are known to be biocompatible materials and could be selec-
tively tailored to protect normal cells while being toxic for tumour
cells [24]. Furthermore, the oxide of these ceramics provides a link-
age for the NPs to be functionalized and made to target tumour
cells [25]. Ceramics have been also used in radiation imaging appli-
cations [26,27], emphasizing the research opportunities they pre-
sent as theranostic materials.
Tantalum pentoxide (Ta2O5) is a ceramic compound which,
when engineered as a nanostructured particle, has been shown
to be an effective radiosensitizer for radiation resistant rat brain
9L cancer cells exposed to 10 MV photon irradiation [7]. The
high-Z of tantalum (ZTa = 73) causes Ta2O5 to behave as a high-Z
NP while it is also biocompatible. Brown et al. [7] found a sensiti-
sation enhancement ratio (SER) of 1.33 with 50–70 nm Ta2O5 NPs
in case of 10 MV X-ray irradiation.
Cerium oxide (CeO2) NPs have been investigated for use as a
radioprotector in cells under photon irradiation [28,29]. The appli-
cation of a radioprotector allows for sufficient damage to tumour
cells to be achieved while normal cells are less susceptible to the
damage due to protective particles working to the advantage of
normal cells. At the same time CeO2 NPs are effectively high-Z
NPs (ZCe = 58) and therefore will enhance secondary electron pro-
duction in proportion to Zn where n is 4–5 depending on photon
energy [6]. The protective nature of these particles is deduced from
their applicability as antioxidants, which outweighs the negative
effect of increased production of secondary electrons due to their
high Z.
Monte Carlo simulations are a useful tool to understand the
physics mechanism of dose enhancement produced by NPs in
radiotherapy and to characterise important associated physics
quantities such as the energy deposition and the energy spectrum
of the electrons emitted by the NP, to provide an insight both in the
direct and indirect damage of radiation [11–13,25,26].
The dose enhancement produced by NPs in proton therapy has
recently been studied by means of simulation studies [30–32].
Wälzlein et al. [30] studied the dose enhancement by various
metallic NPs by means of a customised Monte Carlo simulation.
Lin et al. [31] used a Geant4 based software tool, TOPAS, to simu-
late and compare the dose enhancement from a gold NP with inci-
dent proton or photon beams. Lin et al. [32] showed sensitizer
enhancement ratios (SERs) are lower in proton therapy with gold
NPs compared to kV and MV photon irradiation due to the lower
probability of interaction with the NPs. This study also showed
the effect of NP size on SER, with smaller NPs having a larger effect
when the same weight of NPs is used.
Martínez-Rovira and Prezado [33] recently published a study
examining nanoscale dose enhancement of gold and gadolinium
NPs in proton therapy. This study reported a small dose enhance-
ment local to NPs studied with a dependence on simulation
geometry.
The goal of this work is to quantify for the first time the dose
enhancement produced by novel ceramic oxide NPs such as
Ta2O5 and CeO2 in proton therapy. The dose enhancement pro-
duced by ceramic NPs is compared to gold NPs which have previ-
ously been shown by several studies to be dose enhancing in
proton therapy [17,21–22,25–28].
2. Method
Simulations were performed using Geant4, version 10.1 [34,35].
Geant4 was adopted because it is the only open source and freely
available general purpose code which allows to perform studies
from dosimetry to micro- and nano-dosimetry. The simulation
consisted of monoenergetic proton beams with energy of 5 and
50 MeV, alternatively. The proton energy range was selected to
model a proton radiation field typical of the Spread Out Bragg Peak
(SOBP) region of a prostate cancer treatment. As protons lose
energy continuously with greater depth in water, the lower energy
(5 MeV) protons in this study are representative of the protons
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typically occurring in the distal part of the SOBP while the 50 MeV
protons demonstrate the effect of NP closer to the surface of the
patient, but still within the tumour target. Protons were originated
on one side of a 200 lm sized water phantom and directed towards
the centre of the NP as a pencil beam (null lateral size) or as a
broad beam of 100 nm diameter.
The NP is modelled with a sphere of 100 nm diameter, set in the
centre of the water phantom. The material of the NP was alterna-
tively gold (Au), tantalum oxide (Ta2O5), cerium oxide (CeO2) and
liquid water.
Table 1 summarises the physics models and processes selected
for each particle, in the NP and in the surrounding water medium.
The Geant4-DNA very low energy extensions [36,37], which are
available for liquid water only, were adopted to model in detail
event-by-event particle interactions down to approximately
10 eV for electrons and 100 eV for protons/hydrogen, in the water
phantom.
The Low Energy Electromagnetic Physics Package, based on the
Penelope model and adopting a condensed-history random-walk
scheme approach, was selected to describe photon and electron
interactions in the NP. The Geant4 Urban model was selected to
describe the multiple scattering of protons, electrons and ions in
the NP. The threshold of production of secondary electrons in the
NP was set to 100 eV, corresponding to the recommended low
energy limit of the Penelope-based physics models [38]. Photons
have the same physics models throughout the experimental
set-up (in the NP and in the surrounding liquid water medium).
Atomic de-excitation (fluorescence and Auger electrons) was mod-
elled in the whole experimental set-up, allowing atomic
de-excitation electron production below the 100 eV threshold.
Fig. 1a shows the track (represented in blue) of a 50 MeV proton
in the NP and in the surrounding liquid water medium. The track
structure of secondary electrons, shown in red, is more detailed
in the liquid water due to the physics models adopted in this med-
ium, the Geant4-DNA extension, describing particle interactions
event by event. Physics models based on condensed history
approach used within the NP region result in tracking steps as mul-
tiple interactions are simulated in a single step.
The proton track structure was studied in terms of radial energy
deposition in slices around the proton tracks, calculated in cylin-
drical shells (see Fig. 1b, slices 1–4). The slices are 100 nm wide
along the direction of the incident proton beam and the NP is
located in slice 2, shown in Fig. 1b. The energy deposition was then
scaled by the mass of the water of the corresponding cylindrical
shell to obtain the dose. In all the presented results, the dose
enhancement is expressed as the ratio of dose calculated with
and without NP.
The spectra of secondary electrons produced inside the NP and
escaping from it were also examined for assessment of the LET of
the secondary electrons.
Between 1  105 and 5  105 events were simulated for each NP
material, depending on the incident proton energy. The uncertain-
ties are smaller in the case of lower energy protons due to the
increased number of interactions in NP occurring with higher LET
protons, thus producing higher statistics.
The calculated uncertainties of the results deriving from this
work are statistical only and the uncertainties of the underlying
physics models should also be taken into account for a complete
discussion of the results. At this stage it is not possible to quantify
the uncertainties affecting the physics cross sections adopted in
this work given the lack of nanodosimetric experimental measure-
ments in liquid water, however, Incerti et al. [36] compared the
cross sections of the Geant4 extension against existing experimen-
tal data in water vapour providing an appreciation of the plausibil-
ity of the implemented physics models. The simulation is
modelling an ideal case of protons directly incident on the NP,
where in reality direct interaction of protons with NP imbedded
in a tumour will have a lower probability.
3. Results
3.1. Effect of gold NPs on the radial dose distribution
The radial dose distribution was calculated in slices 1, 2 and 3
shown in Fig. 1b and scaled to the number of incident protons in
the broad beam. The radial dose distribution in 100 nm wide bins
within these slices is shown in Fig. 2 in case of Au NPs. The ratio of
dose calculated with and without the Au NP is reported as well
(shown in red in Fig. 2).
The relatively short range of secondary electrons produced from
the incident 5 MeV proton beam and enhanced by the presence of
NPs results in most energy being deposited in proximity to the NP.
The majority (more than 99%) of the energy is deposited within the
first 300 nm from the beam centre in the water slices
(Fig. 2a and c). More than 95% of energy is deposited from the NP
edge out to 300 nm in slice 2, containing the NP. The dose drops
approximately 97%, from (9.35 ± 0.07) Gy to (0.31 ± 0.01) Gy,
between the edge of the Au NP and 300 nm distance, in slice 2.
Although the dose drops off sharply in the first few hundred
nanometres, the relative difference between the dose distribution
with the Au NP compared to water (shown in red by the ratio of
the dose plots) remains significant even at distances up to 1 lm
from the central axis, although as can be seen from the increase
in the error bars the number of events depositing energy at this
distance is low. Therefore the radial dose distribution produced
by the NP is examined up to 300 nm distance in the following sec-
tions as this is the region of most interest in the study of dose
enhancement of primary proton tracks.
3.1.1. Effect of proton energy
Radial dose distribution in 10 nm wide bins in slice 2, contain-
ing the NP as shown in Fig. 1b, for 5 MeV and 50 MeV incident
broad proton beams, are shown in Fig. 3 as well as the calculated
dose enhancement ratio. Radial dose local to a gold NP was
enhanced for each proton beam energy under study, as shown in
Fig. 3 insets. The absolute value of the dose deposited is much
higher in the case of the lower energy proton beam due to the
higher LET of these protons. The distribution of delta-electrons
produced will be inversely dependent on the energy of the incident
particle [39]. The approximately 10-fold increase in energy
deposited when the proton energy is decreased by a factor of 10
Table 1
Physics processes describing the interactions of the particles in the NP and in the
surrounding liquid water medium in the Geant4 simulation. The models are indicated
when required in parenthesis.
Particle NP (Condensed-history
random-walk scheme)

















Photon Rayleigh scattering (Penelope), Photoelectric effect (Penelope),
Compton scattering (Penelope), gamma conversion (Penelope)
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(from 50 MeV to 5 MeV) is evidence in the simulation of this
expected behaviour.
In the case of the 5 MeV proton beam, Fig. 3 shows the dose
enhancement ratio increases from the NP edge to a maximum
value of (1.87 ± 0.06) at 30 nm from the NP edge (in slice 2) and
remains above 1.5 for several hundred nanometres. The 50 MeV
proton beam shows a similar behaviour, reaching a maximum ratio
of (2.1 ± 0.4) at 30 nm from the NP edge.
The radial dose distribution with respect to depth of slice is
shown in Fig. 4. The figures compare energy deposition between
slices 1–4 with a gold NP in slice 2. The figure shows higher radial
energy deposition in the slice containing the NP (slice 2) compared
to the slices upstream or downstream of the NP. This happens
because the low energy electrons produced in the NP deposit
energy locally to the NP. A similar behaviour is observed in both
the 5 MeV and 50 MeV proton beams, demonstrating highest
Fig. 1. Simulation geometrical set-up. An example 50 MeV proton (blue) and secondary electron tracks (red) through a 100 nm diameter gold NP and surrounding water
medium (a). The radial energy deposited is calculated around the proton beam direction, in 100 nm thick cylindrical slices (b). (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
Fig. 2. Dose enhancement in 100 nm bins in slice 1 (A), slice 2 (B), and slice 3 (C) with a 5 MeV proton beam incident on a Au NP (open circles) and in water (solid circles), per
incident proton. The ratio of the dose calculated with and without the Au NP is shown on the Y axis in red on the right of the plots. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3. Dose enhancement in slice 2 (see Fig. 1b) with a 5 MeV and 50 MeV proton broad beam incident on a Au NP (open circles) and a water sphere (solid circles), per
incident proton.
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energy deposition in slice 2, followed by slice 3 (downstream of the
NP) and then slice 1 (upstream of the NP).
3.1.2. Effect of beam geometry
The effect of changing the beam geometry from broad beam,
incident uniformly on the NP, to a pencil beam directed towards
the centre of the NP is shown in Fig. 5. It can be observed that the
broad beam configuration is characterised by a higher dose
enhancement in slice 2. This happens due to the short range of most
of the secondary electrons produced by protons in the NP. Low
energy secondary electrons escape the NP if generated by proton
tracks close to the surface of the NP. In the case of the pencil beam
only higher energy secondary electrons are likely to escape the NP
and their partial contribution to the radial dose is much less.
3.1.3. Study of different NP materials
A comparison of the radial dose distribution for different NP
materials is shown in Fig. 6. The radial dose is shown in each of
the four slices (see Fig. 1b) around the NPs. The ratio of dose calcu-
lated with and without the NP is represented as well.
The radial dose is enhanced laterally to the NP as well as
upstream and downstream of the NP for each of the materials
investigated. Radial dose enhancement is most pronounced in
the slice containing the NP for Au, CeO2 and Ta2O5 NPs. Significant
enhancement is obtained up to 100 nm behind the NP for the Au,
Ta2O5 and CeO2 NPs. Dose enhancement upstream of each NP (slice
1) is due to enhanced backscattering of low energy electrons from
high Z NPs.
The Au NP offers the greatest dose enhancement of the materi-
als studied. This is due to the higher density of gold (19.3 g/cm3)
compared to Ta2O5 (8.2 g/cm3) or CeO2 (7.2 g/cm3). The cross sec-
tion of production of secondary electrons is dependent on the den-
sity of the medium and inversely dependent on the square of the
velocity of the incident particle [39].
Table 2 shows the dose enhancement in water due to presence
of the NPs under study, integrating the radial dose over slices 1, 2
and 3 of the water phantom, shown in Fig. 1b, up to a radius of
1 lm, in the simulation geometry (equating to a sensitive volume
of 0.3 lm3). The dose enhancement is calculated omitting bins
within 50 nm radius in slice 2, as they contain the NP (reducing
Fig. 4. Comparison of radial dose distribution in water in slice 1 (green squares), slice 2 (red solid circles), slice 3 (blue triangles) and slice 4 (open circles) (as shown in Fig. 1b)
per incident proton with a broad 5 MeV and 50 MeV proton beam incident on a gold NP. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Fig. 5. Ratio of radial dose in water per incident proton with and without the gold NP, for a 5 MeV proton beam incident as a pencil beam (triangles) or a broad beam (black
circles). (A): slice 1; (B): slice 2; (C): slice 3 (see Fig. 1b).
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the sensitive volume by a small amount). Similar results were
obtained with a 50 MeV proton beam.
The average dose enhancement, for both of the proton energies
considered, is (26.4 ± 0.4)% for Au NP, (16.15 ± 0.04)% for Ta2O5 NP,
and (14.5 ± 0.2)% CeO2 NP. Atomic deexcitation accounted for less
than 1% of the dose enhancement from gold in this volume and
particular size of NPs, as low energy electrons deposit energy very
close to the NP surface and therefore the resulting enhancement is
not significant when all energy deposited is averaged over the vol-
ume of the cylindrical slice.
3.2. Study of secondary electron spectra
Secondary electrons were created in the NP above an energy
threshold of 100 eV, when originated by electron ionisation. When
originated by proton ionisation, the threshold of production of sec-
ondary electrons is fixed by default in Geant4 v10.1 to the mean
excitation energy of the materials (for example 790 eV for gold).
Any secondary electrons with energy below this threshold are
not created and their energy is treated in the simulation as being
locally deposited energy at the point of interaction of the proton.
Atomic deexcitation electrons originated with energy below
100 eV cut are transported in the high-Z NP regardless of the sim-
ulation cuts by using the UI command /process/em/deexcita-
tionIgnoreCut true to effectively ignore the cut and transport
Fig. 6. Radial dose distribution deriving from a 5 MeV proton broad beam incident without NP (solid circles), Au NP (open circles), CeO2 NP (crosses) and Ta2O5 NP (triangles)
per incident proton. Comparison of radial dose in slice 1 (A), slice 2 (B), slice 3 (C) and slice 4 (D) (see Fig. 1b). The insert shows radial dependence of the ratio of dose in water
calculated with and without NP.
Table 2
Dose enhancement expressed as a percentage of Dwith NPDwaterDwater , where Dwith NP and Dwater
are doses calculated with and without the NP, integrated over the water cylinder
represented in Fig. 1b. The statistical uncertainty is below 1%.
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electrons down to 0 eV in the special case of atomic deexcitation
processes. Although the recommended low energy limit of physical
validity of the Penelope physics models is 100 eV to describe elec-
tron, positron and photon interactions, our adopted strategy was to
transport Auger electrons with energy below this recommended
threshold to obtain a first indication of their effect on the energy
deposition in the proximity of the NP. This choice was dictated
by the current lack in Geant4 of detailed event by event physics
models addressed to energies below 100 eV in the NP materials
under study.
The number of secondary electrons produced within the NP and
escaping from it was calculated. Fig. 7 shows the secondary elec-
tron spectra emitted from the three different NPs, compared to
water.
The number of secondary electrons increases with the place-
ment of a Au, Ta2O5 or CeO2 NP, compared to water, as expected.
Fig. 7 shows that low energy electrons dominate the spectrum;
approximately 50%, 60% and 70% of the escaping secondary elec-
trons having kinetic energy of less than 1 keV with a proton beam
incident on a Au, Ta2O5 and CeO2 NP, respectively. These values are
averaged over the proton energies studied and compare to approx-
imately 90% of secondary electrons with kinetic energy of less than
1 keV escaping from the equivalent volume of water. It should be
noted that the accuracy of these results is limited by the fact that
a part of the difference in the low energy spectra with and without
NP occurs due to the internal cut in the proton ionisation model
implemented in Geant4, as is evident in the spectra below 1 keV
(at the mean excitation energy of each NP material) in Fig. 7. The
results may be refined in the future provided there will be a more
accurate proton ionisation model at low energies.
Due to the majority of electrons having kinetic energy below
1 keV, secondary electrons escaping the NP predominantly deposit
energy locally. The Au NP is characterised by the highest number of
secondary electrons emitted, compared to Ta2O5 and CeO2, how-
ever the lower densities of Ta2O5 and CeO2 with respect to Au
allows a greater proportion of secondary electrons created within
the NPs to escape. The range of a 10 keV electron (approximate
maximum energy of secondary electrons generated by a 5 MeV
incident proton) in water is 2.5 lm whereas in gold it is only
around 410 nm [40]. Most secondary electrons have much lower
energy than this and would therefore have even shorter range in
gold, leading to an increased number of these electrons being
absorbed by the NP when the beam is incident on the centre of
the particle. A simulation of the range in water with Geant4-DNA
cross-sections of 1 keV electrons from an isotropic source shows
that all energy is deposited within a (150 ± 12) nm radius sphere
around the source. This means that most energy from secondaries
emitted from the NP is deposited within a short range of the NP
surface.
(31 ± 2)% of electrons created within the gold NP escape the NP
compared to (58 ± 1)% and (57.8 ± 0.5)% escaping Ta2O5 and CeO2
NPs, respectively. This proportion becomes (92.2 ± 0.1)% when
the NP is substituted with a water sphere of the same dimensions,
due to the longer range of low energy electrons in water compared
to in the NPs under study. The average number of electrons pro-
duced and subsequently leaving the NP as a ratio of the number
of electrons leaving a water sphere, across both of the proton ener-
gies under investigation, was (2.6 ± 0.5), (1.5 ± 0.1), and (1.8 ± 0.1)
with a Au, Ta2O5, or CeO2 NP, respectively.
3.3. Effect of atomic deexcitation
The inclusion of atomic deexcitation in the physics processes
has only a minor effect on dose enhancement in this study. Fig. 8
shows the effect on secondary electron spectra and subsequent
radial dose distribution in slices surrounding a Au NP, with a
5 MeV incident proton beam. Atomic deexcitation electrons are
originated with discrete energy spectrum up to approximately
8 keV, however more than 70% fall below 1 keV and approximately
50% have kinetic energy below 200 eV.
The Auger electrons form a small part of the total number of
electrons emitted from the NPs, thus not contributing significantly
to the energy deposited in the water around the NP. The total dose
enhancement within the previously described 1 lm radius, 300 nm
long water cylinder (slices 1–3 in Fig. 1b) increases from
(25.3 ± 0.3)% to (26.0 ± 0.3)% in the case of a Au NP with 5 MeV
incident protons. The effect is small because of the low number
of Auger electrons produced compared to ionisation electrons,
and the short range of their effect.
A simulation of the range in water with Geant4-DNA
cross-sections of 100 eV electrons from an isotropic source shows
that all energy is deposited within 30 nm radius sphere. This
Fig. 7. Spectra of the secondary electrons leaving the NP with a 5 and 50 MeV incident proton broad beam (left and right panels, respectively), in comparison with electron
spectra generated by the same initial kinetic energy protons in water (open circles). The NPs are Au, Ta2O5 and CeO2.
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means that most energy from low energy atomic deexcitation elec-
trons is deposited close to the NP surface, within 30 nm. In this
simulation study the dose enhancement in the first 30 nm beyond
the Au NP surface is approximately 5% when atomic deexcitation is
modelled.
4. Discussion
This study shows that the number of interactions an incident
proton or secondary electron encounters is increased compared
to water for all NP materials. The dose enhancement in the region
around a high-Z NP is due to an increased number of secondary
electrons transporting energy to the surrounding water volume.
This increase in secondary electrons is due to the increased num-
ber of ionizations in the NP. In the case of an incident proton beam,
the majority of Auger electrons have a kinetic energy below 1 keV,
in agreement with Wälzlein et al. [30], and contribute a small frac-
tion to the total number of secondary electrons, as the major part is
originated by proton and electron ionisation. Increase in energy
deposition by Auger electrons within 30 nm of the NP surface
was found to be approximately 5%. The greatest effect from atomic
deexcitation is shown to be in the first few tens of nm of the radial
dose distribution and this agrees with the results of Wälzlein et al.
[30], reporting high dose enhancement within the first 5 nm from
the surface of the NP however the small total effect on dose
enhancement observed in this study is in agreement with the
results reported by Martínez-Rovira and Prezado [41].
The secondary electron production due to the presence of the
NPs, increases by factors of (2.6 ± 0.5), (1.5 ± 0.1), and (1.8 ± 0.1)
for Au, Ta2O5, or CeO2 NPs respectively. As the secondary electron
spectra show, proton interactions produce a large number of
higher LET electrons with energy lower than 1 keV.
Fig. 8. Radial dose distribution in slice 1 (A), slice 2 (B), and slice 3 (C) and secondary electron spectra leaving the NP (D) with (circles) and without atomic deexcitation
(crosses, no AD) for 5 MeV protons incident on Au NP, compared to water (black circles).
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The benefit of proton therapy is due to the proton’s densely ion-
ising track, especially at low energy, in the Bragg peak region. The
large number of low energy electrons can result in complex dam-
age to DNA. An increase in the production of low energy secondary
electrons due to the placement of a NP close to the nucleus, and
thus to radiosensitive DNA, or close to other sensitive cell struc-
tures enhances the already high radiobiological effectiveness of
low energy protons at the distal part of the Spread Out Bragg Peak.
The average local dose enhancement within a cylinder (300 nm
long, 1 lm radius) was observed to be (26.4 ± 0.4)% for Au NP,
(16.15 ± 0.04)% for Ta2O5 NP, and (14.5 ± 0.2)% CeO2 NP. The local
dose enhancement around the CeO2 NP indicates this material
has dose enhancement effects that are in counteraction to the free
radical scavenging properties discussed in the literature.
The short range of the low energy electrons emitted from the
NP would necessitate the NP being relatively close (within lm
scale) to critical structures within the cell to induce direct DNA
damage. For this reason, coupled with sub lm dimensions of fab-
ricated NPs, nanodosimetric track structure simulations are an
important investigation tool to understand the physical effects of
NP dose enhancement in radiotherapy, however event by event
particle tracking is currently not implemented in Geant4 in solid
state materials, excluding silicon. Given the limitations of the phy-
sics models adopted when describing particle interactions in the
NPs (based on a condensed-history, random-walk scheme
approach), the results of this project are intended to provide a basic
physics mechanism understanding of the dose enhancement pro-
duced by NPs and a first comparison of ceramic NP materials with
respect to gold. The results shown in this study should be refined in
the future with inclusion of more sophisticated physics models for
a more detailed description of particle tracks in NP materials as
well as a more detailed study of variable NP shape and size as well
as simulation geometry and beam configuration. The plasmon
interactions [42] in the NPs should also be modelled in the simula-
tion to study their possible effect on the dose enhancement.
A limitation of this work is that the Geant4 proton ionisation
does not produce secondary electrons with kinetic energy below
the mean ionisation and excitation energy I of the NP material.
The addition of new proton models simulating secondary electrons
with energy below I may affect the dose enhancement observed in
the vicinity of NP.
The dose enhancement ratio demonstrated in the present study
shows a maximum value of approximately 2 for 5 MeV protons lat-
eral to the Au NP (slice 2 of Fig. 1b). This result is comparable with
the results of the study by Wälzlein et al. [30] although there are
differences in the geometrical set-up and in the physics modelling
of the simulations. The study reported by Martínez-Rovira and Pre-
zado [33] showed a smaller dose enhancement than in previous
studies and the study presented in this paper. This is attributable
to the differences in simulation geometry and beam configuration.
5. Conclusion
This work shows that the fundamental concept of NP enhance-
ment in proton therapy is evident on a nanoscale in the ideal case
of protons incident directly on the NP. Therefore biological effec-
tiveness of proton therapy may be increased due to this localized
increase in secondary electron density, provided an adequate con-
centration of NPs in the tumour. The present study has shown the
applicability of novel ceramic oxide NPs to the local dose enhance-
ment in proton therapy, by the comparison with the known gold
local dose enhancer. The dose enhancement occurs in the presence
of Au, Ta2O5 or CeO2 NPs with incident proton broad beams.
Further work in this project includes the modelling of the pro-
duction and transport of free radicals [43]. Hadronic interactions
should also be modelled in the next stage of the study to evaluate
the effect of these interactions in the NP dose enhancement.
Recent advances in the latest release of Geant4 (version
10.2Beta) allows for the simulation of complete Auger cascades,
on top of the Auger electron emissions currently simulated in the
version used in the present study [44] and the inclusion of these
cascades would be an interesting addition to the simulation in
the future.
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Abstract. The production of secondary electrons generated by carbon nanoparticles and pure water
medium irradiated by fast protons is studied by means of model approaches and Monte Carlo simula-
tions. It is demonstrated that due to a prominent collective response to an external field, the nanoparticles
embedded in the medium enhance the yield of low-energy electrons. The maximal enhancement is observed
for electrons in the energy range where plasmons, which are excited in the nanoparticles, play the domi-
nant role. Electron yield from a solid carbon nanoparticle composed of fullerite, a crystalline form of C60
fullerene, is demonstrated to be several times higher than that from liquid water. Decay of plasmon exci-
tations in carbon-based nanosystems thus represents a mechanism of increase of the low-energy electron
yield, similar to the case of sensitizing metal nanoparticles. This observation gives a hint for investigation
of novel types of sensitizers to be composed of metallic and organic parts.
